Natural sequence variation as a tool to dissect gene expression regulation in Drosophila melanogaster by Forneris, Mattia
  
 
 
 
 
Dissertation 
 
 
submitted to the 
Combined Faculties for the Natural Sciences and for Mathematics 
of the Ruperto-Carola University of Heidelberg, Germany 
for the degree of 
Doctor of Natural Sciences 
 
 
 
 
 
 
presented by 
 
Mattia Forneris 
born in: Savigliano, Italy 
 
 
 
 
Oral examination: 25 September 2019 
 
 
 
 
 
2 
 
  
 
   
 
Natural sequence variation as a tool to dissect 
gene expression regulation in Drosophila 
melanogaster 
 
 
 
 
 
 
 
 
 
 
 
Referees:  Prof. Dr. Henrik Kaessmann 
Dr. Oliver Stegle 
   
 
  
 
 
 
4 
 
 
   
I 
Summary 
Genetic variation is a major cause of differences between individuals and it 
represents a powerful tool to study gene regulation. By interfering with cis- 
Regulatory Modules (CRMs), variants can unravel CRM function. On the other hand, 
predicting the effect of variants on phenotype by the DNA sequence has proven to be 
challenging. In this thesis, I use Drosophila embryonic development as a model 
system to study diversity in gene regulation at the transcriptional level. 
CRMs can be characterized using multiple genome-wide techniques such as DNase 
hypersensitivity. However, despite having comprehensive CRM maps, it is still 
difficult to predict what are the genes regulated by each CRM. Functional methods, 
such as mutagenesis, are effective but poorly scalable. To address this issue, I 
developed an eQTL method (called DHS-eQTL) that makes use of naturally 
occurring genetic variation, to associate CRMs with the genes they regulate. The 
results reveal 2,967 DHS-eQTLs and indicate a high extent of CRM sharing between 
genes. We validated the results with in silico and in vitro approaches and I discuss 
upcoming in vivo experiments. We observed long-range enhancer regulation 
suggesting that commonly used methods to associate genes and enhancers 
underestimate their distance. Also, the DHS-eQTLs show that promoter-proximal 
CRMs have widespread distal activity. 
The separation between populations causes an increase in genetic differences by 
drift and adaptation to different environments. We investigated gene expression 
differences between Drosophila populations from five continents by performing RNA-
Seq on 80 inbred fly lines. We performed multiple quality-control tests to ensure that 
the gene expression dataset is of high quality. Gene expression profiles show 
detectable diversity among the fly lines from different continents and confirm what 
has been observed at the genetic level. In particular, the African population is the 
most separated, while the American, European and Australian ones show less 
diversity. In addition, we identified 903 gene and 2,021 exon eQTLs. 
Genetic variants can interfere with Transcription Factor Binding Sites (TFBS) and this 
might, in turn, lead to changes in chromatin accessibility. We applied LS-GKM (an 
SVM method that uses gapped k-mers) to learn sequence features of tissue-specific 
accessible chromatin and predict the impact of natural sequence variation on 
 
 
 
II 
accessibility. We train LS-GKM on six tissue-specific training sets: neuroectodermal, 
mesodermal and double negative CRMs divided in promoter-proximal and promoter-
distal. The method unbiasedly recovers tissue-specific TFBS and shows good 
performance despite the small training sets. Finally, we score variants from groups of 
inbred Drosophila lines. Interestingly, rare variants have a higher impact on 
accessibility. 
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Zusammenfassung 
Genetische Variation ist eine der Hauptursachen für die Unterschiede, die zwischen 
Individuen bestehen, und stellt ein wirksames Mittel zur Untersuchung der 
Genregulation dar. Variationen, die cis-regulatorische Module (CRMs) beeinflussen, 
können helfen deren Funktion zu entschlüsseln. Allerdings ist die Prognose der 
Auswirkungen genetischer Variationen auf den Phänotypen anhand der DNA-
Sequenz immer noch schwierig. In der vorliegenden Arbeit nutze ich die 
Embryonalentwicklung der Fruchtfliege Drosophila als Modellsystem, um mithilfe der 
genetischen Diversität die Genregulation auf transkriptioneller Ebene zu 
untersuchen.  
CRMs können durch verschiedene genomweite Methoden, wie beispielsweise der 
„DNase hypersensitivity“, beschrieben werden. Obwohl so umfassende CRM-Karten 
erstellt werden konnten, ist die Zuordnung der Gene zu den CRMs, durch die sie 
reguliert werden, weiterhin schwierig. Funktionale Methoden, wie die Metagenese, 
sind effektiv, können aber nur unzureichend auf das gesamte Genom angewandt 
werden. Um auf dieses Problem einzugehen, habe ich eine eQTL Methodik 
entwickelt (genannt DHS-eQTL), welche sich der natürlich vorkommenden 
genetischen Variation bedient, um CRMs den von ihnen regulierten Genen 
zuzuordnen. 2.967 DHS-eQTLs wurden identifiziert und ich konnte zeigen, dass 
CRMs häufig mehrere Gene regulieren. Die Ergebnisse wurden mit in silico und in 
vitro Methoden validiert und ich diskutiere anstehende in vivo Experimente. Unsere 
Beobachtungen zeigen des Weiteren, dass Enhancer ihre Zielgene häufig über 
größere genomische Distanzen hinweg regulieren, und legen damit nahe, dass 
gemeinhin verwendete Methoden für die Zuordnung von Genen und Enhancern 
deren Distanz unterschätzen. Darüberhinaus zeigen die DHS-eQTLs, dass 
Promoter-proximale CRMs umfassende distale Aktivität aufweisen.  
Die räumliche Trennung von Populationen führt zu einer Zunahme der genetischen 
Unterschiede zwischen diesen, verursacht durch Drift und Adaption an die 
verschiedenen Umweltfaktoren. Wir haben die Genexpressionsunterschiede 
zwischen Drosophila Populationen von fünf Kontinenten untersucht. Dazu wurde 
RNA-seq an 80 Inzuchtfliegenlinien durchgeführt. Die hohe Qualität der 
resultierenden Datensätze wurde durch verschiedene Qualitätskontrollen 
sichergestellt. Die Genexpressionsprofile zeigen eine nachweisbare Diversität 
zwischen den Fliegenlinien der verschiedenen Kontinente und bestätigen damit was 
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bereits auf genetischer Ebene beobachtet wurde: Die afrikanische Population grenzt 
sich am stärksten ab, während die amerikanische, europäische und australische 
weniger Diversität aufweisen. Darüberhinaus konnten wir 903 Gen- und 2.021 Exon-
eQTLs identifizieren.  
Der genetischen Variation liegen Änderungen in der DNA-Sequenz zugrunde und 
diese Änderungen können Transkriptionsfaktorbindestellen (TFBS) stören. Diese 
wiederum können zu einer Veränderung des Chromatins führen (offen/geschlossen 
oder „accessible/inaccessible“). Wir haben LS-GKM angewendet (eine SVM 
Methode, die „gapped k-mers“ verwendet), um die Sequenzeigenschaften von 
gewebespezifischer „chromatin accessibility“ zu lernen und den Einfluss von 
natürlichen Sequenzvariationen auf diese Zugänglichkeit zu Chromatin 
vorherzusagen. Dafür haben wir LS-GKM mit sechs gewebespezifischen Datensets 
trainiert: neuroektodermale, mesodermale und doppelt-negative CRMs, jeweils 
unterteilt in Promoter-proximale und Promoter-distale Sequenzen. Trotz dieses 
kleinen Trainingssets erbringt die Methode gute Leistungen und findet in 
unvoreingenommener Weise gewebespezifische TFBS. Abschließend bewerten wir 
Varianten von verschieden Gruppen inzüchtiger Drosophila-Linien. 
Interessanterweise zeigt sich dabei, dass seltene Varianten einen größeren Einfluss 
auf die Chromatin Zugänglichkeit haben.  
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I - Introduction 
 
 
1 - Gene expression is regulated by a plethora of cis 
Regulatory Modules 
 
1.1 - Gene expression drives cell diversity 
In this section, I will discuss the importance of gene regulation to shape cell diversity 
during embryonic development. Precise spatio-temporal regulation of gene 
expression is fundamental for cell differentiation and the definition of anatomical 
structures. In addition, I will introduce Drosophila melanogaster as a model organism 
to study embryonic development.  
 
1.1.1 - All cells of each organism have the same genome but express different 
sets of genes 
Multicellular organisms are complex systems that can perform many functions. From 
tissue regeneration and food digestion to memory and movement, each process is 
carried out by specialized cell types. Cell types are different in both their structure 
and the purpose they fulfill. For example, neurons are very elongated cells with 
multiple branches that form connections with other neurons and transmit electrical 
signals. Hepatocytes, on the other hand, are much smaller and round in shape. Their 
main functions are linked to metabolism and protein synthesis. Despite huge diversity 
between cell types, all cells of multicellular organisms contain the same DNA (with a 
few exceptions, such as erythrocytes or lymphocytes). This means that every cell 
contains all the information necessary to generate a full organism and, consequently, 
any other cell type. Differences between cells arise because of the expression of a 
specific subset of genes in each cell. The messenger RNA (mRNA) is then translated 
into protein that characterizes cell-specific structure and function. For example, 
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human cells generally express between 30 and 60% of all genes encoded in the 
genome1.   
Gene expression is controlled at many stages. The regulation of transcription is the 
first and arguably the most important step. A gene can be switched “on” or “off” only 
at the transcriptional level, while the other steps of gene regulation determine the 
amount, stability and post-translational modifications of the protein product. In the 
next sections, I will focus on gene expression regulation at the transcriptional level. 
 
1.1.2 - Differential gene expression gives rise to cell type diversity and 
anatomical structures during development 
In order to understand how cell types arise through gene regulation, it is essential to 
study how development works. In fact, most animals start their life as one single 
undifferentiated cell. After several replication cycles, cells differentiate into more and 
more specific cell types. At the same time, the major body plan is defined. Cell 
modifications and the formation of anatomical structures are strictly associated with 
gene expression changes.  
Drosophila melanogaster has proven to be a powerful model organism to study 
embryonic development. Besides being cheap to raise and easy to mutagenize2, 
Drosophila has a compact genome3 and can produce large amounts of embryos in a 
short time. In addition, it often harbors a single copy of developmental genes 
(mammals often have multiple genes with overlapping functions), making it easier to 
hack developmental processes2.  
As for the majority of animals, the development of Drosophila starts from a fertilized 
cell that undergoes fast replication cycles. At 2 hours post fertilization (hpf), the 
embryo is made of multipotent cells that contain molecular signals, in form of 
Transcription Factors (TFs), that will determine their fate (Figure 1a,d). The gradients 
of molecules in the egg at this stage define the future axes of the embryo - this is the 
first step to delineate the body plan and it will later lead to the formation of the three 
main segments: head, thorax and abdomen. Gastrulation forms the three germ 
layers – ectoderm, mesoderm and endoderm – and is followed by specification of cell 
types within each germ layer (Figure 1b,e). Finally, after the major body plans have 
1 - Gene expression is regulated by a plethora of cis Regulatory Modules 
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been established, cells differentiate to their final state, giving rise to the variety of cell 
types that are found in the larval and adult body (Figure 1c,f). All chapters of this 
thesis will discuss experiments linked to Drosophila embryonic development and, in 
particular, to the following time intervals: 2-4 hpf (multipotent cells and gastrulation), 
6-8 hpf (cell specification) and 10-12 hpf (terminal differentiation). 
 
Figure 1 - Drosophila embryonic development is guided by precise spatio-temporal gene 
expression.  (A and D) Drosophila embryo at 2 hpf. The cells are still in a multipotent state but the 
major body plans have been already established. (B and E) Drosophila embryo at 6 to 8 hpf. 
Gastrulation has occurred and cells are undergoing specification within germ layers. (C and F) 
Drosophila embryo at 10 to 12 hpf. Terminal differentiation of cell fates is underway. (G) Patterns of Hox 
gene expression in an embryo at 6 to 8 hpf. These precise expression patterns will specify segment 
identity along the anterior-posterior axis. Adapted from Alberts et al.1, (D) and (E) from Turner et al.4, (F) 
from Petschek et al.5, (G) from Kosman et al.6 
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Specific gene expression is also crucial to define the anatomy of Drosophila.  Figure 
1g shows the overlap between gene expression and future anatomical structures in 
an embryo at 6-8 hpf. Colors correspond to the expression patterns of different 
homeotic genes. The precise spatio-temporal expression of these genes is crucial to 
define the body plan. For example, the expression of Antennapedia (Antp) and 
Ultrabithorax (Ubx) identifies the developing thorax, while abdominal A (abd-A) and 
Abdominal B (abd-B) define the developing abdomen. 
 
 
1.2 - Gene expression is controlled by the interplay of many 
cis Regulatory Modules 
Protein coding sequences only make up 15.9% of the Drosophila genome. This 
proportion goes down to 2% in most mammals, including humans. The remaining 
part of the genome - referred to as the non-coding genome - is disseminated of cis 
Regulatory Modules (CRMs): discrete genomic regions that regulate gene 
expression and exert their function by recruiting Transcription Factors to the DNA. 
There are four major classes of CRMs: promoters7, enhancers8, silencers9 and 
insulators10 each with different functions and sequence composition. In the following 
pages, I will briefly introduce them. 
 
1.2.1 - Promoters 
Promoters are short CRMs that regulate the initiation and intensity of gene 
expression and they integrate the cues from distal elements7. Coding and non-coding 
genes have at least one promoter sequence that ensures robust and preferential 
transcription in the direction of the gene. The first transcribed base on the DNA 
sequence is called Transcription Start Site (TSS) and it might vary between 
transcripts. The surrounding area (about ±50 base pairs) is called core promoter. The 
core promoter recruits RNA Polymerase II (Pol II) and the General Transcription 
Factors to assemble the Pre-Initiation Complex (PIC)11. Core promoters are not the 
1 - Gene expression is regulated by a plethora of cis Regulatory Modules 
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only sequences capable of assembling the PIC12, but the main difference with non-
promoter regions is that the latter generally show bi-directional transcription.  
Depending on the core promoter type, transcription initiation can be focused or 
broad13. Narrow (or focused) promoters have a specific TSS and produce transcripts 
that start from the same position. On the other hand, broad promoters have multiple 
TSS over the core-promoter region: the PIC can be assembled on multiple positions 
and they generate transcripts with variable starting positions. The sequence and 
transcriptional properties of core promoters are related to the function of the gene 
they regulate. Core promoters can be divided into three categories found in all 
metazoans that depend on the gene that they regulate:  
1. Adult tissue-specific genes. These core promoters tend to be associated 
with TATA-box and Initiator (Inr) motifs14 and tend to be narrow 
promoters. They are usually active in terminally differentiated cells. 
2. Housekeeping genes. Housekeeping genes are expressed in most cells 
and across developmental stages. In Drosophila they are enriched for 
Ohler 1, Ohler 6 and DNA replication-related element (DRE) motifs15. 
3. Developmental genes. These genes are mostly expressed during 
development and they are required to be efficiently activated and 
inactivated. To achieve fast regulation, they can be “poised” to be 
transcribed. They contain Inr and Downstream Promoter Element (DPE) 
motifs and have focused initiation16. 
Promoters can be characterized by measuring their capability to initiate transcription. 
Methods such as CAGE17,18 and PRO-Seq19 precisely identify the very first bases of 
mRNAs and have been used to map at single base pair resolution the TSS of many 
genes. In addition, these assays can characterize broad and narrow promoters. 
Another method to identify promoter activity genome-wide is SuRe20, a technique 
used to assess self-transcription capability of DNA sequences. 
 
1.2.2 - Enhancers 
Enhancers have been functionally described as sequences capable of increasing 
transcriptional output regardless of their orientation and distance from the gene21. In 
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general, enhancers are clusters of Transcription Factor Binding Sites (TFBS) and 
function by attracting multiple TFs to the chromatin22. Transcription factors 
cooperatively bind to enhancers and displace the nearby nucleosomes. The 
sequence composition of enhancers is more heterogeneous than that of promoters, 
making it more challenging to categorize them. Another difference between 
promoters and enhancers is that while the first tend to be broadly active, the second 
act in a tissue and time-specific manner. The diversity of TFBS composition found in 
enhancers also explains how they can drive such a variety of transcriptional patterns. 
Genes are generally regulated by multiple enhancers and the global expression 
pattern that we observe is the sum of the action of multiple specific enhancers. In 
addition, enhancers act redundantly to increase gene expression robustness. A well-
characterized example of combinatorial enhancer activity is the regulation of the 
Drosophila gene even skipped (eve). At 2 hpf eve is expressed in seven stripes that, 
together with the specific expression of other genes, will guide the segmentation of 
the embryo (Figure 2). This complex expression pattern is driven by multiple 
enhancers, each responsible for the expression of one or two stripes. Other 
enhancers are responsible for eve expression later during embryogenesis in the 
brain and muscle precursors.  
 
Figure 2 – eve expression pattern is guided by the interplay of many CRMs. The figure shows a 
schematic representation of the locus of the eve gene. The coding sequence is represented in red while 
the surrounding enhancers are shown in orange.  Arrows point to the expression patterns driven by 
each enhancer alone. The in situ hybridization images display the total expression of eve (orange) and 
the specific expression driven by each enhancer (dark blue). From Alberts et al.1, adapted from Fujioka 
et al.23 
The Modular Nature of Regulatory DNA Allows Genes to Have
Multiple Independently Controlled Functions
The elaborate patterning process just described depends on the long stretches
of noncoding DNA sequence that control the expression of each of the genes
involved. These regulatory regions bind multiple copies of the gene regulatory
proteins produced by the patterning genes expressed earlier. Like an input–out-
put logic device, an individual gene is thus turned on and off according to the
particular combination of proteins bound to its regulatory regions at each stage
of development. In Chapter 7 we describe one particular segmentation gene—
the pair-rule gene Even-skipped (Eve) —and discuss how the decision whether to
t nscribe the gene is made on the basis of all these inpu s (see Figure 7–55).
This example can be taken further to illustrate some important principles of
developmental patterning.
Individual stripes of Eve expressio  depend on separate r gulatory modules
in the Eve regulatory DNA. Thus, one regulatory module is responsible for driv-
ing Eve expression in stripes 1 + 5, another for stripe 2, another for stripes 3 + 7 ,
and yet another for stripes 4 + 6 ( Figure 22–39 ). Each regulatory module defines
a different set of requirements for gene expression according to the concentra-
tions of the products of the egg-polarity and gap genes. In this way, the Eve reg-
ulatory DNA serves to translate the complex nonrepetitive pattern of egg-polar-
ity and gap proteins into the periodic pattern of expression of a pair-rule gene. 
The modular organization of the Eve reg latory DNA just described is typi-
cal of gene regulation in multicellular animals and plants, and it has profound
implications. By stringing together sequences of modules that respond to differ-
nt combinations of gulatory proteins, i  is possible to generate almost any
pattern of gene expression on the basis of almost any other. Modularity, more-
over, allows the regulatory DNA to define patterns of gene expression that are
not merely complex, but whose parts are independently adjustable. A change in
one of the regulatory modules can alter one part of the expression pattern with-
out affecting the rest, and without requiring changes in regulatory proteins that
would have repercussions for the expression of other genes in the genome. As
described in Chapter 7, it is such regulatory DNA that contains the key to the
complex organization of multicellular plants and a imals, and its prop rti s
make possible the independent adaptability of each part of an organism’s body
structure in the course of evolution.
Most of t e s gme tation genes also hav  important functions at ther
times and places in the development of Drosophila . The Eve gene, for example,
is expressed in subsets of neurons, in muscle precursor cells, and in various
DROSOPHILA AND THE MOLECULAR GENETICS OF PATTERN FORMATION 1339
coding
subset of neurons stripes 4 and 6 stripe 1 stripe 5
stripes 3 and 7
stripe 2
3000 nucleotide pairs
Eve  mRNA
muscle 
precursors
stripes 1 and 5
Figure 22–39 Modular organization of
the regulatory DNA of the Eve gene. In
t  experiment shown, cloned fragments
of the regulatory DNA were linked to a
LacZ reporter (a bacterial gene).
Transgenic embryos containing these
constructs were then stained by in situ
hybridization to reveal the pattern of
expression of LacZ (blue/black), and
counterstained with an anti-Eve antibody
(orange) to show the positions of the
normal Eve expression stripes. Different
segments of the Eve regulatory DNA
(ochre) are thus found to drive gene
expression in regions corresponding to
different parts of the normal Eve
expression pattern. Two segments in
tandem drive expression in a pattern that
is the sum of the patterns generated by
each of them individually. Separate
regulatory modules are responsible for
different times of gene expression, as well
as different locations: the leftmost panel
shows the action of a module that comes
into play later than the others illustrated
and drives expression in a subset of
neurons. (From M. Fujioka et al.,
Development 126:2527–538, 1999. 
With permission from The Company 
of Biologists.)
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By displacing the nucleosomes, the binding of transcription factors on enhancers 
makes the chromatin more sensitive to cutting by endonucleases and insertion of 
transposases. This property is assessed respectively by DNase hypersensitivity24 
and ATAC-Seq25. In addition, ChIP-Seq26,27 can be used to characterize transcription 
factor binding and then identify putative enhancers. Furthermore, STARR-Seq28 is a 
method that can assay enhancer activity genome-wide. Finally, both promoter and 
enhancers are conserved during evolution. A phylogenetic strategy to identify them is 
to study sequence conservation across species29. The expression patterns driven by 
enhancers can be characterized by enhancer assays such as those shown in Figure 
2.  
 
1.2.3 - Silencers 
Silencers operational definition is similar to that of enhancers. In fact, silencers can 
suppress transcription independently of their orientation and distance from the target 
gene30. They are clusters of Transcription Factor Binding Sites and recruit repressor 
proteins to the chromatin. They can act by contacting the promoter (with the same 
mechanism as that of enhancers) or can induce epigenetic modifications that 
suppress transcription. Silencers can be identified with DNase hypersensitivity, 
ATAC-Seq and ChIP-Seq and display similar properties to enhancers making it 
difficult to distinguish the two using only molecular assays. 
 
1.2.4 - Insulators 
Enhancers can influence gene expression even if they are located hundreds of 
kilobases from the target gene. Because of this property, enhancers could engage in 
many unspecific interactions with surrounding genes. Insulators are a category of 
CRM that can stop the interaction between enhancers and promoters if they are 
placed in between the two on the linear genome31. Insulators do not influence 
promoter or enhancer intrinsic activity; they act by blocking the physical interaction 
between the two. In Drosophila, there are at least five classes of known insulators32 
each bound by different combinations of insulator proteins, such as CTCF, GAGA 
binding factor (GAF) and suppressor of hairy wing (Su[Hw]).  
I - Introduction 
 
 
8 
Insulators organize the genome in so called Topologically Associating Domains 
(TADs). TADs are self-interacting regions that usually share the same epigenetic 
marks and are delineated by insulators at their boundaries. Enhancers are unlikely to 
interact with genes outside of the TAD they are located in. The disruption of TAD 
borders can cause non-physiological enhancer-promoter interactions and ectopic 
gene expression that can lead to pathologies such as cancer33. Insulator regions can 
be characterized by ChIP-Seq and motif analysis since most insulator proteins have 
clear binding preferences. In addition, TADs can be studied with chromatin 
conformation capture techniques34 that reveal interaction frequencies between DNA 
fragments. 
 
1.2.5 - The signal from multiple cis Regulatory Modules is integrated at the 
promoter level 
As we have seen, gene expression is regulated by the interplay of many cis 
Regulatory Modules (Figure 3). CRMs recruit regulatory proteins to DNA and, by 
looping, they interact with the target gene promoter. This interaction occurs via the 
mediator complex. The activating and repressing signals from enhancers and 
silencers are then integrated at the promoter and determine the transcription rate. 
Each CRM is bound by a combination of TFs that regulate the effect on gene 
expression and the specificity of interaction with the target promoter. The Drosophila 
genome encodes for more than 1,000 transcription factors allowing for a variety of 
combinations at the CRM level. 
TADs generally include tens of genes and hundreds of CRMs but not all enhancers 
regulate all genes35. In fact, classic models of transcription regulation postulate that 
each CRM regulates only one gene1 and only a handful of CRM sharing examples 
are known36. It is still unclear how specificity in CRM-promoter interactions is 
achieved. Furthermore, developing high throughput assays to discover which CRM 
regulate which promoter has proven to be challenging. In chapter “II - Genetic 
variation as a tool to associate cis Regulatory Modules with their target genes” I will 
introduce a method to perform CRM to gene associations. This method identifies 
almost 3,000 CRM-promoter interactions and reveals a high rate of CRM sharing in 
Drosophila. 
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Figure 3 – Model of gene control region for eukaryotic genes. The figure gives a schematic 
representation of the elements that are involved in gene regulation. The gene X (light grey) is preceded 
by a promoter that recruits the general transcription factors and the PolII to assemble the PIC. Around 
the gene, many CRMs (light green) are bound by transcription factors. By looping, CRMs contact the 
promoter through the mediator complex and activate transcription. From Alberts et al.1 
 
 
 
  
Eucaryotic Gene Activator Proteins Promote the Assembly of RNA
Polymeras  and the Ge eral Transcription Factors at the
Startpoint of Transcription
The DNA sites to which eucaryotic gene activator proteins bind were originally
called enhancers because their presence “enhanced” the rate of transcription
initiation. It came as a surprise when it was first discovered that these activator
proteins could be bound tens of thousands of nucleotide pairs away from the
promoter, but, as we have seen, DNA looping provides at least one explanation
for this initially puzzling observation.
The simplest gene activator proteins have a modular design consisting of
two distinct domains. One domain usually contains one of the structural motifs
discussed previously that recognizes a specific DNA sequence. The second
domain—sometimes called an activation domain —accelerates the rate of tran-
scription initiation. This type of modular design was first revealed by experi-
ments in which genetic engineering techniques were used to create a chimeric
protein containing the activation domain of one protein fused to the DNA-bind-
ing domain of a different protein ( Figure 7–45 ).
Once bound to DNA, how do eucaryotic gene activator proteins increase the
rate of transcription initiation? As we will see shortly, there are several mecha-
nisms by which this can occur, and, in many cases, these different mechanisms
work in concert at a single promoter. But, regardless of the precise biochemical
pathway, the ultimate function of activators is to attract, position, and modify
the general transcription factors, Mediator, and RNA polymerase II at the pro-
moter so that transcription can begin. They do this both by acting directly on
these components and, indirectly, by changing the chromatin structure around
the promoter. 
Some activator proteins bind directly to one or more of the general tran-
scription factors, accelerating their assembly on a promoter that is linked
through DNA to that activator. Others interact with Mediator and attract it to
DNA where it can then facilitate assembly of RNA polymerase and the general
transcription factors at the promoter (see Figure 7–44). In this sense, eucaryotic
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the gene control region for gene X
RNA transcript
TATA
TATA
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spacer DNA
gene regulatory proteins
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transcription
factors
RNA polymerase II
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regulatory
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sequence
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Figure 7–44 The gene control region for
a typical eucaryotic gene. The promoter
is the DNA sequence where the general
transcription factors and the polymerase
assemble (see Figure 6–16). The
regulatory sequences serve as binding
sites for gene regulatory proteins, whose
presence on the DNA affects the rate of
transcription initiation. These sequences
can be located adjacent to the promoter,
far upstream of it, or even within introns
or downstream of the gene. As shown in
the lower panel, DNA looping allows
gene regulatory proteins bound at any of
these positions to interact with the
proteins that assemble at the promoter.
Many gene regulatory proteins act
through Mediator, while others influence
the general transcription factors and RNA
polymerase directly. Although not shown
here, many gen  regulatory proteins also
influence the chromatin structure of the
DNA control region thereby affecting
transcription initiation indirectly (see
Figure 4–45). As noted in the text, for
simplicity, “gene X” refers here to the
coding sequence within the gene.
Whereas Mediator and the general
transcription factors are the same for all
polymerase II transcribed genes, the
gene regulatory proteins and the
locations of their binding sites relative to
the promoter differ for each gene.
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2 - Genetic variation causes diversity between 
individuals of the same species 
 
 
2.1 - Population genetics studies differences between 
individuals 
Despite following the same developmental program, animals of the same species are 
not identical. Population genetics is the branch of genetics concerned with 
understanding diversity between individuals. In this section, I will introduce some 
basic concepts about naturally occurring genetic variation and the consequences on 
phenotype.  
 
2.1.1 - Differences between individuals of the same species are caused by 
genetic variation and interactions with the environment 
Two main factors shape phenotypic variability: the environment and genetic variation. 
Diversity between genomes is generated by, for example, DNA polymerase errors 
during DNA replication and is inherited from parents to the offspring37. Genetic 
variants are locations in the DNA sequence that are polymorphic (different across 
individuals). Alternative versions of a variant are called alleles and together, they 
make the genetic pool of a population. The other source of phenotypic variation is the 
environment. In fact, each individual needs to face different environmental 
challenges that, especially during development, can modify the phenotype. 
Depending on what phenotype is considered, the environmental or the genetic 
component might have a larger influence than the other. A simple way to estimate 
how much genetics alone explains variability in the phenotype is to measure a 
phenotype’s heritability38. For example, in human, height is highly controlled by 
genetics with an estimated heritability over 80%39. On the other hand, body weight is 
mostly dependent on the environment, especially at a young age40.  
2 - Genetic variation causes diversity between individuals of the same species 
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A disadvantage of studying phenotypic variation in natural populations is that it is 
very challenging to disentangle the genetic from the environmental contributions. In 
the example seen before, the heritability of human weight is inflated by common 
eating behaviors within families. This component is independent from genetics but 
increases the heritability estimates. Model organisms can solve this issue and 
represent an outstanding resource for population genetics. In fact, it is possible to 
raise them in controlled conditions that minimize the environmental contribution to 
phenotypic variation. 
 
2.1.2 - The majority of naturally occurring variants have no effect on fitness 
Genetic variants occur at different frequencies across populations. After arising due 
to replication errors, variants can be inherited by the offspring or disappear from the 
population. In fact, the allele frequency of variants can change over time because of 
drift (random changes) or selection (due to impact on fitness). Common alleles are 
generally favored in the population and have a lower chance of disappearing by drift. 
In addition, genetic variation is the raw material for evolution. Natural selection favors 
the reproduction of the fittest individuals and causes an increase in the frequency of 
variants with positive effects and a decrease in frequency of variants with negative 
effects. 
In 1968, Motoo Kimura estimated an exceedingly higher mutation rate in mammals 
than expected at the time41. His calculation from the mammalian hemoglobin 
sequences was that each mammalian zygote harbors four novel mutations. We now 
know that this was an underestimate and that non-coding regions have even higher 
mutation rates than coding sequences. However, this discovery was sufficient to 
propose that the majority of new mutations have no effect on fitness. This concept is 
now known as the neutral theory of molecular evolution42 and is generally used as 
the null model when studying selection on genetic variants. Confirmation of the 
neutral theory of evolution has been accumulating during the years. The most 
relevant is the observation that biological systems show a high degree of robustness: 
the majority of variation at the molecular level is compensated at the phenotypic 
level43 because of mechanisms such as redundancy44, non-linear responses and 
pleiotropy45. 
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In chapter “IV - Impact of natural sequence variation on Drosophila melanogaster 
chromatin accessibility”, I will discuss prioritization of genetic variants. It is still 
challenging to predict the effect of genetic variants on phenotype, despite the 
knowledge accumulated in the last years. To this end, I applied a machine learning 
technique to predict the impact of variants on chromatin accessibility. 
 
2.1.3 - Variants can be under positive or negative selection 
As discussed in the previous paragraph, the vast majority of genetic variation has 
little or no effect on fitness and it is therefore ignored by natural selection. On the 
other hand, variants with an effect on phenotype might confer a fitness advantage or 
a disadvantage. Depending on the effect, the variant will increase in frequency in the 
population over time (positive selection) or decrease (negative selection). In addition, 
variant frequencies can change because of drift. This phenomenon hits neutrally 
evolving variants and has a greater effect on small populations.  
Individuals from the same species tend to be separated in populations that are 
isolated by geographic barriers such as seas or mountains46. By occupying new 
territories, groups of individuals increase their physical distance, which is the major 
factor causing geographic isolation. Populations behave as independent groups of 
individuals, with separated genetic pools. In fact, in isolated populations variant 
frequencies can drift independently and different environments might pose different 
challenges. If the isolation lasts for long periods, individuals from the same species 
eventually accumulate genetic incompatibilities that make interbred offspring less 
and less fit47. 
In chapter “III - Gene expression variation among Drosophila melanogaster lines 
from five continents” I will introduce a novel gene expression dataset that sheds light 
on gene expression regulation differences between five independent populations of 
Drosophila. Differential expression among continents suggests some extent od 
adaptation to different environments. 
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2.2 - Genome Wide Association Studies 
Genome Wide Association Studies (GWAS) are a statistical method to identify 
genomic loci associated with a phenotype48. If a genetic marker (in present days 
genetic variants are used as markers) segregates with a phenotype, then the locus 
where the variant is located is in linkage with the phenotype. This is a correlative 
approach that requires thousands of cases and controls to achieve enough power. 
GWAS have identified many genes associated with multigenic phenotypes, such as 
autism49 and diabetes50. The majority of causal variants identified in GWAS are not 
located in the proximity of genes, making the interpretation of results challenging. 
 
2.2.1 - Quantitative Trait Loci  
Quantitative Trait Loci (QTLs) are genomic regions that are associated with a 
quantitative phenotype. Before the genome-sequencing era, QTLs have been 
identified in a variety of ways that did not require a fine mapping of markers. In 
present days, the approach to map QTLs is similar to GWAS and it is based on the 
correlation between the presence of a variant and the phenotype. This process is 
made easier by inbreeding since inbred fly lines exhibit homozygosity for the majority 
of loci.  
QTLs are commonly used to dissect gene regulation and the phenotypes are 
molecular ones (e.g. gene expression). Expression-QTLs (eQTLs) are mapped by 
correlating the expression of a given gene with the allelic status of the variants 
surrounding the gene. A schematic overview of the eQTL statistical process is shown 
in Figure 4. Other common molecular quantitative phenotypes are chromatin 
accessibility (caQTLs51) and histone binding (hQTLs52). By identifying genomic 
regions linked to molecular phenotypes, QTLs offer a way to understand gene 
regulation. In addition, they can be used to interpret GWAS results and shed light on 
how non-coding regions influence complex phenotypes. 
eQTL can be functionally mapped when a variant impacts gene regulation at some 
level. For example, Cannavò et al.53 describe an eQTL whose minor allele disrupts 
the binding site of Sloppy Paired 1 (Slp1) at the promoter of CG10396. Slp1 
predominantly functions as a transcriptional repressor, causing CG10396 expression 
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to be higher in the minor allele. As in this case, naturally occurring variants can hack 
gene regulation and reveal the function of CRMs. In chapter “II - Genetic variation as 
a tool to associate cis Regulatory Modules with their target genes” I will describe an 
eQTL method that makes use of natural variation to understand the function of 
CRMs. 
 
Figure 4 – Schematic representation of Quantitative Trait Loci analysis. The figure gives a 
simplified overview of the test for association between a genetic variant and the expression of a putative 
target gene. (a) Different inbred lines are genotyped. The black box indicates a variant with a G (Major) 
and C (minor) alleles. Here we assume homozygosity for the variant across all fly lines. (b) The 
individuals are separated into two groups depending on what allele they have. (c) A correlation test is 
performed between the gene expression values of the two groups. If the correlation is significant, the 
locus harboring the variant is considered an expression Quantitative Trait Locus of the tested gene. In 
the case of heterozygosity (C / G alleles), there would be a third group in between the major and minor 
alleles. 
 
2.2.2 - Inbreeding increases power in QTL studies 
Inbred lines can be generated by selecting a few individuals and by crossing them for 
multiple generations. As described before, genetic drift has a larger impact on small 
populations. After many generations (from 10 to 50) of replication between siblings, 
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the genetic pool decreases dramatically, leaving the majority of variant loci with only 
one allele. This, in turn, reduces heterozygosity and makes individuals almost 
genetically identical to each other. Inbred fly lines are generated by starting from a 
common natural population and by repeating the inbreeding procedure in parallel to 
generate multiple lines. If we consider a genetic variant with two alleles in the original 
outbred population, genetic drift will cause some inbred lines to only have the first 
allele and some others to only have the second. An example of inbred fly lines is the 
Drosophila Reference Genetic Panel54 (DGRP). The DGRP is a collection of more 
than 200 inbred fly lines that have been generated and genotyped for population 
genetics studies. 
Inbreeding gives a statistical advantage when mapping QTLs. Heterozygosity often 
masks extreme phenotypes that are present only in homozygosis. By studying lines 
homozygous for one or the other allele it is possible to assess the two extremes of 
the spectrum. Figure 5 shows how power for the discovery of QTL changes when 
using large and/or inbred populations. Inbreeding allows for powerful discovery of 
rare variants even by studying relatively small populations. 
 
Figure 5 – Estimated power to discover eQTL. The figure shows the estimated power to discover 
eQTLs for outbred (blue lines) and inbred (red lines) populations, and for large (dotted lines) and small 
(solid lines) sample sizes. The fixed values in this plot are the number of tests performed (10^8, which is 
a good estimate for cis-eQTL in Drosophila), the eQTL effect size (0.2) and the False Discovery Rate 
(0.05). The power increases as a function of the minor allele frequency (MAF). 
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2.2.3 - Drosophila is a powerful model organism to study population genetics 
Drosophila melanogaster has long been used as a model organism to study 
population genetics. The advantages of Drosophila include a compact genome, fast 
replication time and low cost to maintain. Regarding population genetics, isogenic 
inbred fly lines are easy to obtain and entire populations can be maintained at 
relatively low costs and with reasonable human labor54. Here is a brief list of the main 
advantages of using inbred Drosophila lines for population genetics studies:  
• Isogenic fly lines have homozygous states in the vast majority of variants. 
This results in larger power for association studies, as discussed in the 
paragraph above. 
• Isogenic fly lines yield the possibility to consider individuals belonging to the 
same line as clones. This allows to collect multiple individuals and to perform 
experiments at different times. By pooling individuals from isogenic lines, it is 
possible to increase the overall sample material. This is especially important 
when studying development, given that embryos generally offer little amounts 
of sample. 
• The short generation time of Drosophila and the rarity of chromatin refractory 
to recombination reduce the size of linkage disequilibrium blocks. This allows 
for precise identification of causal variants and increases the information 
content of variants in the same locus. 
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3 - Aim of the study 
In this thesis, I will describe three projects that I developed during the course of my 
Ph.D. The projects are all linked to genetic variation and its effects during Drosophila 
melanogaster embryonic development. Each project will be presented in a separate 
chapter: 
• Chapter II - Genetic variation as a tool to associate cis Regulatory Modules 
with their target genes”.  In this chapter, I will describe a novel application of 
the eQTL framework to map CRM to gene associations. The method 
identifies almost 3,000 CRM to gene associations and indicates widespread 
CRM sharing. 
 
• Chapter III - Gene expression variation among Drosophila melanogaster lines 
from five continents”. In this chapter, I will introduce a novel RNA-Seq 
dataset. We quantified gene and transcript expression of 80 Drosophila lines 
from five continents and identified differentially expressed genes and 
transcripts. In addition, we mapped gene-eQTLs and exon-eQTLs  
 
• Chapter IV - Impact of natural sequence variation on Drosophila 
melanogaster chromatin accessibility”. Here, I applied a machine learning 
approach to prioritize natural variants by their predicted effect on tissue-
specific chromatin accessibility. The method gives insight into CRM sequence 
composition and predicts tissue-specific variant effects. 
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II - Genetic variation as a tool to associate cis 
Regulatory Modules with their target genes 
 
 
1 - Introduction 
 
1.1 - Multiple techniques can be used to identify cis Regulatory Modules 
Gene expression is a tightly regulated process both in space and time, that begins 
with the regulation of gene transcription1. In order to be transcribed, genes need the 
activation of proximal and distal regulatory sequences known respectively as 
promoters and enhancers. In a simplified model: the enhancer is bound by 
transcription factors, contacts the promoter by chromatin looping, and signals to the 
Pre-Initiation Complex, bound at the promoter, to initiate transcription.  
Gene regulatory sequences, such as promoters and enhancers, are combinatorically 
bound by transcriptions factors and this property has been used to identify and 
analyze them. In the past decades, a plethora of techniques has emerged to 
characterize cis Regulatory Modules (CRMs) on a genome-wide scale. For example, 
CAGE17 and PRO-seq19 can shed light on the initiation of transcription, DNase 
hypersensitivity24 and ATAC-Seq25 identify regions of open chromatin and different 
versions of Chromatin Immunoprecipitation55 have been used to characterize 
chromatin states56 and transcription factors binding sites27. The Drosophila 
community has made major efforts in characterizing CRMs across tissues, 
developmental time points and sexes. These efforts provide a wealth of information 
about the CRMs used during embryogenesis and other stages of Drosophila 
melanogaster development. 
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1.2 - Functional and correlative methods to link CRMs and target genes 
Despite the amount of information that has been collected on CRMs, knowing which 
CRMs regulates which genes is far from trivial, but yet crucial to understanding gene 
regulation and its complexity. Databases such as REDfly57 collect evidence for 
enhancer to gene associations, but these annotations come from heterogeneous 
sources, experimental procedures, biological contexts and genetic backgrounds. 
These associations mostly rely on the measurement of putative target genes after 
deleting (or interfering with the function of) the CRM. Genomic alterations are 
complex to achieve in multicellular organisms. Nevertheless, in the last years, 
CRISPR-Cas9 technology58 was introduced as a precise genome editing tool and 
revolutionized the field of genome manipulation. After its introduction, genome 
manipulation has become quicker, easier and more affordable, but it is still far away 
from being applicable on a genome-wide scale for multicellular organisms. For these 
reasons, the information about the regulation of target genes by CRMs is sparse, 
derived from heterogeneous sources and is biased towards a few genes of large 
interest for the community. 
Genetic approaches are still not applicable at a large scale. In fact, many studies still 
rely on assigning CRMs to their closest gene, despite the existence of more 
sophisticated methods and the fact that several lines of evidence indicate that gene-
CRM proximity is not predictive. Scientists have developed correlative methods to 
link CRMs and their target genes genome-wide. Many of these methods look for an 
overlap between the tissues where the CRM is active and the neighboring genes are 
expressed (or the neighboring promoters are active). This approach has been 
applied to a wide range of data, from enhancer assays (e.g. Kvon et al.59) to single-
cell ATAC-Seq (Cicero60). The major shortcomings of correlative approaches are that 
they are very specific to the cellular context and underestimate CRM to gene 
distance (always preferring the closest gene that fits the requirements).  
 
1.3 - Quantitative Trait Loci as a functional method to associate CRMs to target 
genes on a genome-wide scale 
Quantitative Trait Loci analysis61 represents a functional strategy to link genomic 
regions to target genes. In particular, eQTLs62 can link genomic variants to variation 
1 - Introduction 
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in gene expression. eQTL analysis is applied genome-wide and provides functional 
links between genomic loci and target genes. Advantages of the eQTL method are 
that eQTLs are unbiased toward genomic sequence function and “CRM-to-gene-
distance” (though often only elements within a fixed range are tested). Furthermore, 
they can uncover novel functional elements. On the other hand, eQTL results are 
often difficult to interpret because the majority of eQTLs fall outside regions with a 
known function. In addition, eQTLs require an extensive number of tests53, so that 
only the strongest associations are discovered. 
 
1.4 - Overview of the project 
In this project I build on existing eQTL methods to functionally associate CRMs and 
target genes, using DNase hypersensitivity regions as a proxy for CRMs. eQTL 
methods have largely been used in an unbiased way to ask generic questions. Here, 
I bias the test towards DHS and I compromise on search space and single variant 
resolution to increase power and reduce the number of tests. The goal is to maximize 
the number of DHS to gene associations. In this project I make use of the following 
datasets: 
• An extensive map of DNase hypersensitivity during Drosophila embryo 
development generated by James Reddington and David Garfield in the 
Furlong laboratory (unpublished). The data provide time and tissue 
resolution. 
• Full genotype information for 80 inbred Drosophila lines belonging to the 
Drosophila Genetic Reference Panel63 (DGRP). 
• Gene expression information for the corresponding 80 DGRP lines for 3 time 
points during embryo development (2-4 hpf, 6-8 hpf, 10-12 hpf) previously 
generated in the Furlong laboratory by Cannavò et al.53 
  
In the following pages, I will compare different methods, show in silico and in vitro 
validations of the DHS-eQTLs, and I will describe the results and their implications.  
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2 - Results 
 
 
2.1 - An eQTL method to associate cis Regulatory Modules to 
target genes 
In this work, I aim to functionally associate DHS to their target gene. To achieve this 
goal, I developed a new eQTL approach called DHS-eQTL. In this section, I will 
discuss the rationale behind building on existing eQTL methods with the specific 
purpose of performing DHS to gene associations. The method described here 
leverages the information of multiple variants overlapping the same DHS and 
reduces the number of tests to maximize the number of DHS to gene associations. I 
will examine the sources of gene expression variation in our dataset and describe 
how to control for non-cis components. I will finally compare three statistical methods 
to identify DHS to gene associations, their advantages and disadvantages.  
 
2.1.1 - DNase hypersensitivity as a proxy for cis Regulatory Modules 
In this project, I used a comprehensive DHS atlas with tissue and time resolution to 
identify CRMs during Drosophila embryogenesis. The dataset included 19 samples, 
all in duplicates: it spanned 5 tiling time points during Drosophila embryo 
development (2-4 hpf, 4-6 hpf, 6-8 hpf, 8-10 hpf, 10-12 hpf) and 3 FACS sorted 
tissues: neuroectoderm, mesoderm and non-neuroectoderm/non-mesoderm tissues 
(Figure 6). The full dataset was analyzed de novo and mapped to the latest 
Drosophila melanogaster genome assembly (BDGP6). A total of 63,157 DHS was 
identified.  
DHS were separated into two groups depending on their vicinity to a known 
Transcription Start Site (TSS):  
• Promoter-proximal DHS: are located within 500 base pairs of a known TSS. 
Since Drosophila TSS are highly enriched at Topologically Associating 
Domains (TAD) borders64,65, the promoter-proximal DHS represent a 
heterogeneous group. Promoter-proximal DHS include core promoters, 
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promoter-proximal insulators and enhancers. There are 23,268 promoter-
proximal DHS. 
• Enhancers: are more distal than 500 bases from any annotated TSS. TSS 
distal DHS are largely enhancers. There are 39,889 enhancers. Only a small 
proportion of enhancers is bound by insulator proteins. 
 
Figure 6 - DNase hypersensitivity assay. DNase profiles around the mesodermal gene Mef2. The 
tracks show DNA accessibility in different tissues and time points during Drosophila embryonic 
development. Blue: neuroectoderm, Red: mesoderm, Grey: double negative, black: whole embryo. 
 
2.1.2 - High variant density and small linkage disequilibrium blocks in 
Drosophila melanogaster support the use of an eQTL multivariate model 
The Drosophila Genetic Reference Panel (DGRP) lines are a panel of Drosophila 
melanogaster inbred lines that come from a uniform geographic location. They 
harbor more than 6,1 million variants that correspond to a density of one variant 
every 29 genomic bases. Furthermore, variants are slightly enriched in open 
chromatin by a factor of 1.18. Figure 7a shows the density of variants overlapping the 
DHS.  Although 16.1% of DHS do not overlap any variant (and are therefore ignored 
in our following analyses), the majority of DHS (>80%) contained one or more 
variants. Genetic variants located closely in the genome are partially redundant due 
to linkage disequilibrium (LD). While LD blocks generally span tens of kilobases in 
mammals, in the Drosophila genome they are on average smaller than 100 bp63. To 
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test for independence of variants overlapping the same DHS, I performed a Principal 
Component Analysis (PCA) and calculated how many Principal Components (PCs) 
were necessary to explain more than 99% of the variance for each DHS. In the 
extreme case of perfect LD between all variants overlapping the same DHS, one PC 
would explain all of the variance. Figure 7b shows that on average 3 or more PCs 
were necessary to explain the variance on each DHS, indicating high independence 
between variants. The high independence between variants is caused by the short 
reproductive cycles (15 days) of Drosophila melanogaster and the low proportion of 
compacted heterochromatin that is refractory to recombination. Independence of 
variants not only allows for single base resolution eQTL identification53 but it also 
represents a wealth of information that can be leveraged on. In this study, we 
included the variants overlapping the same DHS in one association test to reduce the 
total number of tests and to increase power (Figure 8). The rationale is that variants 
that impair or enhance the function of the same Regulatory Element will affect the 
same phenotype. 
 
Figure 7 - Genetic variants are dense over DHS and are highly independent. (a) Distribution of the 
number of variants overlapping each DHS. About 10,000 DHS do not overlap any variant and cannot be 
analyzed with any eQTL method. The majority of DHS overlaps multiple variants. (b) Number of 
Principal Components (PCs) necessary to explain >99% of the variants overlapping each DHS. If 
variants are in perfect linkage disequilibrium, one PC will explain them all. In the majority of cases >1 
PC is necessary to describe the variation overlapping each DHS showing high independence between 
variants. 
 
In order to further reduce the number of statistical tests, increase power in DHS to 
gene associations and uncover complex DHS to gene associations, I took the 
following steps (Figure 8): 
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• Variants that did not overlap any DHS were excluded from testing 
• If multiple variants overlapped the same DHS they were included in one 
multivariate test 
• All DHS-eQTL statistical tests were corrected for multiple testing in a joint 
FDR approach. This allowed the DHS-eQTL method to discover multiple DHS 
associated with the same gene and vice-versa. 
In our case, these adjustments led to a decrease from 17,234,822 to 483,064 tests.   
 
 
Figure 8 - Schematic representation and comparison of classic eQTL and DHS-eQTL methods. 
The top panel shows a schematic representation of the classic eQTL approach: we perform one test for 
each variant-to-gene association; all variants are tested for association independently of their genomic 
location; usually one association is identified for each gene (arrows). The bottom panel shows a 
schematic of the DHS-eQTL approach: I ignored variants that do not overlap any DHS; I performed one 
test for each DHS to gene association; if multiple variants overlap the same DHS they are pooled in a 
multivariate test; I could find multiple eQTLs for the same gene and for the same DHS. On the right, the 
total number of tests performed by the two methods. Blue: gene models; brown: DNase 
Hypersensitivity; purple dots: genetic variants; magenta and green boxes and arrows: eQTLs. 
 
17,234,822
483,064
eQTL
DHS-eQTL
...
...
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2.1.3 - Variance decomposition analysis shows that population structure is a 
major driver of gene expression variation 
Gene expression is a tightly regulated process but it is not immune to variation. 
Environment, genetic variation and noise are among the causes of gene expression 
variation61. To further investigate what are the main sources of variation in our gene 
expression dataset I performed a variance decomposition analysis66. This method 
quantifies the amount of variance of a dependent matrix that can be explained by 
many independent matrices. For each gene, expression variation was split into four 
components:  
1. Environment: represents expression changes during developmental 
times. This value captures differences among time points in the gene 
expression matrix and it includes batch effects.  
2. Population structure: identifies genetic similarities between individuals. 
The DGRP fly lines come from a uniform geographic location and share 
the same population history. For this reason, population structure and 
trans variation (whole genome variation) could not be distinguished. This 
feature encompassed both population structure and trans variation.  
3. cis variation: corresponds to genetic variation around the gene of interest 
(in this case ±50 kb from the gene).  
4. Noise: is the remaining component and it corresponds to unexplained 
variation.  
For each gene, the four components sum up to one.  
eQTL studies are focused on dissecting the role of genetic variants in changing gene 
expression. Removing confounding factors from the association tests is crucial to 
avoid false positive associations. The variance decomposition analysis is useful to 
estimate the amount of gene expression variation explained by components other 
than cis genetic variation. In this project, I focused on eQTLs in the vicinity of the 
target gene, making developmental stage, batch effects, population structure and 
trans variation potential sources of false positive associations.  
Figure 9 shows the amount of gene expression explained by the four components 
mentioned above. Environment (i.e. in our case developmental time) was the main 
driver of variation with a mean explanatory power of 36%. The Drosophila embryos 
are undergoing great anatomical modifications during the stages in this study making 
developmental time the largest predictor of gene expression changes. To remove 
2 - Results 
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environment, together with batch effects, as a confounding factor in the DHS-eQTL 
test, I used PEER (see Methods). To confirm that PEER is actually removing the 
environment component I performed a variance decomposition of PEER residuals: 
the median amount of variance explained by the environment component was 0, 
proving that PEER effectively removes environmental sources of variation. 
Population structure and trans variation were also major drivers of gene expression 
variation with an average explanatory power of 33%. This corresponds to line-to-line 
similarity and it is removed by LIMIX and mtSet as I will discuss in the next sections. 
cis variation explained on average 13% of gene expression variation, with a very 
wide distribution: for 326 genes, this component explained more than 50% of gene 
expression variation. Finally, noise is completely orthogonal to the other three 
components and it does not represent a source of false positive eQTLs. It had an 
average explanatory power of 18%. These results show how cis variation could be 
confounded by other sources of gene expression variation (in particular population 
structure, environment and batch effects), calling for methods that can control them. 
 
Figure 9 – Variance decomposition of gene expression. The plot shows the amount of gene 
expression variation explained by three features: environment, population structure and cis variation. 
For each gene, gene expression is decomposed by these three components and residual noise (up to 
1). Each dot corresponds to an expressed gene. 
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2.1.4 - Testing three eQTL methods within the DHS-eQTL pipeline 
We assayed three QTL methods to identify DHS to gene associations: Linear Mixed 
Model (LIMIX67), Principal Component multiple Regression (PC-regression) and 
multiple Set test (mtSet68). The three QTL methods are different in many aspects. In 
particular, LIMIX performs a univariate test: it fits one test for every variant-to-gene 
association. On the other hand, PC-regression and mtSet are multivariate 
approaches that can integrate the information from multiple variants. The two 
multivariate approaches are different in some regards. In particular, mtSet can model 
multiple phenotypes (in our case we have gene expression values for three time 
points during development) as the sum of the variants in the genetic region, 
population structure and residual noise. mtSet performs a single test for each DHS to 
gene association and it can leverage the three gene expression measurements for 
each gene. Finally, PC-regression can estimate the effect size of genetic variation on 
gene expression but it cannot model multiple phenotypes requiring 3 tests for each 
DHS to gene association. In order to compare the performance of LIMIX, mtSet and 
PC-regression, I performed an eQTL call using the same inputs for the three 
methods. Figure 10 outlines the pipeline used to call DHS-eQTL (see also Methods). 
Briefly, I quantified gene expression from 3’-Tagged Sequencing reads published by 
Cannavò et al.53. This dataset reports gene expression for 80 inbred DGRP lines and 
spans three time points during development. I corrected for hidden batch effects with 
PEER69 and for mapping biases using WASP70. Finally, association tests were 
performed between corrected gene expression and sets of variants overlapping each 
DHS. I performed (i) one test for each variant-to-gene association using LIMIX, (ii) 
one test for each DHS-to-gene association using mtSet and (iii) three tests for each 
DHS-to-gene association using PC-regression. The three association methods were 
well calibrated as shown by their qqplot (Supplementary Figure 2). 
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Figure 10 - Schematic of the pipeline used to call DHS-eQTLs. The three eQTL methods (LIMIX, 
PC-regression and LIMIX) were applied to the same inputs. 3’-Tagged sequencing reads were 
processed to identify polyadenylation (pA) sites. pA sites were quantified using mappability filtered 
reads (WASP) and the sum of pA usage was used as a measure of gene expression. Hidden factors 
and batch effect were removed with PEER. We include in the test only variants that overlap DHS. The 
three eQTL methods use the same phenotypes. Regarding the genotypes, LIMIX uses single variants 
while PC-regression and mtSet all the variants that lay on the same DHS. 
 
2.1.4 - mtSet is the only multivariate eQTL method that controls for population 
structure 
After correcting for residual linkage disequilibrium, PC-regression identified 5,478 
DHS-eQTLs while mtSet finds 2,967. Both multivariate approaches discovered more 
DHS-eQTLs than the univariate approach LIMIX: 1,449 (Figure 11a). The larger 
power of multivariate models and the reduced number of tests explains this 
difference.  
PC-regression might identify more DHS-eQTLs than mtSet because it does not 
correct for variation in gene expression caused by population structure. On average, 
population structure explained 32% of gene expression variation (Figure 9). To 
assess if population structure could drive false DHS-eQTLs, we tested if DHS-eQTLs 
identified only by one statistical method have a larger proportion of variance 
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explained by population structure. Figure 11b shows that DHS-eQTLs discovered by 
both mtSet and PC-regression have a lower proportion of variance explained by 
population structure than DHS-eQTLs found exclusively by mtSet (p < 5.57e-06) and 
PC-regression (p < 0.036). This indicates that DHS-eQTLs discovered by PC-
regression and not by mtSet have higher chances to be driven by population 
structure. On the other hand, even if DHS-eQTLs found only by mtSet have a higher 
proportion of variance explained by population structure, this component is removed 
from the association test. These observations justify the use of a multivariate 
approach that corrects for population structure. We then chose to use mtSet results 
as our set of DHS-eQTLs.  
 
Figure 11 - Comparison of results between eQTL methods. (a) The UpSet plot shows the 
intersection between the DHS-eQTLs identified by the 3 methods. PC-regression discovers more DHS-
eQTL than any other methods, most of which are unique. LIMIX, the univariate method tested, is the 
least powerful. (b) Proportion of variance explained by population structure for genes involved in DHS-
eQTLs discovered by both mtSet and PC-regression (Common), only mtSet, only PC-regression and 
genes not involved in any DHS-eQTL (Not Significant). 
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2.1.5 - DHS-eQTLs discovered by the univariate model are a subset of those 
discovered by the multivariate model 
Figure 11 shows that LIMIX identified 543 unique eQTLs. This is unexpected given 
the higher power and similarity to mtSet: both implement a population structure 
correction, but mtSet leverages on multiple variants and requires fewer tests. To 
investigate this, I plotted the uncorrected p-values for the significant associations 
from mtSet (Figure 12a) and LIMIX (Figure 12b). LIMIX did not reproduce well the 
results from mtSet. The distribution of LIMIX p-values from DHS-eQTLs discovered 
by mtSet (Figure 12c) showed that sub-threshold p-values from LIMIX are semi-
randomly distributed. In contrast, mtSet reproduced to a higher extent the significant 
results from LIMIX (Pearson correlation: 0.662). The DHS-eQTLs unique to LIMIX 
had p-values from mtSet close to the FDR cutoff (Figure 12d).  
Changes in gene expression can be driven by a single variant or by multiple variants 
acting in a cooperative or antagonistic manner. mtSet, by testing the effect of multiple 
variants at the same time, can capture complex scenarios while LIMIX tests are 
confined to the effect of single variants. We can then expect simple scenarios to be 
captured by both methods (LIMIX is more powerful here with some tests just below 
the FDR cutoff for mtSet) but the complex scenarios are captured by mtSet alone 
(shown by low correlation between the two methods when looking at mtSet 
significant DHS-eQTLs). It is worth noting that this reasoning is confined to causal 
variants only. In fact, there were on average more variants on DHS-eQTLs found 
only by LIMIX than on those found only by mtSet (Supplementary Figure 3). This 
counterintuitive observation may be explained by the fact that a high number of 
neighboring variants might dilute the effect of a single causal variant and decrease 
the power of mtSet. In conclusion, these observations confirm that LIMIX results are 
always captured by mtSet (even if under the FDR cutoff), while the reverse is not 
always true. 
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Figure 12 – LIMIX unique eQTLs are subthreshold eQTLs in mtSet. The scatterplots show the p-
values for significant eQTLs for either mtSet or LIMIX. (a) The scatterplot shows the uncorrected -log10 
p-values from mtSet (x-axis) and LIMIX (y-axis) for DHS-eQTLs discovered by mtSet. The vertical 
dashed line indicates the FDR cutoff for mtSet, while the horizontal dashed line indicates the FDR cutoff 
for LIMIX. The p-values have a Person correlation of 0.432 (b) The scatterplot shows the uncorrected -
log10 p-values from mtSet (x-axis) and LIMIX (y-axis) for DHS-eQTLs discovered by LIMIX running on 
DHS only. The vertical dashed line indicates the FDR cutoff for LIMIX while the horizontal dashed line 
indicates the FDR cutoff for mtSet. The p-values have a Person correlation of 0.662. (c) The violin plot 
represents the -log10 p-value distribution for mtSet and LIMIX of DHS-eQTL discovered by mtSet. The 
horizontal solid line indicates the FDR cutoff for LIMIX. The dotted line corresponds to a p-value of 0.05. 
(d) The violin plot represents the -log10 p-value distribution for mtSet and LIMIX of DHS-eQTL 
discovered by LIMIX. The horizontal solid line indicates the FDR cutoff for mtSet. The dotted line 
corresponds to a p-value of 0.05. 
 
 
2.2 - Overview of the DHS-eQTL results 
mtSet discovered a total of 2,967 DHS-eQTL. The nature of the method allowed for 
the discovery of multiple DHS associated to the same gene and multiple genes 
linked to the same DHS, in particular, the 2,967 DHS-eQTL involve 1,673 genes and 
2,693 DHS. Depending on the type of DHS involved in the eQTL, we can split the 
results in promoter-proximal-eQTLs and distal, putative enhancer-eQTLs. 1,805 
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promoter-proximal-DHS (7.8% of all promoter-proximal DHS) were involved in 2,005 
promoter-proximal-eQTLs. 888 distal-DHS, which I refer to as enhancers from now 
on (representing 2.4% of all enhancers) were involved in 962 enhancer-eQTLs. 
Figure 13a shows the number of DHS associated to each gene. While the majority of 
genes were involved in one DHS-eQTL, 635 (38%) of them were linked to two or 
more DHS, up to 19 DHS. The majority of eQTL studies have focused on the best 
association for each gene. By including all DHS to gene associations in the multiple 
testing correction, the DHS-eQTL approach represents a step forward in capturing 
the complexity of gene regulation. 
Figure 13b displays the number of genes associated to each DHS. The ground 
assumption is that every CRM regulates only one target gene, because only a 
handful of examples of enhancers that regulate multiple genes are reported in the 
literature71. Our results showed that 231 DHS (8.6% of DHS involved in DHS-eQTLs) 
were associated to 2 genes and 21 (0.8%) are associated to 3 or 4 genes. Of those, 
173 were promoter-proximal-eQTLs and 58 were enhancer-eQTLs. This result gives 
functional evidence that CRM sharing is more widespread than previously anticipated 
and gives new functional insights into the complexity of a gene’s regulatory 
landscape. One could argue that DHS that are involved in multiple DHS-eQTLs 
represent trans interactions. Unfortunately, it is impossible to separate cis from trans 
interactions within populations of inbred individuals so we cannot directly estimate 
the amount of trans-eQTL within these results. On the other hand, testing cis window 
of ±50 kb around each gene makes it unlikely to discover trans associations. I will 
expand more on the estimation of trans-eQTLs in “2.6.1 - Different types of activity 
from promoter-proximal DHS”. 
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Figure 13 – Number of genes associated to each DHS and vice versa. (a) Number of DHS 
associated to each gene. (b) The plot shows the number of genes associated to the same DHS. DHS 
are divided in promoter-proximal DHS and enhancers. Enhancer-eQTL are shown in red, promoter-
proximal-eQTL are shown in blue. 
 
2.2.1 - Distal enhancer-eQTLs 
A current key challenge in our understanding of genome regulation is how to link 
regulatory elements (CRMs) to their target genes.  This is particularly difficult for 
distal enhancers, which can be separated by tens or hundreds of kb from their target 
gene, with many non-target genes in between. Given the increased statistical power 
of our approach, mtSet identified 962 enhancer-eQTL, one enhancer of which is 
shown in Figure 14. An enhancer, open only in the neural tissue, is associated with 
the gene aret (also called bruno 1), an RNA binding protein involved in splicing. The 
DHS is overlapping an enhancer genomic fragment tested by Kvon et al. The 
fragment has an enhancer activity specific to the ventral nerve cord (Figure 14). In 
addition, the expression patterns of the gene aret have been characterized and 
available on BDGP72. The gene is expressed in the ventral nerve cord and other 
tissues. The DHS-eQTL approach is completely unbiased towards this orthogonal 
information that in turn validates this association. We can conclude that the DHS-
eQTL method identifies a novel distal enhancer for aret located 31 kb away, with 7 
genes in between.  
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Figure 14 – Example of DHS-eQTL. (a) Screenshot displaying an example of a DHS-eQTL. A 
neuroectoderm specific enhancer is associated to aret. The tracks on top represent the DNase assay in 
neuroectoderm, mesoderm and double negative tissues at 10-12 hpf. The DHS overlaps a known 
enhancer (the region represented by the orange track was tested in an enhancer assay59). (b) 
Expression pattern induced by the region in orange when tested in an enhancer assay. (c) Gene 
expression pattern of gene aret. The gene expression induced by the enhancer region overlapped the 
expression pattern of aret. (d) Gene expression difference between major and minor alleles of the 
causal variant. The minor allele has consistently higher expression in all three time points. 
 
 
2.3 - Validations of the results 
The DHS-eQTL approach is intentionally focused on regulatory regions, to achieve 
more power in DHS to gene associations. In this section, I will compare the results 
from the DHS-eQTL with a Tiling Window eQTL method that takes the entire cis 
window into account. In addition, I will present two in silico validations of the results 
(overlap of DHS and gene tissue-specificity and Hi-C signal enrichment between 
DHS-eQTL), one in vitro validation (qPCR confirmation of major/minor allele 
expression) and one in vivo (validation by CRISPR mutagenesis). 
 
2.3.1 - DHS are enriched for eQTL signal 
By focusing on DHS, we exclude a substantial portion of the genome. The 
advantages of this approach are a 6-fold reduction in the number of tests and a 
definition of genomic windows that correspond to biologically functional units. To 
assess the impact of these two features, I tiled the genome in 300 bp large windows 
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(equal to the median DHS size) and tested all Tiling Windows within 50 kb of each 
gene for association, using mtSet (Figure 15). This approach considered the entire 
cis genomic region and is completely agnostic to DHS information, making it a 
traditional multivariate eQTL approach. The pipeline used to test for association is 
identical to the DHS-eQTL one. Tiling Windows have a similar variant frequency to 
DHS, but variants were less independent, indicating that DHS had smaller linkage 
disequilibrium blocks than the rest of the genome (Supplementary Figure 4). In total, 
I identified 9,855 Tiling Windows eQTLs. 1,237 TW-eQTL overlapped a DHS and 
reassuringly, 1,005 (81.2%) of them were associated to the same gene as in the 
DHS-eQTL (Figure 16).  
 
Figure 15 – Schematic representation of the Tiling Window-eQTL (TW-eQTL) approach. The entire 
genome is divided into Tiling Windows of 300 bp each. I perform one association test for each window. 
This method is similar to the DHS-eQTL method; the only difference is on the definition of the tested 
regions. 
 
Considering the entirety of the genome identified many more eQTLs (9,855 TW-
eQTLs vs 2,957 DHS-eQTLs). On the other hand, the DHS-eQTL discovered a 
higher number of DHS to gene associations (1,237 TW-eQTLs overlap a DHS vs 
2,957 DHS-eQTLs): this comparison was the most relevant given the goal of this 
project. In addition, despite increasing the number of tests by six times (2,892,787 vs 
483,064), the TW-eQTL only provided 3.3 times more associations than the DHS-
eQTL. By comparing DHS-eQTL and TW-QTL performance directly with a joint test, I 
observed a 1.46-fold enrichment of DHS-eQTL, demonstrating that p-values from the 
DHS-eQTL tests are globally lower. 
 Number of tests:  2,892,787TW-eQTL
...
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Figure 16 – Venn diagram comparing the results from TW-eQTL and DHS-eQTL. The TW-eQTL 
approach identifies more than three times more associations than the DHS-eQTL. However, by focusing 
on DHS only, the DHS-eQTL method is the best to associate CRMs to target genes. 
 
TW-eQTL are unbiased toward what genomic region is tested. This allowed us to 
identify genomic features that were enriched or depleted for eQTLs. Figure 17 shows 
how frequently TW-eQTLs overlap different genomic features, compared to the 
background. TW-eQTLs were enriched at promoter-proximal DHS and exons. 
Genetic variants that overlap promoters are known to have larger effects on gene 
expression compared to enhancers53 thus making promoter-proximal DHS more 
likely to harbor an eQTL.  Exons are also known to be enriched in eQTLs53: 42% of 
the TW-eQTLs overlapped exons. On the other hand, exons are depleted in DHS 
and had little relevance within the scope of this project. TW-eQTLs were depleted in 
introns and intergenic regions; they were also slightly depleted in enhancers. While 
introns and intergenic regions are known to be depleted for eQTLs (because they are 
depleted for regulatory elements), we expected enhancers to be enriched for eQTLs. 
A possible explanation for depletion of eQTLs on enhancers is that genes are 
generally regulated by multiple enhancers with overlapping activities44. Mutations on 
enhancers can be buffered more effectively than on promoters, making it less likely 
to cause measurable changes on gene expression. 
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Figure 17 – Enrichment of TW-eQTL on genomic features. The dark green bars show the observed 
frequency of TW-eQTLs on each genomic feature. The light green bars show a randomized background 
of frequencies. All frequencies sum up to 100%. 
 
2.3.2 - DHS-eQTL method is sensitive to precise DHS identification 
Tiling Windows are defined as consecutive windows on the genome and create 
breaks that do not take into account genomic function. On the other hand, DHS are 
biologically meaningful and correspond to separate CRMs. To test if pooling variants 
in a biologically meaningful way leads to a difference in test significance, I performed 
a pairwise comparison between p-values from the DHS-eQTLs and the TW that 
overlaps most bases. The DHS-eQTL p-values were globally significantly lower (one 
tailed Wilcoxon test: p<0.0034) than those from the TW-eQTL that overlaps most 
bases. This result indicates that a precise definition of window borders leads to 
stronger associations.  
In conclusion, focusing on biologically defined genomic regions and decreasing the 
number of tests enabled the DHS-eQTL approach to identify more than twice DHS to 
gene associations than the TW-eQTL approach. The TW-eQTL approach is perfectly 
valid and it gave insights into how multivariate approaches work, but it identifies less 
DHS to gene associations compared to the DHS-eQTL method.  
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2.3.3 - Enhancer and gene tissues of activity overlap more than at random 
To validate our DHS to gene associations we tested for a correspondence between 
the tissues where the DHS is active and the target gene is expressed. Since the 
DHS-eQTL method does not incorporate information about tissue-specific activity of 
DHS and gene expression, we can use this important feature to test if our DHS-
eQTLs are enriched for concordant DHS and gene tissues of activity. As many genes 
are annotated as having ubiquitous expression at early developmental stages, we 
focused on the latest time point of the DNase hypersensitivity data. We 
complemented our DHS data with gene expression information from the Berkeley 
Drosophila Genome Project72 (BDGP). This resource provides annotated expression 
patterns for more than 8,000 genes. Figure 18a shows an example of a coherent 
tissue match between a DHS and gene pair in a DHS-eQTL. The gene Mp20 is 
expressed in the visceral muscle at stage 16 (Figure 18b) and was associated to a 
mesoderm specific DHS about a kilobase away from its Transcription Start Site. On 
the other hand, Figure 18d shows an example of an incoherent association: 
CG10602 is a gene expressed in the crystal cells at stage 16 but was associated to a 
neuroectoderm specific enhancer by mtSet (Figure 18e).  
There are multiple reasons why we might find incoherent associations. First, in situ 
hybridization may not target all gene isoforms and it might not capture some tissues 
where the gene is expressed. Second, BDGP annotation is based on manual 
annotation of in situ hybridization images and it is prone to human errors. The BDGP 
dataset provides invaluable insight and it is powerful enough for a global validation, 
but the very nature of the assay does not enable assumptions about every single 
case. Third, DHS data, despite being tissue-specific, might miss rare cell types (for 
example, crystal cells represent only a small proportion of the Double Negative 
tissue). Fourth, the TSS distal DHS might be a silencer and therefore it could be 
active in tissues where the gene is not expressed and should be inversely associated 
with the gene’s expression. 
I globally tested if DHS-eQTLs are enriched for coherent associations. I defined 
tissue-specific enhancers at 10-12 hpf as those having a summit only in one time 
point and having a significantly different coverage using DESeq273. Gene expression 
annotation was downloaded from BDGP and we mapped the anatomical tissue terms 
at stages from 13 to 16 (that correspond to 10-12 hpf) to the 3 tissues in the DHS 
study. I focused on DHS-eQTL that link tissue-specific enhancers to tissue 
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specifically expressed genes. Among these DHS-eQTLs there were 38 coherent and 
24 incoherent associations. To test for significance, I performed 10,000 permutations 
of random DHS to gene associations and obtained a background distribution of 
coherent and incoherent associations (Figure 18c,f). Coherent associations were 
enriched in our results while incoherent ones were depleted. Incoherent associations 
might point to false discoveries but they do not display lower quality signatures. In 
fact, they have the same DHS to gene distance and p-value distributions as coherent 
associations. These results show an enrichment of coherent tissue of activity 
between DHS and target gene among the DHS-eQTLs. 
 
Figure 18 – Enhancer and gene tissues of activity overlap more than at random. (a) The gene 
Mp20 is associated to a mesoderm specific enhancer. (b) Expression pattern of Mp20 at stage 16 
(corresponding to 10-12 hpf). (c) The vertical bar shows the proportion of observed coherent 
associations. The transparent distribution represents the permutation background. (d) The gene 
CG10602 is associated to a neuro specific enhancer. (e) Expression pattern of CG10602 at stage 16 
(corresponding to 10-12 hpf). (f) The vertical bar shows the proportion of observed incoherent 
associations. The transparent distribution represents the permutation background. 
 
2.3.4 - DHS involved in DHS-eQTL are enriched for Hi-C contacts 
Distal regulatory elements – such as enhancers – can be located hundreds of 
kilobases away from their target promoter, but they are known to function by coming 
in physical proximity with the target gene’s promoter. In physiological contexts, 
enhancers known to regulate a gene are closer in the 3D space to the target gene 
promoter than those that do not regulate it, independently of the linear distance35. In 
the past years, many chromosome conformation capture techniques have been 
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developed to investigate the genome spatial arrangement. Among them, Hi-C34 
quantifies all pairwise contact frequencies between genomic regions, providing a 
measure that can be interpreted as spatial distance.  With the help from Aleksander 
Jankowski, a post-doc in the Furlong laboratory, we analyzed Hi-C in wild type 
embryos staged at 6-8 hpf to quantify chromosome contact frequency. DHS to gene 
associations are expected to be closer in space than random associations. We 
globally observed that DHS involved in a DHS-eQTL contact their target promoter 
more frequently than random DHS at the same linear distance from the promoter 
(Wilcoxon p<10^-188) (Figure 19). This indicates that the DHS are regulating the 
gene there are associated with, by the DHS-eQTL method. 
 
Figure 19 – DHS-eQTL have stronger Hi-C signal than random DHS to gene associations. The plot 
shows the Hi-C signal intensity distribution between DHS and target gene TSS. The top violin plot 
represents the distribution of shuffled DHS-eQTL (DHS are shuffled while genes are kept constant, DHS 
to gene distance is matched). The bottom violin plot represents DHS-eQTLs intensity signal distribution 
between DHS and target gene TSS. Hi-C signal correlates with proximity. 
 
2.3.5 - qPCR validates gene expression differences between major and minor 
alleles 
Gene expression differences between genotypes are essential to identify eQTLs. But 
since the test is correlation based, differences might be subtle and challenging to 
reproduce. In this study, we used mtSet, a statistical method that can take multiple 
variants into account. By performing a multivariate test, mtSet cannot identify a 
putative causal variant among the ones that are tested. To achieve this, I defined the 
variant with the lowest p-value in the univariate (LIMIX) test, as the putative causal 
variant. This allowed for splitting gene expression between alleles and estimating the 
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effect size of the variant on gene expression (Supplementary Figure 5). To confirm 
both the direction of the causal variant effect on gene expression and the fold change 
in gene expression, we used Real Time quantitative PCR (RT-qPCR). The 
experiments were performed by Rebecca Rodriguez Viales, a technician in the 
Furlong laboratory. We selected 5 promoter-proximal-eQTLs and 5 enhancer-eQTLs 
in which the target gene TSS is at least 10 kb away from the DHS (Supplementary 
Figure 5a-b). For each DHS-eQTL, we chose two DGRP lines harboring different 
alleles of the causal variant. The median fold change in gene expression between 
the two genotypes is lower than 2, indicating that the causal variants had minor 
effects on gene expression. We could reliably confirm mtSets associated expression 
differences for 9 out of 10 genes (eIF3f1 gave discordant results in different 
replicates and with different primers) and we confirmed our fold change estimates by 
quantifying expression in the two genotypes with RT-qPCR. All genes were 
differentially expressed between the two genotypes and in 8 out of 9 cases the 
direction of expression was the same as measured with 3’-Tagged Sequencing 
(Supplementary Figure 5c,d). RT-qPCR and 3’-Tagged Sequencing fold changes in 
gene expression between major and minor alleles are highly correlated (Pearson 
correlation: 0.85) (Figure 20). RT-qPCR validates the gene expression 
measurements from 3’-Tagged Sequencing, the direction of the eQTL effect and the 
fold-change in gene expression between lines harboring the Major and minor alleles.  
  
Figure 20 – qPCR maj/min fold change correlates with 3’-Tagged Sequencing measurement. The 
plot shows the correlation between log2 fold changes in gene expression between major and minor 
allele as measured by 3’-Tagged sequencing and quantitative Real Time PCR (qPCR). The orange dots 
represent enhancer-eQTLs while the blue dots represent promoter-eQTLs. The correlation between 
qPCR and 3’ Tagged-Sequencing log2 fold changes is: 0.858. The grey dot represents the fold change 
in expression of RpS5b, for this sample the fold change in gene expression does not agree and it is 
excluded from the correlation. 
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2.4 - The DHS-eQTL approach indicates that correlative 
methods underestimate the distance between enhancers and 
target genes 
 
Direct methods to associate enhancers to target genes (such as enhancer deletion) 
tend to be poorly scalable and time consuming: it is currently impossible to apply 
them at a genome-wide scale to a developing organism. For these reasons, 
molecular biologists have relied on correlative methods or on cell-culture based in 
vitro proxies of development to associate enhancers and target genes genome-wide. 
The most trivial approach is to associate enhancers to their closest gene. This 
simplistic method represents the best guess when nothing is known about the 
biology of the enhancer or of the gene, but it is poorly accurate. Another approach is 
to link enhancers and target genes based on the patterns of enhancer activity and 
gene expression. In a seminal study, Kvon et al.59 tested more than 10% of the 
Drosophila genome in an enhancer assay that reveals what tissues the enhancer is 
capable of driving expression in. They assigned enhancers to the closest gene with a 
compatible expression pattern. The major drawback of the method is that it relies on 
sparse data: tissues of expression is annotated for only a fraction of genes. This 
method is more accurate than linking enhancers to their closest gene, but it is still 
biased towards short distance. 
On the other hand, the DHS-eQTL approach is completely agnostic about the 
distance between the enhancer and the target gene (within our tested +/- 50 kb cis-
window). Figure 21 shows an example of long-distance enhancer-eQTL. A 
mesoderm specific enhancer was associated to PH4alphaSG1, about 30 kb away. 
The enhancer was associated to its 11th closest gene. In this section, I will compare 
the distribution of enhancer-to-gene distances obtained from different association 
methods. 
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Figure 21 - Mesoderm specific enhancer skips 6 genes to reach its target. (a) Browser shot of a 
mesoderm specific enhancer associated to the gene PH4alphaSG1. The enhancer (red box) is located 
30 kb away from the gene promoter and skips 6 genes to reach it. (b) Gene expression pattern of 
PH4alphaSG1: the gene is expressed in the circular visceral mesoderm and in the salivary gland at 10-
12 hpf. 
 
2.4.1 - Enhancers act over longer distances than promoter-proximal DHS 
The eukaryotic genome is highly compacted in the nucleus making linear distance a 
poor estimate of 3D-space distance. Chromatin Conformation Capture technologies 
show that long distance interactions are frequent35. These observations suggest that 
the idea of enhancers regulating the closest gene in linear distance might not 
represent a general rule. When looking at the distribution of distances between the 
DHS and the associated target gene TSS among the DHS-eQTL, we see that they 
are skewed toward short distances (Figure 22a). On the other hand, the same figure 
shows that the majority of DHS to gene interactions span more than 10 kb indicating 
that long distance (within the compact Drosophila genome) DHS to gene interactions 
are very common. The same result can be observed in Figure 22b: the figure shows 
the number of genes that a DHS skips to reach its target. 74.2% of DHS were not 
associated to their closest gene, with 14.4% of the DHS skipping more than 10 
genes. Virtually all eQTL studies showed the same distributions in  Figure 2253 and 
this is consistent with the idea that DHS are still more likely to regulate genes in their 
proximity. It is important to stress again that DHS to gene distance is not a parameter 
in the eQTL model, making the distributions in Figure 22a a completely unbiased 
result. If we separate enhancers from promoter-proximal DHS we observe distinct 
behavior for the two classes. In particular, enhancers act more distally than 
promoters. To summarize, Figure 22 indicates that: (1) Both enhancers and 
promoter-proximal DHS are more likely to regulate a gene in their proximity than a 
distal one. (2) Enhancers often span long distances to reach their target genes. (3) 
Enhancers act over longer distances than promoter-proximal DHS. (4) There is 
widespread distal activity from promoter-proximal DHS. 
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One caveat of the results presented here is that the eQTL approach does not make it 
possible to distinguish cis from trans associations. For example, a variant might 
marginally affect the expression of a transcription factor in its vicinity, which in turn 
might have larger effects on the regulation of a gene many kilobases away. The 
proximal effect would not be detected while the distal would: this association would 
show as a long distance eQTL. A second caveat is that eQTLs are just capturing a 
small proportion of DHS to gene interactions. In particular, eQTLs can be found when 
a variant (or a combination of variants) changes the property of a regulatory region 
that in turn influences gene expression. Variant density is not uniform across the 
genome making some regions more likely to harbor an eQTL. The variant also has to 
affect expression in a consistent manner in order to detect a significant association. 
eQTLs in general (including DHS-eQTL) are enriched for metabolic genes whose 
changes in expression have a smaller effect on fitness. Considering these limitations, 
the results of the DHS-eQTL approach are not necessarily representative of the 
entire regulatory landscape.  
 
Figure 22 – Distribution of distances between DHS and target genes for enhancer-eQTLs and 
promoter-proximal-eQTLs. (a) Distribution of DHS to target gene TSS distance split by enhancer-
eQTLs and promoter-proximal-eQTLs. (b) Genes around each DHS-eQTL are ranked from the closest 
to the farthest (based on their TSS position). The plot shows the rank of the target gene for each DHS-
eQTL. 751 DHS are associated to their closest gene, 525 to the second closest and so on.  
 
2.4.2 - Annotation methods based on expression patterns underestimate 
enhancer to gene distance 
Enhancer activity can be tested in an ectopic context via an enhancer-reporter assay. 
This assay works by cloning a genomic region with unknown enhancer activity in 
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front (or downstream) of a reporter gene with a minimal promoter. Without enhancer 
activity from the assayed region, the reporter gene will not be expressed.  When 
integrated into the genome, an enhancer assay also reveals the tissues and times 
where the enhancer is active. This is achieved by visualizing the reporter gene 
expression. Kvon et al.59 have used such transgenic enhancer assays to study 
enhancer activity for thousands of elements during embryogenesis. They tested 
more than 10% of the Drosophila non-coding genome by dividing it in more than 
7,000 Tiles (so called Vienna Tiles) each one tested in an enhancer assay. In their 
work, the researchers associated enhancers to the closest gene with a known 
expression pattern (from BDGP72) that overlapped the enhancer assay expression. 
This gene assignment approach has a few shortcomings: (1) The Tiles span a few 
kilobases, while known enhancers are generally smaller, in the range of 300-500 bp. 
Tiles might include multiple enhancers with different activity patterns and each of 
them might regulate different genes. (2) The method relies on sparse gene 
expression data from BDGP. Less than half of Drosophila melanogaster genes had 
entries in the database at the time of the study. (3) Genes are not randomly 
dispersed in the genome; this is especially relevant for the compact Drosophila 
genome. In fact, neighboring genes tend to have similar expression patterns, 
meaning that around each enhancer there can be many genes with expression 
patterns that overlap the enhancer activity.  
Figure 23 shows the distance distribution between enhancers and target genes 
assigned by 3 methods: closest gene, the Vienna Tiles approach from Kvon et al. 
and the enhancer-eQTLs identified here. Both Kvon et al. approach and enhancer-
eQTLs show that associating enhancers to their closest genes largely 
underestimates enhancer to gene distance (Figure 23a). The main difference 
between the Vienna Tiles and the enhancer-eQTL results is in the number of genes 
skipped by each enhancer (Figure 23b). Kvon et al. associate 47.8% of enhancers to 
their closest gene while this correlation could only be found for 19.2% of enhancer-
eQTLs. This difference might be explained by the fact that the search stops at the 
first gene whose expression overlaps the enhancer activity. The DHS-eQTL 
approach shows that enhancers act over longer distances than suggested by 
correlative methods. 
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Figure 23 - Distribution of distances between enhancers and target genes from three association 
methods. (a) Distribution of enhancer to target gene TSS distance split by the method of enhancer to 
gene association: closest gene, Vienna Tiles and enhancer-eQTLs. Enhancers-eQTLs span longer 
distances than the other methods. (b) Genes around each enhancer are ranked from the closest to the 
farthest (based on their TSS position). The plot shows the rank of the target gene for each enhancer to 
gene association method. Enhancers associated to their target the “closest gene” method fall in the first 
bar by definition.  
 
 
2.5 - Enhancers and promoter-proximal DHS can regulate 
multiple genes 
In the textbook view of gene regulation, CRMs control only one target gene1. In fact, 
biological systems need to regulate gene expression in a very specific way, 
especially during embryonic development74. The assumption is that to achieve this 
accuracy, each gene has a set of unique regulators. This view is challenged by many 
observations coming from topological studies and co-expression. In fact, breaking 
insulator elements brings enhancers in contact with new target genes75, suggesting 
that some enhancers are rather promiscuous if they are given the chance to interact 
with new genes. In addition, genes that are close in the linear genome tend to be co-
expressed76, suggesting regulatory elements sharing among genes77. Despite these 
global evidences, there are only a few known examples of enhancers that regulate 
two genes71. The DHS-eQTL method tests, on a genome-wide scale, associations 
between DHS and target genes. The results provide hundreds of examples of CRM 
sharing and estimate that at least 8% of CRMs are shared by genes during 
Drosophila embryonic development.  
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2.5.1 - Example of enhancer sharing 
Figure 24 shows an example of enhancer sharing. An enhancer, open only in the 
Double Negative (non-neuro non-meso) tissue, is associated to both Caf1 and 
mRpS10 genes. BDGP reports the expression patterns of the two target genes and 
they are both expressed in the midgut, an endoderm derived tissue that is included in 
the Double Negative tissue from the FACS sorting. The DHS-eQTL model is 
unbiased towards the tissues of expression of the genes, making this an independent 
validation of the results. 
 
Figure 24 – A Double Negative specific enhancer is associated with two distal genes both 
expressed in the midgut. The figure shows an enhancer open only in the Double Negative tissue at 
10-12 hpf, associated to two distal genes: Caf1 and mRpS10. The expression patterns at stage 11-12 
(corresponding to 8-10 hpf) are displayed on the right. Both genes are expressed in the midgut. 
 
2.5.2 - The expression of genes linked to the same DHS is highly correlated 
The DHS-eQTL approach discovered hundreds of promoters and enhancers 
associated to two genes i.e. cis Regulatory Modules sharing. Variants that modify the 
function of a DHS that regulates two genes should have an impact on both genes, 
leading to co-expression across DGRP lines. To test this hypothesis, I performed a 
Pearson correlation between expression (here I used gaussianized PEER residuals) 
of genes associated to the same DHS. The qqplot in Figure 25a shows the 
correlation p-values in red. 100 (43.5%) genes associated to the same DHS were 
indeed correlated in gene expression and the p-values were lower than expected by 
chance. Genes regulated by the same DHS are not randomly located in the genome 
but tend to be in proximity of each other (Figure 25b). This result was unbiased since 
the model does not take into account the distance between genes and indicated that 
genes in the same neighborhood are more likely to be coregulated. To assess the 
significance of this result I added two controls. Firstly, the light grey dots (Figure 25a) 
show correlation p-values of random pairs of genes across the whole genome. The 
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p-values from this correlation follow closely the distribution expected for random 
correlations. Secondly, since genes located in the same neighborhood tend to be co-
expressed76, I tested if the correlation between genes that share a CRM could be 
explained by vicinity alone. I selected random pairs of genes whose distance 
matches the distribution in Figure 25b and plotted the p-values in dark gray in Figure 
25a. Genes located closely in the genome were correlated to a higher extent than 
random pairs of genes, but to a lower extent than genes that share a DHS. This 
shows that genes that share a DHS had a high degree of co-expression that cannot 
be explained by vicinity alone. 
The correlation of expression between genes associated to the same DHS can lead 
to a circular argument. In fact, the DHS-eQTL is a correlation-based test and the 
three elements (two genes and one DHS) all correlate with each other. On one hand, 
one could argue that since the eQTL tests are based on correlation, if the dependent 
variables are correlated, then they will be associated to the same independent 
variables. This would mean that only one of the genes is truly regulated by the DHS, 
while the other gene’s expression is correlated to the first. But on the other hand, 
gene expression does not correlate across the whole genome (Figure 25a) indicating 
that co-expression is caused by cis regulation. In addition, this argument is of 
concern only if the correlation of expression is caused by a factor other than cis 
regulation, such as batch effects, population structure or trans effects. The pipeline 
adopted here removed these confounding effects to the best of our knowledge, 
leaving only cis regulation as an explanation for co-expression. Other than logical 
arguments, the best way to understand causality in such an interconnected system is 
to interfere with one element and observe what happens to the others. Therefore, we 
are performing CRISPR deletion of 11 DHS associated to two genes and we will 
quantify the changes in gene expression for both targets (see “3.1 - Validation of 
complex DHS-eQTLs by in vivo CRISPR-Cas9 mutagenesis”). 
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Figure 25 – Genes associated to the same DHS are close and have highly correlated gene 
expression. (a) qqplot of Pearson correlation p-values of expression from gene pairs. The correlation is 
measured among DGRP lines. The p-value reported here is the lowest among the three time points. 
The red dots represent correlation between genes associated to the same DHS in the DHS-eQTL 
results. The light grey dots represent the correlation between random pairs of genes. The dark grey dots 
represent the correlation between random pairs of genes with a distance distribution matched to the 
genes pairs in the DHS-eQTL results. The solid line shows the expected p-value distribution for non-
significant tests, the dashed lines show 95% confidence interval. (b) Distance distribution between pairs 
of genes associated to the same DHS. The gene pairs are divided into two categories depending on if 
they are associated to an enhancer (red) or a promoter-proximal DHS (blue). Cumulative curves are 
shown on top. 
 
2.5.3 - Promoters and enhancers that regulate multiple genes show different 
relationships with target genes 
Promoter-proximal-DHS and enhancers that are associated to two genes, can have 
different physical relationships with the target genes. To better understand their 
behaviour, I separated the DHS associated to two genes in four categories 
depending on where the DHS and the target genes are located: 
• Overlapping both genes: the DHS is located in proximity (< 500 bp distance 
or overlaps) of both genes. 
• Overlapping one gene: the DHS is located in proximity (< 500 bp distance or 
overlaps) of one gene but it is distal to the other. 
• Between genes: the DHS is distal to both genes and is located in between 
them. 
• External: the DHS is distal to both genes and is located externally to them. 
Figure 26a shows a schematic of these four categories and Figure 26b displays the 
counts for promoter-proximal DHS and enhancers. While promoter-proximal DHS 
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were frequently located close to at least one of the two targets, enhancers generally 
did not overlap any of the target genes and are more often external. The promoter-
proximal DHS that overlap one gene might point to trans-eQTLs. In fact, the DHS 
could have a cis effect on the expression of the proximal gene that in turn has a trans 
effect on the second distal gene. I will further discuss this observation in the next 
section.  
 
Figure 26 – Position of DHS associated to two genes relative to the targets. (a) A schematic 
representation of four possible relationships between the DHS and the two target genes. Yellow arrows 
represent short (< 500 bp) distance between the DHS and the target gene and red arrows represent 
long distance. I classified the relationships in four categories: the DHS can overlap both genes, overlap 
one gene and be distal to the second, be distal to both genes and be located either in between the two 
genes or externally. (b) The bar plot shows the counts of  DHS belonging to the four categories. DHS 
are divided in enhancers and promoter-proximal DHS. 
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2.6 - Promoter-proximal DHS have widespread distal activity 
In this project, I divided DHS in two groups depending on their proximity to known 
TSS: enhancers are TSS distal and promoter-proximal DHS are TSS proximal. The 
promoter-proximal group included a broad range of genomic elements other than 
core promoters that are challenging to separate from each other. For example, 
promoter-proximal DHS were highly enriched for insulators (59.7% of them have an 
insulator binding site), compared to enhancers (15.2%). Within the DHS-eQTL 
results, we unexpectedly observed a high proportion of distal activity from promoter-
proximal DHS. Distal activity could come from non-core promoter elements such as 
insulators or promoter-proximal enhancers. In this section, I will expand more on the 
observation that promoter-proximal DHS are often associated with distal genes. 
 
2.6.1 - Different types of activity from promoter-proximal DHS 
Promoter-proximal DHS can have different modalities of activity depending on the 
distance to the target gene. I divided promoter-proximal DHS activity into four 
categories: local, distal, local and distal, and multiple distal. Figure 27 shows a 
schematic representation of these types of activity and an example for each.  
Assuming that promoter-proximal DHS behave as core promoters, we expect them to 
regulate genes in their vicinity. Figure 27 shows an example of promoter-proximal 
DHS with local activity: the gene Tfb4 was linked to a DHS that overlaps its TSS. 
Promoter-proximal DHS have a 3,68 odds-ratio enrichment for local activity 
compared to any other distal activity. In fact, 615 DHS-eQTLs described an 
association between a promoter-proximal DHS and a gene with a TSS within 500 bp 
from the DHS. This result is not novel, but it is very reassuring. 
1,004 DHS-eQTL describe distal activity from promoter-proximal DHS. Figure 27 
shows an example of promoter-proximal DHS with distal activity: the promoter of 
gene CG8378 was linked to the distal gene Hen1. This was an unexpected behavior 
for a core promoter, but promoter-proximal DHS also include enhancers and 
insulators that can have distal activity. One could argue that these DHS-eQTLs 
represent trans-eQTLs. In fact, a variant on a promoter might have a mild effect on 
the expression of the gene regulated by the promoter itself, that in turn leads to 
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larger effects on the gene’s targets. For example, returning to the example in Figure 
27, CG8378 is a transcription factor belonging to the Smyd gene family. If we 
suppose that CG8378 regulates Hen1, the variant causing the DHS-eQTL between 
the promoter of CG8378 and Hen1 might cause an undetectable expression change 
to CG8378 itself (mtSet uncorrected p-value > 0.1); that in turn would cause larger 
differences in the expression of Hen1. Then we will discover only the association 
between the promoter of CG8378 and Hen1. To assess if trans effects could globally 
explain distal regulation from promoter-proximal DHS, I tested if this category of 
promoter-proximal DHS is enriched to be in the vicinity of a transcription factor’s 
TSS. Compared to all the expressed genes, promoter-proximal DHS with distal 
activity were not enriched for being located at the 5’ of Transcription Factors (3.60% 
were at a transcription factor TSS, within 500 bp, compared to 3.62% of all 
expressed genes that are annotated as transcription factors). On the other hand, 
promoter-proximal DHS with local activity were depleted for being close to a 
Transcription Factors TSS (1.26%). The proportion of promoter-proximal DHS with 
distal activity in the vicinity of a transcription factor is marginal, suggesting that this 
mechanism cannot be explained by trans effects alone. 
Out of the 173 promoter-proximal DHS associated to two genes, 96 were linked to a 
gene in their vicinity together with a distal gene, while 77 were linked to two distal 
genes. Figure 27 shows an example of a promoter-proximal DHS associated to a 
local and a distal gene: the promoter of e(y)2b was associated both to itself and the 
distal gene CG1091. It also shows an example of promoter-proximal DHS associated 
to two distal genes: the promoter of gammaTub23C was associated to CG9641 and 
CG3165. Again, there was no evidence for enrichment of transcription factors TSS 
close to these DHS (4.40% of promoter-proximal DHS with local and distal activity 
were promoters of transcription factors, as were 2.74% of promoter-proximal DHS 
linked to two distal genes). 
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Figure 27 – Four types of activity from promoter-proximal DHS. Promoter-proximal-eQTLs can be 
divided into four categories. PROXIMAL: 615 promoter-proximal DHS are associated to a gene that has 
a TSS within 500 bp. On the right, a DHS-eQTL between the promoter of Tfb4 and the gene Tfb4 itself. 
DISTAL: 1004 promoter-proximal DHS are associated to a gene that does not have a TSS within 500 
bp. On the right, a DHS-eQTL between the promoter of CG8378 and the distal gene Hen1. PROXIMAL 
AND/OR DISTAL: 96 promoter-proximal DHS are associated to two genes, at least one of which has a 
TSS within 500 bp. On the right, the promoter of e(y)2b is associated to e(y)2b itself and the distal gene 
CG1091. TWO DISTAL: 77 promoter-proximal DHS are associated to two genes whose TSS are further 
than 500 bp. On the right, the promoter of gammaTub23C is linked to the two distal genes CG9641 and 
CG3165. The two genes are divergently transcribed from the same promoter and their expression is 
highly correlated. 
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2.6.2 - Promoters of convergently transcribed genes are associated to each 
other 
Within our DHS-eQTL dataset, we observed 3 cases of convergently transcribed 
genes whose promoters are associated to both genes. These may be special cases 
of promoter-proximal DHS that have both proximal and distal activity (Figure 27). 
Figure 28 shows an example: Sec61gamma and Arp10 were short genes transcribed 
in a convergent direction. Their 3’-UTR did not overlap because they use 
independent polyadenylation sites. Expression of the two genes was positively 
correlated (Pearson correlation = 0.49), indicating strong coregulation. The DHS-
eQTL results imply that both genes were linked to each other’s promoters (the 
promoter of Sec61gamma was associated to itself and Arp10 and the promoter of 
Arp10 was associated to itself and Sec61gamma). In addition, both promoters were 
bound by BEAF and CP190, two insulator proteins. These independent lines of 
evidence suggest that the promoters might loop together and regulate each other’s 
expression. These features are common to the other two promoter couples (dnk and 
snRNP-U1-C, Cdc2rk and mRpL42) indicating that this might be a rather common 
mechanism of gene regulation. We will test these three cases performing six 
independent deletions of the promoters (as discussed in “3.1 - Validation of complex 
DHS-eQTLs by in vivo CRISPR-Cas9 mutagenesis”). 
 
Figure 28 – Sec61gamma and Arp10 promoters are associated to both genes. The genes 
Sec61gamma and Arp10 are transcribed in convergent direction, but their polyadenylation sites do not 
overlap. Both promoter-proximal DHS (in red boxes) are associated to both genes, suggesting 
coregulation from promoter-proximal elements. The expression of the two genes is highly and positively 
correlated across DGRP lines. 
 
2.6.3 - Promoter-proximal DHS with distal activity show weak evidence of 
enhancer behavior 
Promoter-proximal DHS are a heterogeneous group of CRMs that encompasses 
core promoters, enhancers and insulators. We observe widespread distal activity 
from promoter-proximal DHS that cannot be explained by trans effects alone. 
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Another possible explanation is that promoter-proximal DHS with distal activity 
behave as enhancers. To assess this, I performed three tests to measure if 
promoter-proximal DHS with distal activity are in some ways different from those with 
local activity.  
Firstly, recent work from the Furlong laboratory shows that the textbook definition of 
promoters and enhancers just represents two extremes of a continuum where most 
CRMs are placed. Mikhaylichenko et al.78 showed that transcriptional Orientation 
Index (OI) is an indication of enhancer/promoter activity. Classically defined 
enhancers have bidirectional transcription while promoters are transcribed in one 
direction only. In their study, Mikhaylichenko et al. observe a continuum between 
these two extremes reflected both at the OI and the activity level. For this analysis I 
used the OI data from Mikhaylichenko et al., obtained genome-wide at 6-8 hpf, and I 
assigned an OI to each DHS in our study. Promoter-proximal DHS with strong distal 
activity (skipping at least 10 genes) showed more bidirectional transcription than 
promoter-proximal DHS with only local activity (Figure 29). The difference, despite 
being significant, is minor and it is lost when considering all promoter-proximal DHS 
with distal activity.   
Secondly, STARR-Seq79 is an in vitro technique that assesses in a direct and 
systematic way, the whole genome for enhancer function in cell culture based 
assays. STARR-Seq tests genomic fragments for enhancer function by placing them 
in a construct downstream of a core promoter. If the fragment has enhancer activity, 
it will activate the core promoter and self-transcribe. I downloaded the STARR-Seq 
data from Arnold et al.28 which was conducted in S2 cells and compared differences 
in STARR-Seq signal between promoter-proximal DHS with local and distal activity. I 
could not find any difference between the two groups, both by using the continuous 
signal from the assay or counts of STARR-Seq peaks. Enhancers act in a tissue-
specific way and the cellular context in which they are tested can bias the results. In 
particular, the STARR-Seq experiments were performed in S2 cells making it difficult 
to interpret the results in an embryonal context.  
Thirdly, I tested if the promoter-proximal DHS with proximal or distal activity show 
differences in their Transcription Factors Binding Sites (TFBS) motifs. I used a de 
novo motif discovery approach (DREME80: using the promoter-proximal DHS with 
distal activity as tested sequences and the ones with local activity as background) as 
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well as a motif enrichment approach (AME80: with the same setup). Both analyses do 
not show any noticeable difference in motif composition between the two groups. 
These results show that promoter-proximal DHS with distal activity have only weak 
enhancer signatures. Distal activity from promoter-proximal DHS does not globally 
come from elements that have enhancer-like behavior, although a portion of them 
might still be enhancers. One caveat is that DHS-eQTL described only a small 
proportion of all CRM interactions, meaning that some promoter-proximal DHS with 
local activity might have undetected distal activity as well, this would make our 
comparisons less powerful. Another explanation is that most promoter-proximal DHS 
are bound by insulator proteins, suggesting that distal activity might come from 
alterations of chromatin looping (despite we do not observe insulator binding 
enrichment in promoter-proximal DHS with distal activity). 
In conclusion, distal activity from promoter-proximal DHS probably arises from a 
combination of factors: modifications of chromatin 3D structure, enhancer activity 
from promoter-proximal DHS and trans regulation from proximal genes. 
 
Figure 29 – Promoter-proximal DHS with strong distal activity have significantly higher 
bidirectional transcription than promoters with proximal only activity. Promoter-proximal DHS are 
divided in two groups: distal activity, if they are associated to a gene that is the tenth closest or more 
distal to the DHS; proximal only if they are only associated to one of the two closest genes. The y-axis 
reports the distribution of transcription Orientation Index from PRO-Cap of the promoter-proximal DHS 
at 6-8h. 
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3 - Perspectives 
We are currently performing in vivo experiments to further validate the DHS-eQTL 
results. In particular, 12 DHS involved in complex interactions are being deleted with 
CRISPR-Cas9 mutagenesis and expression changes will be measured in the target 
genes. Furthermore, we will perform double in situ hybridization to observe the 
expression patterns of genes regulated by the same DHS. 
 
3.1 - Validation of complex DHS-eQTLs by in vivo CRISPR-Cas9 mutagenesis 
In order to validate the DHS-to-gene associations from the DHS-eQTL results, we 
are currently performing 12 DHS deletions using CRISPR technology in collaboration 
with Katharina Bender from the Furlong laboratory. The elements that will be deleted 
represent a collection of interesting results from the DHS-eQTLs and focus especially 
on CRM sharing. We plan to remove the DHS and measure gene expression of the 
genes linked by the DHS-eQTL, to further validate our discoveries. Among the 12 
CRISPR deletions there are: 
• One enhancer associated to a distal gene as discussed in “2.2.1 - Distal 
enhancer-eQTL”. We will perform one CRISPR deletion of the enhancer. 
• Two cases of enhancers associated to two distal genes (further discussed in 
“2.5.1 - Example of enhancer sharing”). We will perform 2 CRISPR deletion of 
the enhancers. 
• One case of genes whose promoters-proximal DHS are associated with each 
other but the genes are distal (further discussed in “2.6.1 - Different types of 
activity from promoter-proximal DHS”). We will perform a total of 2 
independent CRISPR deletions of the promoters. 
• Two promoter-proximal DHS associated to two distal genes (further 
discussed in “2.6.1 - Different types of activity from promoter-proximal DHS”). 
We will perform a CRISPR deletion of the promoter-proximal DHS. 
• Three cases of convergently transcribed genes, in which both promoter-
proximal DHS are associated to both genes (further discussed in “2.6.2 - 
Promoters of convergently transcribed genes are associated to each other”). 
A total of 6 independent CRISPR deletions of the promoters will be 
performed. 
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3.2 - Double in situ hybridization to validate CRM sharing 
To further validate CRM sharing, Katharina Bender, a technician from the Furlong 
laboratory, is performing double in situ hybridizations for 6 pairs of genes associated 
to the same promoter-proximal DHS and 6 pairs of genes associated to the same 
enhancer. The rationale of this experiment is that genes that are regulated by the 
same elements should be co-expressed in similar tissues and time points. We also 
know the activity patterns of the DHS, so we can expect the two targets to be co-
expressed in the same tissues where the DHS is active. For each of the 12 
experiments, the setup is similar to Figure 24 but the expression patterns will be 
observed from the same embryos. 
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4 - Discussion 
DHS-eQTLs is an effective method to associate CRMs to their target genes. By 
making use of a multivariate eQTL framework and focusing on specific genomic 
regions, it increases power and reduces the number of tests necessary in a 
traditional eQTL approach. I identified 2,973 DHS-eQTLs that describe functional 
CRM to gene associations: 2,005 are promoter-proximal DHS to gene associations 
and 962 are enhancer to gene associations. Both enhancers and promoters 
appeared to act over longer distances than suggested by other methods and I 
discussed how the field tends to underestimate long range interactions. In addition, 
the results showed hundreds of examples of promoter and enhancer sharing among 
genes, indicating that co-expression might come from sharing the same regulatory 
elements. The results also indicated that promoter-proximal DHS have widespread 
distal activity, though it is not clear through what mechanism. I described different 
modalities of regulation from enhancers and promoter-proximal DHS associated to 
multiple genes. In addition, I in silico validated the results by (1) overlap of tissue 
activity for enhancers and target genes, (2) enrichment of eQTL signal on DHS, and 
(3) Hi-C contacts enrichment, and experimentally by (4) qPCR and (5) in situ 
hybridization. Finally, I discussed 12 upcoming CRISPR deletions of DHS that will 
serve as further validations of complex DHS-eQTLs. 
The DHS-eQTL method compromised on search space and unbiased testing to 
maximize the number of DHS to gene associations. It is not an alternative to 
traditional eQTL testing but it represents a functional strategy to address a specific 
issue. This method could be successfully applied to other model organisms, including 
mammals. The genome of mammals has different properties than the Drosophila 
melanogaster one and it will present different challenges including larger linkage 
disequilibrium blocks, heterozygosity and increased genome size. Larger linkage 
disequilibrium blocks might reduce power and single CRM resolution, while the total 
number of tests will be much higher than in Drosophila. On the other hand, reducing 
the search space to DHS will have a greater impact on mammalian systems (since a 
smaller proportion of mammalian genomes is functional compared to Drosophila). In 
conclusion, the DHS-eQTL method can associate regulatory elements to target 
genes and shed light on gene expression regulation. 
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5 - Methods 
 
 
5.1 - Identification and quantification of polyadenylation sites 
and gene expression 
Gene expression is measured through Tagged Sequencing of polyadenylated RNA. 
The technique was used to redefine polyadenylation (pA) sites in Cannavò et al.53. It 
can also be used to quantify gene expression by summing the expression of all pA of 
each gene with a correlation of 0.90 to RNA-Seq53. For the best performance, it is 
necessary to refine the existing annotation of pA sites. The work from Cannavò et 
al.53 was performed by mapping reads to the Drosophila assembly BDGP5, so I 
repeated the analysis refining the methods used by Nils Koelling in Ewan Birney 
laboratory, using the more recent Dm6 (BDGP6) assembly.  
 
5.1.1 Polyadenylation sites definition 
In this work I used the Tagged sequencing data published in Cannavò et al. This is a 
collection of 3’ Tagged sequencing across 80 DGRP (Drosophila Genetic Reference 
Panel) lines and 3 developmental time points. To identify the pA sites, I pulled all 
reads across lines and time points. Since 14 samples were re-sequenced there are a 
total of 254 samples. 
3’-Tagged-Sequencing reads were trimmed to remove adapters to a uniform length 
of 44 bp using Trimmomatic81 (version 0.33). pA sites were identified with two rounds 
of mapping. In the first round, I mapped the reads to the Drosophila reference 
genome (version BDGP6) using bwa mem82 (version 0.6.1) and options “-n 5 -e 10 -q 
20”. I then excluded the reads that were mapping at this stage, as they were likely to 
be 5’ of the termination site. I selected the unmapped reads that contained at least 5 
terminal A nucleotides. In the second round, I remapped these unmapped reads in 
the same way as before after removing the terminal As. Reads that were mapped at 
this stage were defined as polyadenylation reads (pA reads). We produced a strand 
specific coverage of pA reads and defined polyadenylation sites (pA sites) as regions 
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with coverage ³ 15.  
We then applied a combination of filters to exclude low quality pA sites. Due to a 
partial failure of strand specificity in generating the sequencing libraries, highly 
expressed pA sites showed a corresponding antisense site. To remove these 
artifacts, I excluded pA sites that were perfectly included in an antisense site. In 
addition, to remove noisy and genotype specific pA sites, they are required to have 
non-zero expression (check “Quantification of pA sites and gene expression”) in at 
least 50% of the DGRP lines in at least one of the time points. 
Finally, the pA sites were expanded 200 bases upstream or until the next pA site, 
whichever is the shortest. 
 
5.1.2 - Association of pA sites to genes 
I downloaded the genome annotation from Flybase83, version 6.13. I then selected all 
annotated polyadenylated transcripts (mRNAs and ncRNAs) and produced a series 
of strand-specific genomic intervals from this subset of Flybase annotation. In 
particular, I defined: 
• mRNA pA sites: as regions 500 bases upstream and downstream from the 
last base of annotated mRNA. 
• ncRNA pA sites: as regions 500 bases upstream and downstream from the 
last base of annotated ncRNA. 
• exon: as annotated exons plus 500 bases downstream. 
• introns: as annotated introns plus 500 bases downstream. 
• distal mRNA pA sites: as regions 500 bases upstream and 10,000 bases 
downstream from the last base of annotated mRNA. 
Each of these intervals was associated to their corresponding gene according to 
Flybase 6.13 annotation from which they were derived. The pA sites identified as in 
the previous sections were intersected with these intervals. If a single pA site multiple 
features it was assigned to the highest priority feature. The priority order corresponds 
to the list above, with mRNA pA sites having the highest priority and annotated distal 
mRNA pA sites having the lowest. In the rare cases when a single pA site was 
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assigned to multiple features of the same priority but belonging to different genes, 
the pA site was left without association. 
Through this approach, a total of 24,169 (93%) pA sites were uniquely associated to 
a gene. 1,884 (7%) could not be associated to a single gene. 
 
5.1.3 - Quantification of pA site usage and gene expression 
To quantify pA site usage, I utilized the reads mapped in the first round of alignments 
described in the section in “5.1.1 Polyadenylation sites definition”. These are reads 
that map to the genome without requiring to be trimmed of terminal A nucleotides.  
Reads are then filtered for mappability issues. This step ensures comparability of 
gene expression across DGRP lines. Since all reads are mapped to the same 
reference, variants across lines might favor mapping of reads harboring the 
reference allele. These bias in quantification caused by mapping to a common 
reference are globally called mappability issues. To address this issue I used 
WASP70 (downloaded from GitHub on 2 November 2015) pipeline for mappability 
bias filtering. All reads are tested for mapping as if they were harboring any 
combination of variants across all 80 DGRP lines. Firstly, I use 
find_intersecting_snps.py to identify all variants across the DGRP lines that intersect 
any mapped read. Reads that do not overlap variants are kept. Reads that overlap 
variants are changed to all haplotype combinations across the population and 
remapped as in “5.1.1 Polyadenylation sites definition”. I then run 
filter_remapped_reads.py. The script checks that all version of each read mapped 
with a MQ>20, if so, the read is kept. I then merge all reads that passed WASP 
filtering and obtain WASP filtered bam. 
I assigned the reads to the corresponding expanded pA sites using htseq-count84 
(version 0.7.2) with options “-m intersection-nonempty -s yes –q”. I proceeded in a 
sample specific manner: I quantified pA sites usage and gene expression for our 254 
samples separately. I reasoned that gene expression could be computed by 
summing all isoforms expression following Cannavò et al. In fact, each mRNA 
molecule can generate a single unique read from its pA tail. I then summed the 
counts of all pA sites assigned to each gene to compute gene expression. Finally, I 
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library-size normalized the counts by scaling the counts by the ninetieth percentile 
(equivalent to DESeq2 library size normalization, Pearson r = 0.98). I consider 
expressed those genes that have non-zero expression for half of the DGRP lines in 
at least one time point. There is a total of 9,054 expressed genes. 
 
5.1.4 - Removal of hidden factors within the expression matrix 
I used PEER69 to correct for batch effects and hidden factors within the gene 
expression data. PEER discovers hidden factors within a matrix, fits them and can 
subtract them from the original matrix by outputting residuals. It is a useful tool to 
remove batch effects and increase power in eQTL discovery. First, I gaussianized 
the gene expression data by gene and time point (I substituted gene expression with 
the rank and fit the ranks on a gaussian distribution). I then ran PEER on 
gaussianized expression full matrix (75 lines, by 9,054 expressed genes and 3 time 
points). I used PEER with 10 hidden factors to obtain the residuals. Finally, I 
gaussianized the residuals. 
 
 
5.2 - DNase Hypersensitivity Sites analysis 
In this work I used the DNase Hypersensitivity dataset from Reddington et al. The 
data was obtained from staged Drosophila melanogaster embryos at tiling intervals 
from 2-4 hpf to 10-12 hpf. Embryos were fixed and FACS sorted for different 
markers: Mef2 was used as mesodermal marker; Wormiu at 4-6 hpf and elav from 6-
8 hpf to 10-12 hpf were used as neuroectoderm markers; cells that were not sorted 
for either mesodermal or neuroectodermal marker belong to the Double Negative 
tissue. All time points were also complemented by whole embryo (not FACS sorted) 
data. 2-4 hpf time only has whole embryo data. 6-8 hpf time mesodermal tissue was 
further sorted for bin positive and bin negative cells. This leads to a total of 19 
samples all in duplicates. 
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5.2.1 - DHS identification 
In a DNase Hypersensitivity assay, an endonuclease (DNase) digests nucleosome 
free DNA, cleaving DNA regions that are not protected by the binding of TFs. By 
analyzing sequence reads, cleaved and uncleaved sites can be identified, thus 
revealing which sites bind a lot of transcription factors (e.g. an enhancer) and which 
do not. Sites that are protected from cleavage are called hypersensitive sites. 
Although typically referred to as open chromatin regions, DNase Hypersensitive Sites 
(DHS) are by definition TF-bound regions throughout the genome.  
 
I reanalyzed the DHS data to move the annotation from the old genome assembly 
Dm3 (BDGP5) to the newer Dm6 (BDGP6) assembly that is used throughout this 
project. I followed the same analysis pipeline in Reddington et al. with the help of 
Charles Girardot from the Genome Biology Computational Support and Sascha 
Meiers from the Korbel laboratory at EMBL. We mapped the reads to Dm6 assembly 
using bwa mem keeping duplicates separate, sorted and removed duplicates and 
unmapped reads.  
 
5.2.2 - Peak calling, IDR, summit merge across samples. 
DHS peaks and summits were identified for each of the 19 biological conditions 
separately using the Irreproducible Discovery Rate (IDR) workflow described in Landt 
et al.85 and implemented with the following details. Reads in the form of BAMPE files 
devoid of duplicates were used (two biological replicates were available for each 
condition) as workflow input. MACS286 version 2.1.1.20160309 was used as the peak 
caller with parameters “-g 1.2e8 -p 0.5 --keep-dup all --call-summits”; and a 
maximum of 100,000 peaks were passed to subsequent IDR analysis. The IDR 
analysis was executed using summits reported by MACS2 “slopped” by 30 bp 
(resulting in 60 pb regions centered on MACS2 reported summits). Merging and read 
shuffling operations were performed with SAMTools87 1.3.1 (merge & bamshuf). This 
procedure resulted in 19 DHS peak sets defined as the peaks passing an IDR 
threshold of 0.05 from the IDR analysis executed on the pooled pseudo-replicates. 
This peak set is often referred to as the “optimal” peak set.  
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We then merged these 19 DHS optimal sets into the final set of DHS peaks using the 
following custom procedure. The 1 bp summits from the optimal DHS sets were 
pooled together in a coordinate-sorted BAM file using BEDTools’s bedtobam88 
2.24.0. A smoothed coverage bedgraph (representing the summit density) was then 
generated using bamCoverage from deepTools89 version 2.5.1 with parameters “--
outFileFormat bedgraph --fragmentLength 1 --binSize 1 –smoothLength 80 --
missingDataAsZero yes”. Continuous stretches of bases with non-zero scores were 
extracted as the final DHS peaks. In each final DHS peak, the summit is defined as 
the base with the highest coverage. Visual inspection of the resulting DHS peaks 
revealed that larger DHS peaks were sometimes made of two or more sub-regions. 
DHS peaks larger than 300 bp were therefore post-processed and split into different 
DHS peaks provided that each resulting peak contains at least 2 DHS summits (from 
the 19 DHS optimal sets) and is located at least 80 bp apart from another DHS peak.  
After identifying summits across conditions, I expanded them ±150 bases to define 
DHS peaks.  If two summits were closer than 300 bases, the boundary between 
them was set at the midpoint, so that the DHS peaks would not overlap. In the text, I 
always refer to DHS as the here defined DHS peaks. The final set contains 63,157 
DHS peaks.     
 
5.2.3 - Tissue-specific DHS 
I defined tissue-specific DHS in a time point specific manner. For each time point, I 
tested if a DHS is open only in one of the three tissues (Neuroectoderm, Mesoderm, 
Double Negative). In order to be called tissue-specific, a DHS is required to have a 
summit only in one tissue and to be differentially accessible in the same tissue. 
Summits are defined for each condition as described in the previous section. I 
calculated differential accessibility with DeSeq273. For each peak and condition (time 
point and tissue), I obtained a coverage track from the mapped bam files. I then 
quantified the coverage for each condition with Rsubread90 package and performed 
all pairwise comparisons between tissues at the same time point with DeSeq2. A 
DHS was considered to be differentially accessible if it had significantly higher 
accessibility in both comparisons. 
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5.2.4 - Intersection with variants 
For the DHS-eQTL tests, I tested for association only variants that were overlapping 
DHS. Firstly, I moved the DGRP vcf (Freeze 2) coordinates to the Dm6 assembly 
using GATK91. During this process, 99.7% of the variants were successfully moved to 
Dm6. Then I subset the vcf to the 75 DGRP lines included in this work. Finally, I 
filtered the vcf using vcftools92 with the following options: “--maf 0.05 --max-maf 0.95 
--min-alleles 2 --max-alleles 2 --max-missing 0.2” to include only biallelic variants 
with a minor allele frequency greater than 5% and a maximum of 20% unknown 
genotypes. The filtered vcf was then intersected with the DHS using bedtools. 
 
 
5.3 - Comparison of alternative methods to perform DHS-eQTL 
In “2.1.4 - Testing three eQTL methods within the DHS-eQTL pipeline” I tested three 
eQTL association methods to get the best performance and reliability in discovering 
DHS to gene associations. The three methods used the same input gene expression 
matrix (gaussianized PEER residuals as discussed in the section above) and 
genotype matrix. LIMIX tests for association all variants within 50 kb of the gene 
body, while mtSet and PC-regression tested for association all DHS within 50 kb of 
the gene body. In the following tests, I only included the 75 DGRP lines with 
complete gene expression data across the three time points to avoid the imputation 
of phenotypes. 
 
5.3.1 - Linear mixed model (LIMIX) 
LIMIX67 was the only univariate method tested here. It is based on a linear mixed 
model that explains a matrix (samples by conditions) of gene expression as a sum of 
a fixed effect (F) and random effects (U).  
𝑌 = 	$𝐹&
'
&()
+	$𝑈,
-
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The phenotype matrix is a 75 (DGRP lines) x 3 (time points) matrix. I used a simple 
genotype vector as fixed effect and a Kinship relatedness matrix as random effect. 
The relatedness matrix is obtained from neutrally evolving variants only. I defined 
neutrally evolving variants as those that only overlap short introns (>65 bp) following 
Grenier et al.93 and I filtered them with the same criteria as in “5.2.4 - Intersection 
with variants”. The neutrally evolving variants are then used to obtain a Kinship 75 X 
75 (sample by sample) matrix that describes the similarity between each DGRP line 
couple. 
LIMIX is used with the “any effect test” to test for any association (time-point specific 
or not) between the variant and the gene expression. I performed a total of 
17,234,822 variant-to-gene association tests. For each gene, I selected the lowest p-
value variant and corrected the p-value with Bonferroni correction (I multiplied the p-
value by the number of variants tested for association with that gene). Then, I 
corrected the best p-values for each gene with Benjamini-Hochberg FDR approach94. 
I considered FDR corrected p-values lower than 0.05 as significant. Finally, variants 
significantly associated with a gene were mapped to the DHS they overlap using 
bedtools88 to identify DHS-to-gene associations. 
 
5.3.2 - PC-regression 
I used Principal Component Regression (PC-regression) as a simple implementation 
of multiple regression. This method directly tested for association between DHS and 
the target gene. Since the number of variants overlapping the same DHS is variable 
and goes up to 90, I used Principal Components to reduce the number of 
independent variables in the regression and avoid overfitting. In particular, for each 
DHS I obtained a N x V (where N is the number DGRP lines in this study and V the 
number of variants overlapping the DHS) matrix of variants and perform principal 
components on this matrix. I then sorted the PCs by the amount of variance 
explained and defined an N x P matrix, where p is the number of principal 
components. I considered as many PC as necessary to explain 99% of the variance 
up to a maximum of 7, to avoid overfitting. The PCs are then used as independent 
variables in a multiple regression with a number of regressors from 1 to 7, depending 
on the DHS. 
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The phenotype matrix was the same used for LIMIX. In this case, I did not use any 
fixed effect. The genotype matrix corresponded to a N x V matrix where N is the 
number of samples and V the number of variants overlapping a DHS. mtSet is based 
on set test that does not incur into overfitting. For this reason, I could enter the full 
genotype matrix. The relatedness matrix was the same used for LIMIX. mtSet 
provided a p-value for each DHS-to-gene association and performed a total of 
483,064 tests. All p-values were then corrected with Benjamini-Hochberg FDR 
correction and I considered FDR corrected p-values lower than 0.05 as significant.  
 
5.3.3 - mtSet 
mtSet68 is a mixed model approach that allows for the association between multiple 
variants and multiple phenotypes while accounting for population structure. mtSet 
models a matrix of gene expression (in our case N x 3) as the sum of fixed effects 
(𝐹𝐵), the genotype matrix (𝑈6), the relatedness matrix (𝑈7) and residual noise (𝜓). 
𝑌 = 𝐹𝐵 +	𝑈6 +	𝑈7 + 	𝜓 
The phenotype matrix is the same used for LIMIX. In this case, I did not use any 
fixed effect. The genotype matrix corresponds to a N x V matrix where N is the 
number of samples and V the number of variants overlapping a DHS. mtSet is based 
on set test that does not incur into overfitting. For this reason, I can input the full 
genotype matrix. The relatedness matrix is the same used for LIMIX. mtSet provides 
a p-value for each DHS-to-gene association and performs a total of 483,064 tests. All 
p-values are then corrected with Benjamini-Hochberg FDR correction and I consider 
as significant associations those with FDR corrected p-values lower than 0.05.  
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5.3.4 - Removal of associations in linkage disequilibrium  
Despite the small LD blocks in Drosophila, neighboring DHS can still be in linkage. In 
order to avoid spurious associations caused by LD, I removed any DHS-eQTL whose 
DHS was in LD with another DHS-eQTL with strong association. In fact, both mtSet 
and PC-regression reported multiple associations for the same gene. To remove 
associations in LD I applied a stringent approach. I performed all variant to variant 
correlation and considered as in LD all correlation with a Pearson coefficient greater 
than 0.8. Any couple of DHS was considered to be in LD, if at least one variant on 
the first DHS was in LD with a variant on the second DHS. I then ranked all DHS-
eQTL from the lowest to the highest p-value and I discarded any DHS-eQTL in LD 
with another having a lower p-value. Following this procedure, 28% of DHS-eQTL 
from mtSet and 31% from PC-regression were discarded. 
 
 
5.4 - Validations of results 
 
5.4.1 - Tiling-windows-eQTL 
Tiling Windows were defined as consecutive windows of 300 bp. Each chromosome 
was split into 300 bp tiling windows and all windows within 50 kb of a gene’s body 
were tested for association with that gene. The association pipeline was identical to 
“5.3.3 - mtSet”.  
The enrichment of eQTL signal on DHS was obtained by merging the uncorrected p-
values from the 483,064 DHS-eQTL tests and the 2,892,787 TW-eQTLs tests. The 
raw p-values were corrected for multiple testing using Benjamini-Hochberg FDR and 
the enrichment was obtained by odds ratio. 
Enrichment of TW-eQTLs on genomic features was obtained by overlapping TW-
eQTLs with the BDGP6 genome annotation from FlyBase 6.13. The number of bases 
between the TW-eQTL and the feature was counted for every TW-eQTL and divided 
by the total number of TW-eQTL bases. Enrichments were obtained by using 10 
random sets of TWs. 
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5.4.2 - DHS and genes tissue overlap  
I downloaded the BDGP annotation72 on the 24 of July 2017.  The annotation 
reported a fixed term tissues of expression annotation by stage of development. I 
focused on stages from 13 to 16 that overlap the 10-12 hpf time point. All BDGP 
specific terms were mapped to more general terms, that were in turn assigned to the 
3 tissues from the DHS FACS sorting to have matching terms between datasets. In 
particular, Table 4 showed the correspondence between general BDGP terms and 
the 3 FACS sorted tissues. I ignored terms mapped to “none” annotation. For each 
gene, I took the union of all annotations it was mapped to. I excluded genes that are 
expressed in “ambiguous” tissues (these tissues cannot clearly be assigned to only 
one of the three FACS sorted tissues). Finally, I defined as tissue-specific, those 
genes that are expressed in only one of the three FACS sorted tissues. 
I identified tissue-specific enhancers as described in “5.2.3 - Tissue-specific DHS” 
and considered only enhancer eQTLs where both the gene and the DHS are tissue-
specific. I excluded promoters from this analysis because the majority of them are 
ubiquitously open and in close proximity to the target gene. I then divided the tissue-
specific enhancer-eQTL into two categories:  
• coherent enhancer-eQTLs were associations between a tissue-specific 
enhancer and a tissue-specific gene active in the same tissue. 
• incoherent enhancer-eQTLs were associations between a tissue-specific 
enhancer and a tissue-specific gene active in different tissues. 
The enrichment of coherent enhancer-eQTLs was assessed by performing 10,000 
random enhancers to gene associations. In particular, I selected 2,973 random DHS 
to gene associations among all those tested in the DHS-eQTL. I then proceeded as 
for the enhancer-eQTLs and obtained the proportion of coherent versus incoherent 
enhancer-eQTLs. Finally, I obtained an empirical p-value by comparing the coherent 
versus incoherent ratios from the permutations to that observed from the enhancer-
eQTLs. 
 
5.4.3 - CRISPR deletions 
The entire CRISPR deletion protocol was performed together with Katharina Bender 
and Songjie Feng. The deletions were performed in the vasa-Cas9 Drosophila 
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melanogaster line95 (Bloomington ID: 51324). The guide RNAs were designed using 
Target Finder website (http://targetfinder.flycrispr.neuro.brown.edu) using the fully 
sequenced vasaCas9 personalized genome to identify potential off-target sites. We 
always deleted the entire DHS involved in the DHS-eQTL and designed the guides 
so that the entire peak signal in all tissues would be deleted. The deletions sizes 
range from 450 to 2,000 bases. The guide RNAs are 20 nucleotides long. In order to 
minimize the chance of off-target cuts, we always preferred guide RNAs identified 
with “maximum” stringency setting. In case this was not possible, we used guide 
RNAs with “high” stringency and 0 predicted off-targets. The guide RNAs were 
cloned in the bacterial plasmid #1823 pBs-U6-gRNA-BbsI. 
In order to have an efficient deletion of the target sites after CRISPR cuts the 
genome, we designed homology arms flanking the deleted region. The homology 
arms were PCR amplified from the vasa-Cas9 genomic DNA using oligos with a 
melting temperature of approximately 60°C and a GC content ranging from 40 to 
60%. The homology arms are approximately 1 kb long. The homology arms were 
cloned into the bacterial vector pHD-dsRed-attP #1473. To insert the homology arms 
into the vector, we used AarI restriction enzyme for the left and SapI for the right 
homology arms. If the restriction site was not present, restriction cloning was used. 
Finally, if there were internal cut sites, we either switched to InFusion cloning or 
changed the order of homology arms insertion.  
After bacterial amplification of the homology arms, they were injected, together with 
the guide RNAs, into approximately 100 embryos of the vasa-Cas9 line. The injection 
mixes contained 150ng/µL donor plasmid for recombination and 75ng/µL of each 
gRNA in 20µL injection buffer. 
The vasa-Cas9 line expresses the Cas9 protein in the ovary giving rise to chimeric 
progeny. The first cross of F0 will be crossed with yellow-white flies to amplify the 
transgenic flies. The offspring will be crossed with the respective balancer lines, 
depending on what chromosome harbors the deletion. Finally, the third cross will be 
performed between siblings to obtain a homozygous stock if it is viable. 
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5.5 - Comparison with external databases 
The enhancer to gene associations from Kvon et al.59 were obtained from 
Supplementary Table 4 at: https://doi.org/10.1038/nature13395. The coordinates 
were moved to BDGP6 genome assembly. The Tile to gene distance was measured 
from the center of the Tile to the major gene TSS. The “closest gene” associations 
were obtained by assigning all enhancers involved in an enhancer-eQTL to their 
closest gene. Enhancer to gene distances were measured from the center of the 
enhancer to the major TSS of the gene both for the DHS-eQTL associations and the 
“closest gene” associations. 
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III - Gene expression variation among Drosophila 
melanogaster lines from five continents 
 
 
1 - Introduction 
 
1.1 - Geographic isolation causes population structure 
Individuals from the same species often cannot intermix as they are restricted by 
geographic limitations. Geographic isolation leads to the formation of populations, 
that behave as semi-independent groups of individuals. In fact, geographic isolation 
of populations causes an accumulation of differences that lead to population 
structure. If individuals from two populations remain isolated and therefore cannot 
mate, their variant pool will accumulate differences through two mechanisms. Firstly, 
variants that appear after the separation of the two populations will not be shared 
among them. Secondly, the allele frequency of the variants they shared before the 
separation will change due to drift or selection. Therefore, geographic isolation 
causes uneven allele frequency among populations, which can be assessed by 
statistical tests such as the fixation index (𝐹9: ). The accumulation of differences 
among populations may be under selective pressure, which could ultimately lead to 
phenotypic differences between populations. Measuring differences between 
populations is crucial to retrieve the migration history of a species and understand 
the mechanism through which species adapt to new environments. 
 
1.2 - The Global Diversity Lines are a panel of Drosophila lines from five 
continents 
Drosophila melanogaster has long been used as a model organism to study 
population genetics. The majority of population genetics studies on D. melanogaster 
have focused on inbred lines from a defined geographic location63. This setup 
increases power in association studies by removing population structure and allows 
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for the application of models that assume random mating. However, a few studies 
have focused on capturing differences between D. melanogaster populations. In 
particular, the laboratory of Andrew Clark has generated a panel of D. melanogaster 
inbred lines from five continents called the Global Diversity Lines93 (GDL) to further 
investigate population structure and infer D. melanogaster migration history. The 
GDL include a panel of 85 populations from 5 defined geographic locations: 
Netherlands, Tasmania, Ithaca, Beijing and Zimbabwe. The GDL were obtained by 
collecting multiple individuals from the same locations, which were allowed to inter-
breed to create a stable genetic pool. Subsequently, a few individuals from the pool 
were selected and went through ten cycles of inbreeding, giving rise to each line. 
To infer population structure among the GDL, Grenier et al.93 performed a Principal 
Component analysis on neutrally evolving variants. Variants evolving neutrally arise 
and drift at a constant speed because they are not under positive or negative 
selective pressure. Figure 30 shows the results of the PCA. The first PC separates 
the Zimbabwe lines from the non-African populations, indicating that it is the most 
different from the others. The second PC separates the Beijing population. 
European, Australian and North American populations cluster together, reflecting 
their more recent separation from a common population. 
 
Figure 30 – Population structure among the Global Diversity Lines (from Grenier et al.93). The 
plots show the first three PCs from the neutrally evolving variants of the GDL.  
 
1.3 - Migration history of Drosophila melanogaster 
Drosophila melanogaster is a human commensal and its migrations history is closely 
related to that of our species96. This fly species originated in the sub-Saharan 
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region97 and colonized all continents in recent times. It is estimated that D. 
melanogaster left Africa for the first time after the end of the last ice age and quickly 
spread in Europe and Asia98. Following human migration, D. melanogaster recently 
colonized the Americas and Oceania99. Similarly to human, the African populations 
represent the most ancient and diverse population from the genetic variation 
standpoint. Moreover, they are the most subdivided populations from the other 
continents93. Different populations are not completely isolated from each other. 
Arguello et al.99 estimated the extent of admixture between D. melanogaster 
populations finding a high correlation with commercial routes. In particular, the 
European, American and Australian populations have inter-mixed to a high extent, 
while the African and Asian populations have remained more isolated. 
The population genetics studies presented so far are based on genetic variation. As 
discussed in chapter “IV - Impact of natural sequence variation on Drosophila 
melanogaster chromatin accessibility”, the majority of genetic variants do not have 
any obvious impact on phenotype. In this chapter, I will present a newly generated 
gene expression database of the Global Diversity Lines. The goal is to assess the 
impact of genetic variation on gene expression during embryonic development within 
this diverse genetic populations. 
 
1.4 - Overview of the project 
In this project, we aim to measure and analyze gene expression patterns across the 
Global Diversity Lines during embryonic development. We performed RNA-Seq on 
83 GDL whole embryos staged at 10-12 hpf. The goal of the project is to gain insight 
into the transcriptome differences between D. melanogaster inbred lines from five 
continents. In addition, we used the newly generated gene expression dataset to call 
expression QTLs.  
The project has been developed in collaboration with the laboratory of Andrew Clark 
at Cornell University, USA. They performed the staged embryo collections and 
shipped the samples. The RNA extraction and library preparation were performed by 
Lucia Ciglar, a technician from the Furlong laboratory. I have performed the analysis 
of the RNA-Seq data with the collaboration of Federica Mantica, a visiting scientist in 
the Furlong laboratory.  
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2 - Results 
We performed RNA-Seq on whole embryos from the GDL lines staged at 10-12 
hours post fertilization and performed multiple quality control steps to ensure high 
data quality. We identified genes that were differentially expressed among 
populations and characterized them. In addition, gene expression-QTL and exon 
expression-QTL were called to dissect the regulatory landscape of D. melanogaster. 
 
 
2.1 - A panel of Drosophila gene expression from 5 continents 
The Global Diversity Lines constitute a panel of fully genotyped D. melanogaster 
lines from five continents93. To complement the genotype information and gain 
insight into developmental patterns across continents, we performed RNA-Seq on 
whole embryos staged at 10-12 hpf. The RNA-Seq dataset includes (Figure 31): 
• 18 lines from Tasmania (Oceania) 
• 14 lines from Ithaca (North America) 
• 18 lines from the Netherlands (Europe) 
• 16 lines from Beijing (East Asia) 
• 17 lines from Zimbabwe (Africa) 
 
 
Figure 31 – Schematic representation of the Global Diversity Lines RNA-Seq dataset. We 
performed RNA-Seq on 83 Global Diversity Lines coming from five continents. The figure indicates the 
geographic location of origin of the lines and the number of sequenced lines belonging to that region. 
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In addition, to gain insight into the dynamical expression changes during 
development, we performed RNA-Seq on 6 lines (two lines from Ithaca and one line 
of the other populations) staged at 2-4 hpf and 5 lines (one per population) staged at 
6-8 hpf. Finally, two lines were sequenced in duplicates for a total of 96 RNA-Seq 
samples. In the following pages, I will discuss the quality control pipeline and the 
filtering steps that were adopted to remove problematic samples. In particular, we 
controlled for: 
• RNA-Seq mapping quality by analyzing multiple metrics from Samtools87 and 
Picard100;  
• RNA-Seq protocol reproducibility by correlation of technical duplicates; 
• Sample staging by comparing each sample with the corresponding 
modENCODE RNA-Seq data101; 
• Potential batch effects caused by sample transportation, RNA extraction, 
mRNA isolation and sequencing. 
 
2.1.1 - RNA-Seq mapping and quality control 
The raw reads files were mapped to the BDGP6 assembly using STAR102. Gene 
expression was quantified with RSEM103 (See “5 - Methods” for a complete 
discussion of the mapping pipeline). We assessed the mapping quality using multiple 
metrics from Samtools87 and Picard100 and we summarized and compared them 
using MultiQC104.  All samples showed high quality in all metrics except for one 
sample from Tasmania (T36B) that showed evidence of RNA degradation. The 
sample was removed from the subsequent analysis. 
 
2.1.2 - Batch effect quality control and correction  
Samples from different populations were processed and sequenced in a randomized 
manner to better dissect potential sources of batch effects. In particular, we 
controlled for four batch effects by Principal Component Analysis: 
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• Transportation box (the embryos staged at 10-12 hpf were shipped in 10 
separate boxes) 
• RNA extraction batch (the RNA extraction was performed in 10 separate 
days) 
• mRNA isolation batch (the mRNA isolation was performed in 10 separate 
days, randomizing the batches for the RNA extraction) 
• Sequencing set (the samples were sequenced on 4 independent Illumina 
lanes) 
Supplementary Figure 8 displays the RNA-Seq data separated by the first three PCs 
and colored by the four potential batch effects. The samples showed no structure 
when divided by mRNA isolation date and sequencing sets. On the other hand, the 
first principal component clearly separated the samples shipped in box 9 and whose 
RNA was extracted on the 18/01/2017 (Box 9 was processed on day 18/01/2017, so 
it was impossible to disentangle the two effects). We concluded that the RNA 
samples shipped in box 9 were corrupted and removed them from the following 
analysis. Further analysis showed that these same samples have high rRNA 
percentage despite mRNA isolation by polyA enrichment. Following this observation, 
we excluded all samples that had a rRNA content higher than 35% of total RNA. This 
step removed all visible batch effects from our data. 
 
2.1.3 - RNA-Seq provides a reliable measure of gene expression 
Two RNA-Seq samples were sequenced in duplicates to assess technical variability. 
The RNA extractions and sample preparations were performed independently from 
the same embryo collections ensuring a control of the entire RNA-Seq protocol. 
Figure 32 shows the correlation between ZS29 and ZW190 technical duplicates. The 
correlations exceed 0.98 showing high reproducibility of the RNA-Seq 
measurements. 
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Figure 32 – Biological replicates show high correlation. The scatterplot shows the correlation 
between two biological replicates for the Zimbabwe lines ZS29 and ZW190. The Spearman correlation 
coefficient is shown under the line’s names. 
 
2.1.4 - Staging of samples by comparison with modENCODE gene expression 
In order to confirm that the staging of the embryo collections was at the expected 
time point during development, we performed an in silico staging analysis, as we’ve 
performed previously53. In particular, we correlated the gene expression 
measurements from our GDL samples with a two-hour time-course done in reference 
strain (modENCODE105). The modENCODE gene expression data were generated at 
time points ranging from 2-4 hpf to 22-24 hpf. We downloaded and processed the 
modENCODE RNA-Seq samples in the same way as the GDL samples (see “5 - 
Methods”) and performed a Spearman correlation between gene expression values. 
Figure 33 shows the correlation of GDL samples staged at 10-12 hpf with 
modENCODE samples from 2-4 hpf to 12-14 hpf. The GDL samples were highly 
correlated with the corresponding modENCODE samples and showed a slight shift 
towards the later time window (12-14 hpf). This is consistent with the results from 
Cannavò et al.53 (Supplementary Figure 1) confirming that the samples are tightly 
staged. All GDL samples displayed the same trend except for one sample that was 
removed from subsequent analysis (the unstaged sample is also visible in Figure 34 
as clustering with samples at 6-8 hpf). We repeated the same analysis for the GDL 
samples staged at 2-4 hpf and 6-8 hpf obtaining the highest correlations at the 
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expected time point for all samples. These results confirm that the collections have 
been performed ensuring precise staging of the embryos. 
 
Figure 33 – Staging of samples at 10-12 hpf. The plot shows the correlation between GDL whole 
embryo samples staged at 10-12 hpf and modENCODE whole embryo samples staged from 0-2 hpf to 
12-14 hpf. 
 
2.1.5 - Samples separate by stage 
As a final quality control, we assessed if all GDL samples separated by stage. We 
included all sample from 2-4 hpf to 10-12 hpf and performed a PCA. Figure 34 shows 
the results of the PCA. The samples are clearly separated by developmental stage 
by the first PC. The first PC explains a high proportion (38.2%) of gene expression 
variation. This is a comforting result that confirms the high quality of the final dataset. 
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Figure 34 – PCA separates samples by stage. Principal Component Analysis of all sequenced 
samples. The samples are colored by stage. The first PC explains 38.2% of gene expression variation 
and clearly separates samples by stage. 
 
 
2.2 - Transcriptome differences among continents 
We performed a differential expression analysis across populations to identify 
patterns of expression that are population specific. Through differentially expressed 
genes, we quantify the differences across transcriptomes. Below, I discuss the 
strategy to identify and classify differentially expressed genes.  
 
2.2.1 - Differential expression is more accentuated at the transcript level 
The GDL populations have accumulated genetic differences during thousands of 
reproductive cycles. The larger dissimilarities at the genetic level can be seen 
between the African lines and the other populations. In addition, the African and 
Asian lines have experienced little admixture, meaning that their genetic pool is more 
isolated99. On the other hand, the European, American and Australian lines were 
separated recently and are less differentiated. We investigated if the population to 
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population distances visible at the genetic level is also present at the transcriptomic 
level.  
Firstly, we performed a PCA on gene expression levels and were surprised to obtain 
no clear separation between populations. This indicates that there is no global 
structure at the transcriptome level. Performing the PCA on specific gene groups that 
are more likely to be under selective pressure (such as metabolic or olfactory genes) 
also gave no clear population structure. 
Secondly, we implemented a differential expression analysis both at the gene and 
transcript level. Gene and transcript expression was quantified using RSEM103 and 
differential expression was computed with DESeq273. We compared each population 
against all the others taken together to identify population specific patterns of 
expression. Figure 35 a and c respectively show the number of differentially 
expressed genes and transcripts per population. In both cases, the Zimbabwe 
population has the most differentially expressed elements compared to the others, 
consistent with the findings at the genetic level. Surprisingly, the Beijing line, despite 
being more recent, has a similar number of differentially expressed genes. This could 
be explained by the relative isolation that this population has experienced99. On the 
other hand, the most recently separated populations (Ithaca and Tasmania) only 
have a handful of differentially expressed genes and transcripts. Another interesting 
observation is that differences are more accentuated at the transcript level compared 
to the whole gene level. 
A technical caveat of the “1 vs all” setup is that it might underestimate differential 
expression for the populations of European descendance (Netherlands, Ithaca and 
Tasmania). In fact, these three populations are similar to each other and by having 
two lines with similar expression patterns in the background group, DESeq2 is less 
likely to find differentially expressed elements. To address this issue, we performed a 
“1 vs 1” differential expression analysis between all population pairs (Figure 35b,d). 
When comparing populations of European descendance with the African or Asian 
populations directly, we identify a comparable number of differentially expressed 
gene except for the Tasmania lines, that show more differentially expressed genes 
than in the global analysis. The strongest effect is seen in the “Zimbabwe vs 
Tasmania” comparison. In addition, the pairwise comparisons between populations 
of European descendance show that the “1 vs all” test underestimates the number of 
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differentially expressed genes in these populations. In conclusion, the “1 vs 1” setup 
shows a higher extent of differential expression for the Tasmania lines than 
estimated “1 vs all” setup, but it confirms that Ithaca and Netherlands populations 
have less transcriptional differences from the other lines. 
 
Figure 35 – Number of differentially expressed genes and transcripts. (a) The bar plot shows the 
number of differentially expressed genes for each population within the GDL. (b) The bar plot shows the 
number of differentially expressed genes for each one to one contrast between populations. (c) The bar 
plot shows the number of differentially expressed transcripts for each population within the GDL. (d) The 
bar plot shows the number of differentially expressed transcripts for each one to one contrast between 
populations. Differential gene and transcript expression were obtained by comparing one line with all the 
others. 
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2.2.2 - Genes enrichment among differentially expressed genes 
To characterize the differentially expressed genes among populations we performed 
a Gene Ontology enrichment analysis. In all the population except for the Netherland 
and the Tasmania, we did not identify significantly enriched groups of genes among 
the differentially expressed ones. This suggests that a large portion of differential 
expression is caused by drift and is not necessarily functional, though further 
analyses are required to corroborate this statement.  
On the other hand, the differentially expressed genes in the Netherland lines are 
more than 20-fold enriched in genes linked to cuticle development. This is observed 
both in the global and pairwise tests. The cuticle is secreted from embryonic stage 
16106 (corresponding to 13 hpf to 16 hpf) until later larval stages and it confers the 
embryo a protection from water and external stresses. The cuticle production genes 
are overexpressed in the Netherland population at 10-12 hpf indicating an anticipated 
or more abundant secretion of cuticular proteins in the European lines. The 
overexpression of cuticle genes might confer resistance to environmental conditions 
specific to the Netherlands, such as the colder weather.  
In addition, a Gene Ontology analysis of the differentially expressed genes in the 
Tasmania lines shows that they are enriched for translation, mitochondrial functions 
and energy metabolism in general. These results are seen only when contrasting the 
Tasmania line against the African and Asian populations (Figure 35b,d) and indicate 
metabolic differences between the Australian lines and the others. 
Taken together these results support the hypothesis that a large proportion of 
differential gene expression might be caused by drift. Nevertheless, the Netherlands 
and Tasmania lines show evidence of adaptation by having differentially expressed 
genes associated respectively to cuticle secretion and energy metabolism. 
 
 
2.3 - Identification of gene and exon eQTLs 
The GDL expression dataset represents a wealth of information that can be used for 
association studies. In contrast to our previous eQTL study on the DGRP lines, which 
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used 3’-Tagged-Sequencing as a measure for gene expression53, here we can use 
the full length RNA-seq data described above.  This has the advantage of reducing 
the impact of mapping biases, due to the extensive RNA-seq coverage over the body 
of the gene.  However, the major challenge of this dataset is its inherent high degree 
of population structure. To address this, we used LIMIX, a linear mixed model that 
accounts for population structure in the association test to identify eQTLs. As input 
we used the filtered set of RNA-seq data for 65 lines that were fully genotyped  
(Grenier et al.93) and passed all quality control steps, and then corrected for hidden 
batch effects with PEER69 and for mapping biases using WASP70 (see “5 - 
Methods”). In total, we quantified the expression for 11,382 genes and 63,607 exons. 
We separately tested for eQTLs that are linked to gene expression (gene-eQTLs) 
and exon coverage (exon-eQTLs). In total, we discovered 903 gene-eQTLs and 
2,021 exon-eQTLs. The gene-eQTLs and exon-eQTLs show a similar distribution of 
distances from the target gene TSS (Figure 36a). The distribution is consistent with 
previous eQTL studies in D. melanogaster53 and in vertebrates107 (see also “II - 
Genetic variation as a tool to associate cis Regulatory Modules with their target 
genes”). Exon-eQTLs are more concentrated on the target gene body than gene-
eQTLs (Figure 36b).  Although expected, this is very reassuring and suggests a 
direct regulation of exon usage at splice junction sites. On the other hand, gene-
eQTLs are found more often at the TSS and in the target gene surroundings.  
 
Figure 36 – Distribution of gene-eQTL and exon-QTL distance from TSS and around target gene. 
(a) Distribution of eQTL distance from target gene TSS. gene-eQTL are shown in blue, exon-eQTL in 
red. (b) Distribution of eQTLs around target gene. TSS: Transcription Start Site; TES: Transcription End 
Site 
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2.3.1 - gene-eQTL 
64.7% of genes with a gene-eQTL also have an exon-eQTL. If the total level of gene 
expression changes, this should be reflected at the exon level as well. On the other 
hand, the exon-eQTL require a 6-fold higher number of statistical tests and exons are 
covered by fewer reads than genes, making the exon-eQTL analysis less powerful. 
As seen in other studies53, eQTL genes are weakly enriched for metabolic processes. 
Figure 37 shows an example of gene-eQTL where the coverage is uniformly higher 
for all exons in the minor allele flies. 
 
Figure 37 – A gene-eQTL in the second intron of Sas-6 increases the gene expression. The 
heatmap shows in blue the forward RNA-Seq coverage for all GDL lines divided by Major and minor 
allele. The average coverage for the Major and minor alleles is shown in red. The star indicates the 
position of the causal variant. 
 
2.3.2 - exon-eQTL 
45.6% of genes with an exon-eQTL also have a gene-eQTL. The tests are performed 
independently from each other making it likely for exon-eQTLs to be discovered for 
genes with a gene-eQTL. The remaining 54.4% of exon-eQTLs point to specific exon 
usage changes that do not globally affect gene expression. This fraction of exon-
eQTLs has an effect on alternative splicing alone because it is not associated with 
changes in total gene expression large enough to lead to a gene-eQTL. Genes 
involved in exon-eQTLs are weakly enriched for RNA binding and catalytic activities. 
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An example of exon-eQTL is shown in Figure 38, where the 10th exon of the gene 
FANCI has 2.3 times higher coverage in the minor allele compared to the major.  
Coverage differences supporting differential inclusion are visible exclusively at the 
level of this exon. The exon coverage change is associated with a variant in a 
neighboring exon that might cause differences in splicing preferences between the 
two alleles. 
 
Figure 38 – An exon-eQTL in the 12th exon of the gene FANCI decreases the usage of its 10th 
exon. The heatmap shows in blue the reverse RNA-Seq coverage for all GDL lines divided by Major 
and minor allele. The average coverage for the Major and minor alleles is shown in red. The star 
indicates the position of the causal variant. The black box indicates the exon with differential coverage 
between Major and minor alleles. 
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3 - Perspectives 
 
 
 
 
3.1 - RNA sequencing of whole embryo samples at 2-4 hpf and 6-8 hpf 
The gene expression dataset presented in this section is staged during cell 
differentiation (10-12 hpf). To complement the dataset with additional time points 
during development, we plan to obtain samples stage at 2-4 hpf (during multipotent 
stage) and at 6-8 hpf (during cell specification) for the same GDL lines. This will 
increase our time resolution and allow us to make gene expression comparisons 
during development. In particular, since development is a canalized process, we aim 
to assess if gene expression diversity increases during development. To better 
achieve this goal and control for batch effects, we already sequenced one line per 
population at 2-4 hpf and 6-8 hpf. This will allow us to disentangle clustering by hours 
post fertilization from sequencing batch. 
 
3.2 - Identification of selective pressure on gene expression 
In addition, in collaboration with other groups, we plan to expand on the evolutionary 
insights that can be acquired by analyzing this dataset. The differential expression 
analysis confirms the population separation observed at the genetic level. On the 
other hand, except for the cuticle gene overexpression in the Netherlands population 
and the energy metabolism genes in the Tasmania population, the genetic signatures 
of differentially expressed genes are difficult to interpret. We aim to identify genes 
under selective pressure to find patterns of adaptation among the five populations. 
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4 - Discussion 
 
In this chapter, I have discussed the generation of an RNA-Seq dataset of D. 
melanogaster staged whole embryos from the Global Diversity Lines. The dataset 
included a few problematic samples that were carefully identified and excluded from 
the analysis. The other samples displayed high quality scores on multiple metrics 
and are at the expected stage of embryogenesis (comparison to modENCODE data).  
In contrast to the DNA variants, Principal Component Analysis of gene expression 
does not show any visible population structure. The same is true when sub-setting 
for genes in functional categories, suggesting that the majority of gene expression 
variation is not under selection. Differential expression analysis confirmed that the 
African population is the most separated from the other populations, with the 
difference being stronger at the transcript compared to the gene level. In addition, the 
differential expression analysis revealed an overexpression of cuticle related genes 
in the Netherlands population at 10-12 hpf and differential expression of genes linked 
to energy metabolism in the Tasmania population. Finally, we identified 903 gene-
eQTLs and 2,021 exon-eQTLs. By using a linear mixed model, the high degree of 
population structure was controlled for. Variants with an effect on exon usage tended 
to be spread along the gene body.  
The gene expression dataset presented here represents a wealth of information for 
the Drosophila population genetics community interested in migration and evolution 
of the melanogaster species. 
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5 - Methods 
 
 
5.1 - RNA-Sequencing and mapping  
 
5.1.1 - Generation of staged, high quality RNA-Seq libraries 
The samples were collected by the laboratory of Andrew Clark at Cornell University. 
The embryos were fixed in formaldehyde, frozen and shipped with dry ice to the 
Furlong laboratory. RNA was extracted and prepared for sequencing using NEBNext 
ultra directional RNA library prep kit for Illumina sequencing (NEB). The NEBNext 
protocol performs mRNA isolation by poly-A enrichment. The RNA was directionally 
reverse transcribed to cDNA. The cDNA was amplified with 11 PCR cycles. The 
samples were multiplexed and sequenced in 4 batches on Illumina NextSeq 500 HI. 
Reads were 75 bp long and paired-end. We achieved a median of 10 million unique 
mapping reads per sample. 
 
5.1.2 - Mapping and gene expression quantification 
We built the gene expression quantification pipeline around RSEM103. RSEM uses 
STAR102 to map directly on the transcriptome. It can also model the likelihood of a 
read coming from different isoforms if the read does not clearly belong to any. We 
merged the fastq of technical duplicates to increase coverage. Reads were mapped 
using STAR (version 2.5.2a) with default parameters and the quantification of both 
genes and isoforms was performed using RSEM (rsem-calculate-expression). The 
transcript assembly was based on BDGP6 genome assembly and Flybase 6.13 
genome annotation. RSEM provides Transcript Per Million (TPM) as a measurement 
of transcript and gene expression. 
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5.2 - RNA-Seq quality control 
 
5.2.1 - FastQC and Picard quality control statistics 
We collected a wealth of quality control statistics from unmapped (fastq files) and 
mapped (bam files) reads. In particular, we used fastqc to collect metrics about the 
sequencing. In addition, we run Picard100 MarkDuplicates, CollectRnaSeqMetrics, 
CollectAlignmentSummaryMetrics and CollectMultipleMetrics on the mapped files 
from STAR. The statistics were collected with MultiQC104 for easier visualization. 
 
5.2.2 - Principal component analysis to control for batch effects 
We performed principal component analysis on TPM gene expression measurement 
from RSEM. We included samples staged at 10-12 hpf and colored them by: 
transportation box, RNA extraction day, mRNA isolation day and sequence set. After 
removing all samples with high rRNA content, mRNA degradation and incorrect 
staging, we were left with 72 high quality RNA-Seq samples. 
 
5.2.3 - Staging comparison with modENCODE data 
We downloaded the RNA-Seq data from modENCODE (Celniker et al.101) as a 
reference for staging. Gene expression was quantified using RSEM as in “5.1.2 - 
Mapping and gene expression quantification”. We performed Spearman correlation 
between gene expression for each GDL sample with each modENCODE sample to 
check if samples had the expected gene expression signature associated with their 
time point. To this end, we ascertained that the GDL samples had the best 
correlation scores with the corresponding modENCODE sample. 
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5.3 - Differential gene expression between continents and 
gene enrichments 
 
5.3.1 - Retrieving population structure from gene expression  
We performed a Principal Component analysis on gene expression values to 
separate the lines by population. No visible structure was present. We then 
performed the same analysis on gene groups that could potentially be under 
selective pressure. We performed a PCA on genes annotated as belonging to the 
following Gene Ontologies: “Metabolic Process”, “Heat-Related”, “Olfact-related”,  
 
5.3.2 - Differential gene and transcript expression 
We quantified gene expression using RSEM (as described above) for the 72 lines 
staged at 10-12 hpf that passed all quality control steps. The “expected counts” from 
RSEM were rounded to the next unit and used as a measure for gene expression. 
Differentially expressed genes and transcripts were identified with DESeq273. We 
compared each population against all others (e.g. Ithaca vs Netherlands, Tasmania, 
Zimbabwe and Beijing) performing 5 tests in total. In this way population specific 
patterns of gene expression could be identified. On the other hand, Ithaca, 
Netherland and Tasmania populations are very similar to each other: to assess the 
impact of this setup, we performed all 10 pairwise comparisons.  
 
5.3.3 - GO enrichment of differentially expressed genes 
We performed Gene Ontology enrichments using R package GOstats108. The 
enrichments were performed separately for the 3 major GO categories: “Molecular 
Function”, “Cellular Component” and “Biological Process”. The enrichments were 
calculated using Fisher exact tests and the p-values were corrected using the 
Benjamini-Yekutieli procedure.  
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5.4 - QTL call 
We built an eQTL pipeline to discover gene expression-QTL (gene-eQTL) and exon 
usage-QTL (exon-eQTL). We mapped reads to the reference genome and removed 
controlled mappability biases using WASP70. The major challenge for association 
studies represented by the Global Diversity Lines is the high degree of population 
structure. Relationships between samples create spurious associations between both 
variants and gene expression. To this end, we used a linear mixed model approach 
that includes the population structure and excludes associations that arise from the 
population structure alone. We used LIMIX67, a python implementation of linear 
mixed models. 
 
5.4.1 - Mapping and WASP filtering  
We mapped the reads using STAR102 (version 2.5.2a) with options: “--alignIntronMax 
100000 --outFilterIntronMotifs RemoveNoncanonical --outFilterType BySJout --
outSAMunmapped Within --readFilesCommand zcat”. We filtered reads with 
mapping biases using WASP70. We then removed duplicates reads with Picard tool. 
This pipeline didn’t allow us to use RSEM for quantification since WASP requires two 
rounds of mapping to the genome.  
 
5.4.2 - Gene and exon expression 
To quantify gene and transcript expression we used htseq-count84 both on genes and 
exons from Flybase 6.13 genome annotation. Gene and exon expression were 
library size normalized using DESeq273. The following pipeline was the same for 
gene and exon expression measurement. We filtered expressed genes and exons as 
those with expression greater than 0 in at least half of the GDL. Gene expression 
values were gaussianized to increase power in QTL discovery. To remove batch 
effects and hidden factors in the data and increase power we used PEER69 with 10 
hidden factors. PEER is a Bayesian method that discovers hidden factors in the gene 
expression data matrix and outputs residuals that are free of those effects. Finally, 
we gaussianized the residuals and used them as inputs in the eQTL call. 
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5.4.3 - Variants filtering and population structure 
We used the variant calls from Grenier et al.93 and subsetted it to the lines we had 
gene expression data for. We used GATK109 LiftOverVcf to move the vcf coordinates 
from BDGP5 to BDGP6 assembly. We removed variants with minor allele frequency 
smaller than 5% and more than 20% missing values. Multiallelic loci were excluded. 
For each gene we defined a cis window as ±50 kb from both gene’s ends and tested 
the variants within this window for association. To better identify population structure 
we replicated the work in Grenier et al.93. Starting from the filtered vcf, as described 
above, we annotated variants based on the genomic features they overlap using 
SnpEff110. We defined neutrally evolving variants as those overlapping introns shorter 
than 65 bp. The data recapitulated the population structure seen in Grenier et al.93. 
The neutrally evolving variants were used to obtain the Kinship matrix to control for 
population structure in LIMIX. 
 
5.4.4 - gene-eQTL and exon-eQTL call with LIMIX 
To perform the eQTL call we used LIMIX67. LIMIX implements the following linear 
mixed model: 	
𝑌 = 	$𝐹&
'
&()
+	$𝑈,
-
,()
 
Where Y is the gene expression vector, F is a NxN kinship (Fixed Effect) matrix 
representing sample by sample relationship and U is the genotype vector (Unknown 
Effect). The kinship matrix is obtained by calculating the sample by sample similarity 
from neutrally evolving variants. We computed empirical p-values by permuting 
10,000 times the Y vector and obtaining a background p-value distribution. The test 
p-value was then ranked among the background p-value. The empirical p-value was 
obtained with the formula: 
𝑝<=>,6,?@A = 	
𝑅>CD@AE<
𝑁><6=EG@G,HIJ + 1
 
Where 𝑅>CD@AE<  is the rank of the test p-value when compared the permuted p-
values. 
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We considered only the lowest raw p-value association for each gene (one gene-
eQTL and one exon-eQTL per gene) and we correct the empirical p-values with 
Benjamini-Hochberg FDR using a 0.1 cutoff. If multiple variants were in linkage 
disequilibrium by showing an uncorrected p-value within one order of magnitude from 
the lowest, we consider them as belonging to an eQTL cloud. 
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IV - Impact of natural sequence variation on 
Drosophila melanogaster chromatin 
accessibility 
 
 
1 - Introduction 
 
1.1 - Non-coding variants are a major source of phenotypic variation 
Individuals from the same species share genes and follow the same developmental 
plan, but have different phenotypes. Phenotypic diversity is caused by the interaction 
of the environment (especially during development) and genetic variation. While the 
environmental cues can be measured and controlled to a certain extent, the genetic 
variants constitute an innate and hidden pool of variation.  
Although genetic variants that impact coding sequences can be interpreted based on 
the changes that they cause on protein sequence, non-coding variants provide a 
greater challenge. GWAS111,112 and QTL53,113 studies consistently reveal that the 
majority of functional variants are located in the non-coding genome. This 
phenomenon is conserved across organisms, from humans to Drosophila.  
The mechanisms through which non-coding variants lead to variation in the 
phenotype are still poorly understood. The main hypothesis is that non-coding 
variants influence the phenotype by modifying gene regulation. An example is the 
human rs11708067 variant, located in an enhancer of the gene ADCY5. The variant 
has a common G allele and a rare A allele: the A allele disrupts the enhancer 
function and causes lower expression of the gene ADCY5, that in turn leads to higher 
diabetes risk114. In addition to altering enhancer function, variants can influence gene 
expression by causing changes in chromatin topology115 and epigenetic marks52. In 
general, functional non-coding variants modify gene regulation by interfering with cis 
Regulatory Module (CRM) function. 
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1.2 - Specific activation of CRMs drives tissue development 
The non-coding genome harbors a plethora of CRMs that perform a variety of 
functions related to gene expression regulation (see “I - Introduction”). CRMs 
function by recruiting Transcription Factors to the DNA, this leads to higher chromatin 
accessibility that can be measured with many techniques, including DNAse 
hypersensitivity assay24. Recent single-cell studies116 show that the majority of CRMs 
are active only in a subset of tissues. In fact, tissue-specific features emerge 
because of precise gene regulation117 and, as a result, every cell type expresses a 
unique set of genes. Spatial gene expression specificity is achieved by the precise 
activation of CRMs. Consistent with the observation that a high proportion of CRMs 
are activated in a tissue-specific manner, the effect of many functional variants differs 
among tissues118, and is, therefore, context dependent. 
 
1.3 - Methods to predict the effect of variants on regulatory regions 
Each individual harbors millions of variants, but the vast majority of them has little to 
no effect on gene expression42. Since the regulatory code is still poorly understood, it 
is difficult to predict which variants have an effect on gene expression based solely 
on DNA sequence. In recent years, many machine learning methods have been 
developed to summarize the features of regulatory modules and have been 
successfully applied to estimate the impact of variants on chromatin accessibility. 
These methods scan the DNA sequences of CRMs and look for enrichment of 
features that distinguish them from the rest of the genome. This knowledge can then 
be used to prioritize variants for their predicted effect on CRM function. 
Machine learning approaches look either for k-mer or Position Weight Matrix (PWM) 
enrichment within regulatory sequences. For example, gkm-SVM119 is a support 
vector machine method based on k-mer enrichment while PRIME120 is a random 
forest method based on PWMs enrichment. Methods based on k-mers outperform 
those based on PWMs because they describe Transcription Factors Binding Sites 
(TFBS) in a more flexible way119. Recently, Neural network approaches have gained 
popularity because they achieve better performances than other methods on very 
large datasets. Basset121 is a neural network approach based on PWMs enrichments, 
which was successfully applied to ENCODE human data showing better performance 
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than k-mer based approaches. The main disadvantage of neural networks is that 
they require large training sets and their results are challenging to interpret. 
 
1.4 - Overview of the project 
In this project, I apply LS-GKM122, an enhanced version of gkm-SVM, to prioritize 
genetic variants for their effect on Drosophila melanogaster chromatin accessibility 
during embryogenesis. I applied a gapped k-mer support vector machine method 
(LS-GKM) developed in Michael Beer’s laboratory on a set of tissue-specific DNase 
Hypersensitive Sites (DHS). The small genome size of Drosophila proves to be a 
challenge for machine learning methods, but LS-GKM shows good performance on 
small training sets. The DHS dataset has been introduced in “II - Genetic variation as 
a tool to associate cis Regulatory Modules with their target genes”. The SVM model 
is then used to score variants for their tissue-specific effect on chromatin 
accessibility. The genetic variants analyzed here come from two different 
populations: 
• The Drosophila Genetic Reference Panel (DGRP63) is a panel of more than 
200 Drosophila melanogaster lines coming from a unique geographic 
location. The population has 6,131,648 mapped variants. 
• The Global Diversity Lines (GDL93) are a group of 80 Drosophila 
melanogaster lines from 5 continents (see also chapter “III - Gene expression 
variation among Drosophila melanogaster lines from five continents”). They 
capture genetic variation caused by geographic isolation and adaptation to 
different environments. The population has 6,752,029 mapped variants.  
The variant sets for the two populations have 2,828,011 (28%) variants in common. 
The goal of this project is to gain insights into the tissue-specific effects of variants 
and to provide a resource to the Drosophila population genetics community for 
prioritizing causal variants. 
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2 - Results 
 
 
2.1 - A machine learning approach to uncover tissue-specific 
features of chromatin accessibility 
In this work we aim to prioritize genetic variants for their predicted effect on 
chromatin accessibility to produce a resource database for the Drosophila 
community. Genetic variation can affect phenotype by altering gene regulation. In 
particular, genetic variation can alter the function of CRMs by modifying Transcription 
Factor Binding Sites (TFBS). Here we apply a gapped k-mer support vector machine 
method developed by Beer, Gandhi, Lee et al.119,123, to discover tissue-specific open 
chromatin features. These features are then used to score genetic variants for their 
predicted effect on chromatin accessibility. The entire project was developed in 
collaboration with Federica Mantica, a visiting scientist in the Furlong laboratory. 
 
2.1.1 - Identification of tissue-specific DHS 
The LS-GKM model learns features that distinguish a positive from a negative set of 
sequences. In this project, we aimed at distinguishing open from closed chromatin in 
order to score variants for their ability to increase or decrease accessibility. To 
dissect the regulatory landscape of the developing Drosophila embryo, we used the 
DNase hypersensitivity dataset generated in the Furlong laboratory by James 
Reddington and David Garfield (described in “II - Genetic variation as a tool to 
associate cis Regulatory Modules with their target genes”). The dataset offers both 
time and tissue resolution for a total of 19 samples, all in duplicates. Since the 
majority of non-coding variants has an effect only on a subset of tissues, we trained 
LS-GKM on tissue-specific DHS. This allowed us to score variants for their tissue-
specific effect on accessibility. We obtained a collection of DHS that were exclusively 
open in one of the three FACS sorted tissues in at least one of the 5 time points. 
DHS were further separated into promoter-proximal DHS (closer than 500 bp to a 
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known TSS) and promoter-distal, putative enhancers (distant more than 500 bp to a 
known TSS). In total we identify: 
• 1,466 promoter-proximal DHS and 9,658 (putative) enhancers that are 
accessible exclusively in the neuroectoderm tissue. 
• 436 promoter-proximal DHS and 2,937 (putative) enhancers that are 
accessible exclusively in the mesoderm tissue. 
• 1,105 promoter-proximal DHS and 4,811 (putative) enhancers that are 
accessible exclusively in the Double Negative (non-neuro, non-meso) tissue. 
Figure 39 shows an example of DNase hypersensitivity coverage tracks and depicts 
tissue-specific DHS. 
 
Figure 39 – Identification of tissue-specific DHS. The figure shows DNA Hypersensitivity tracks in 3 
tissues across 4 time points (from 4-6 hpf to 10-12 hpf). Colors correspond to different FACS sorted 
tissues. Blue: neuroectoderm; Red: mesoderm; Green: Double Negative. The boxes identify tissue-
specific DHS (DHS open exclusively in one tissue at least at one time points). The box color indicates in 
what tissue the DHS is exclusively accessible. Blue: neuroectoderm, red: mesoderm, green: double 
negative tissue. 
 
2.1.2 - A machine learning approach to distinguish open from closed chromatin 
In this project, we used large-scale gkm-SVM (LS-GKM122) following the pipeline 
shown in Figure 40. LS-GKM was trained using our set of tissue-specific DHS and a 
mono- and di-nucleotide matched background. LS-GKM fits an SVM model to 
separate the positive and negative sets, which can then be used to score all possible 
10mers and learn the vocabulary of the regulatory sequences, in our case, tissue-
specific motifs (as discussed in “2.3 - Enrichment of tissue-specific Transcription 
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Factors motifs”). Finally, the regulatory vocabulary can be used to score DNA 
sequences for their likelihood to belonging to DHS or inaccessible chromatin. By 
scoring sequences that incorporate the different alleles of a variant, and computing 
the difference between the two, LS-GKM outputs a deltaSVM: a score that 
summarizes the impact of the non-reference allele on chromatin accessibility. 
 
Figure 40 – gkm-SVM pipeline to train the gapped k-mer SVM model and score variants for their 
predicted effect on open chromatin (from Lee et al., Nature Genetics, 2015).  The figure shows the 
pipeline implemented in gkm-SVM. Firstly, the model is trained on a positive and a negative training set 
of sequences. The gapped k-mer weights are used to score all possible 10-mers. These scores are then 
used to assess the impact of variants on the local genomic sequence. Finally, the model provides a 
deltaSVM for each variant. If a variant has positive deltaSVM, it means that the sequence with the 
variant is more similar to the positive training set, while a negative deltaSVM means that the sequence 
with the variant is more similar to the negative training set. 
 
LS-GKM was trained on our six sets of tissue-specific DHS. For each positive set, we 
selected a background that matched the same nucleotide and di-nucleotide 
composition. The training was repeated five times with different backgrounds to 
increase the stability of the results. The background is composed of intergenic 
sequences selected to match the nucleotide and di-nucleotide composition of the 
positive set. Figure 41 shows the ROC curves from ten cross-validations of the six 
trainings. Only the ROC from the first training are shown but the results are very 
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similar across the five trainings. The Area Under the Curve (AUC) are higher for 
enhancers than for promoter-proximal DHS, probably because the enhancer sets 
include more sequences. After training the models on tissue-specific DHS, all 
variants can be scored for their tissue-specific effect on chromatin accessibility. The 
10-mers scores were averaged across the five trainings and the deltaSVM were 
computed from the averaged 10-mers scores. 
 
Figure 41 – ROC curves from 10 cross-validations of LS-GKM training. The figure shows the ROC 
curves from LS-GKM training on tissue-specific DHS divided in promoter-proximal DHS and enhancer. 
Only the results from the first training out of five performed are shown here. n: number of positive (and 
negative) sequences in the training set. AUC: Area Under the Curve. 
 
 
2.2 - Prediction of chromatin accessibility QTLs 
The genome of Drosophila melanogaster is over 25 times smaller than the one of 
human and includes far fewer CRMs. This results in a smaller amount of sequences 
that can be used for training compared to mammalian systems. To corroborate the 
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good training performance shown by the AUC (Figure 41), we tested the predictive 
power of the deltaSVM scores. Therefore, we assessed how well the deltaSVM could 
predict the direction of the effect of chromatin accessibility QTLs (caQTLs). caQTLs 
describe the associations between a genetic variant and changes in chromatin 
accessibility. Specifically, we used LS-GKM to predict the caQTLs in the eye-
antennal imaginal discs of adult Drosophila published by Jacobs et al.124. We 
identified eye-antennal imaginal discs specific DHS and trained LS-GKM on three 
sets of tissue-specific DHS: promoter-proximal DHS (1,863 sequences), enhancers 
(12,819) and all DHS (14,682). The deltaSVM scores could predict the direction of 
the caQTLs in the enhancer and all DHS, but not in the promoter-proximal DHS 
(Figure 42). The predictive power of LS-GKM is lower than for human caQTLs123. In 
addition, by analyzing the results of Lee et al.123 we observed that LS-GKM predicts 
caQTL effect on promoter-proximal DHS as well as on enhancers in human. These 
observations could be caused by the smaller amount of sequences used in training 
because of the smaller Drosophila genome size.   
We repeated the analysis by training LS-GKM on all (tissue and non-tissue-specific) 
ATAC-Seq peaks (9,049 promoter-proximal, 21,725 enhancer and 30,774 all DHS) 
obtaining very comparable results to the eye-antennal imaginal disc specific set. This 
confirmed that it is possible to train LS-GKM on a subset of sequences and use the 
model to score variants not included in the training set. 
 
Figure 42 – Prediction of caQTL direction of effect. The plot shows the correlation between caQTL 
Pearson r and deltaSVM for the causal variant. The ATAC-Seq peaks from Jacobs et al.124 were divided 
in promoter-proximal and distal. Only the ATAC-Seq peaks that did not overlap any embryonic DHS or 
coding region were used in the training set. The “ALL” category includes both promoter-proximal and 
enhancer peaks.  
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2.3 - Enrichment of tissue-specific Transcription Factors 
motifs 
LS-GKM learns the regulatory motifs enriched in CRMs by scoring gapped k-mers for 
their likelihood of belonging to CRMs or not. After training the model, we can retrieve 
SVM weights for all ungapped 10-mers. This set is composed of short sequences 
that distinguish CRMs from background DNA. LS-GKM was trained on 6 sets of 
sequences belonging to: neuroectoderm, mesoderm and Double Negative tissue 
divided in promoter-proximal and enhancer DHS. To retrieve the regulatory features 
of each set of sequence, we looked for PWMs enrichments within the scored 10-
mers.  
Figure 43 shows enrichment scores for many regulatory TFs across the training sets. 
Erect wings (Ewg) is a transcription factor involved in synaptic growth125 whose motif 
was strongly enriched within the top k-mers of the neural tissue. The mesoderm 
shows strong enrichment of many known regulators of muscle development. Mef2 is 
an essential regulator of muscle differentiation, being required for all muscle types126 
and its motif is strongly enriched in both promoter-proximal DHS and enhancers 
exclusive to the mesodermal tissue. In the same way, motifs for the transcription 
factors Biniou (necessary for visceral mesoderm development) and Tinman (required 
for dorsal somatic muscles and heart formation) are both strongly enriched in the 
mesoderm. Finally, the Double Negative tissue represents a pool of tissues 
dominated by ectoderm and endoderm. The motif for GATAe (a TF required for 
endoderm development127) is enriched in the Double Negative tissue together with 
grainy head, a regulator of epithelial development128. 
The majority of PWMs had similar enrichment patterns in promoter-proximal DHS 
and enhancers, with some exceptions. For example, Ewg enrichment was stronger in 
promoter-proximal DHS, suggesting a direct regulation of transcription at the 
promoter level. On the other hand, Hairy and Tinman motifs showed a stronger 
enrichment in enhancers, suggesting that they mainly function by binding to promoter 
distal elements. In fact, Tinman regulates heart formation by specifically binding to 
enhancer regions129. In addition, almost all TFs are specifically enriched in one 
tissue. One exception is Sloppy paired 1 (Slp1) that is weakly enriched in all 
promoter-proximal tissues. Slp1 is expressed across tissues during development and 
it mainly represses gene expression by binding at the promoter of target genes as a 
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cofactor of Hox proteins130. Taken together these results speak for the high quality of 
our DHS dataset and prove that LS-GKM can unbiasedly learn tissue-specific motif 
features. 
 
Figure 43 – Motif enrichment within the k-mers from the 6 conditions. The plot shows the median 
score of k-mers matching Transcription Factors PWMs. Positive values indicate that k-mers that match 
the PWM are associated with the positive training set. For example, the top k-mers in the mesoderm 
tissue match the Mef2 PWM well, but the same PWM is not found in the top k-mers of neuroectoderm 
and Double Negative tissue. The enrichment scores correspond to the median LS-GKM score of the top 
10-mers matching each PWM, scaled by the range of the distribution. Enrichment score can range 
between -1 and 1. P: promoter-proximal DHS; E: enhancer. Ewg: Erect wing; Mef2: Myocyte enhancer 
factor 2; Bin: Binou; Fd64A: Forkhead box L1; Slp1: Sloppy paired 1; Tin: Tinman; Grh: Grainy head; H: 
Hairy; Ttk: Tramtrack; Twi: Twist. 
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2.4 - deltaSVM scores give insight into the impact of variants 
on chromatin accessibility 
LS-GKM provides deltaSVM scores that correspond to the likelihood of the non-
reference allele to increase or decrease chromatin accessibility. These scores 
represent a useful resource to prioritize variants that are more likely to have an 
impact on accessibility and to predict the direction of the effect. In this section, I will 
discuss how deltaSVM scores can provide global information about the impact of 
variants on accessibility.  
 
2.4.1 - Variants in enhancers have a larger impact compared to promoter-
proximal DHS 
The deltaSVM scores follow a normal distribution: variants with high absolute 
deltaSVM values are more likely to have an effect on chromatin accessibility 
(Supplementary Figure 6). The distribution of deltaSVM is shifted towards negative 
values indicating that non-reference variants are more likely to reduce accessibility. 
In addition, promoter-proximal DHS and enhancers have very different deltaSVM 
ranges, with the distribution on enhancers being two times broader than on promoter-
proximal DHS. This observation suggests that enhancer variants have a larger effect 
on accessibility, while promoter-proximal DHS are more robust to variation. 
 
2.4.2 - Rare variants have a larger impact on chromatin accessibility 
By combining the allele frequency and deltaSVM information, we observe that rare 
variants have larger absolute deltaSVM values. Figure 44 shows the comparison of 
deltaSVM scores between rare and common variants. Rare variants, within the 
DGRP population, were identified as having a non-reference frequency smaller than 
0.01; common variants had a non-reference allele frequency greater than 0.5. In all 
cases, rare variants had higher deltaSVM than common variants, except for the 
mesodermal promoter-proximal DHS (the training condition with the smallest positive 
set and lowest AUC). Rare variants were previously observed to have larger 
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effects131, and therefore it was suggested that they are more likely to be under 
negative selection. In conclusion, the deltaSVM scores indicate that enhancer 
variants generally have larger effects compared to variants in promoter-proximal 
DHS, with rare variants have larger impact on chromatin accessibility compared to 
common variants. 
 
Figure 44 – Rare variants have a larger impact on chromatin accessibility. The plot compares the 
distribution of absolute deltaSVM between rare and common variants. The absolute deltaSVM scores 
are divided by tissue and promoter-proximal DHS and enhancer. The number comparing the 
distributions corresponds to the Wilcoxon p-value. Rare variants have a non-reference allele frequency 
smaller than 0.01 while common variants have a non-reference allele frequency greater than 0.5. 
 
2.4.3 - Many variants have tissue-specific effects 
deltaSVM scores can be visualized and compared across tissues (Figure 45). The 
heatmap shows the deltaSVM across tissues for the 1,000 variants with the highest 
scores, each row represents a variant. Promoter-proximal DHS show variable scores 
across tissues, with many variants having tissue-specific effects: a high score is 
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observed in one tissue and a near zero score in other tissues. There are a few 
examples of discordant scores at the top and at the bottom of the heatmap. 
Enhancers show more uniform behavior with roughly 60% (top of the heatmap) of the 
variants behaving in the same way across tissues. The remaining 40% (bottom of the 
heatmap) have discordant behaviors across tissues. The latter cases are especially 
interesting to examine because they provide examples of variants increasing 
accessibility in one tissue and decreasing it in another.  
The high variability of deltaSVM scores between tissues for the promoter-proximal 
DHS is unexpected given that promoters tend to function in a constitutive way. It is 
important to notice that the heatmap only shows the 1,000 variants with the highest 
deltaSVM scores out of 342,760 scored variants within enhancers and 193,554 
variants within promoter-proximal DHS. At the global level, deltaSVM scores have 
higher correlation across tissues in promoter-proximal DHS (Person correlation 
between deltaSVM scores of the three tissues range between 0.83 and 0.93) than in 
enhancers (Pearson correlation between deltaSVM scores of the three tissues range 
between 0.08 and 0.29). This indicates that globally variants on enhancers tend to 
act more often in a tissue-specific way than on promoter-proximal DHS. 
 
Figure 45 – Heatmap of tissue-specific variant scores divided by promoter-proximal DHS and 
enhancers. The heatmaps report the top 1,000 variants with highest deltaSVM scores for promoter-
proximal DHS and enhancers (the variants are not the same across the two heatmaps). Heatmap colors 
correspond to deltaSVM values.   
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2.5 - Merging of variant calls from different populations 
To provide a unified set of variant scores, we merged the variant calls (vcf files92) for 
the DGRP and GDL. When considering both variant files, 72% of variants are 
uniquely called in one of the vcf files, while the remaining 28% are common between 
the two panels. Specifically, the DGRP vcf includes 6,131,648 variants and the GDL 
vcf includes 6,752,029 variants, 2,828,011 of which are in common. The vcf files 
were merged using two strategies: 
• All variants from the two files were merged. If a variant was genotyped only in 
one file, we assumed that all lines in the other file were harboring the 
reference allele. 
• Only the variants genotyped in both vcf files were joined. 
The first strategy does not cause any loss of data but it assumes the genotype for 
72% of the variants. The assumption would hold true only if the vcf files were 
including all true positive variants. The second strategy is more conservative and 
does not require any assumption, but it causes a significant loss of data. 
To assess the quality of the two merged vcf files, we retrieved the population 
structure of the lines from them. Following the protocol in Grenier et al.93, we 
performed a PCA on neutrally evolving variants selected from the two merged vcf 
files. The expected clustering of the 5 populations within the GDL is shown in Figure 
30 from Grenier et al.93. In addition, the DGRP population should cluster with the 
Ithaca population, given their common origin in the same geographic location.  
I then performed a PCA using the merged vcf file containing all variants and 
assuming reference genotypes (Figure 46, top) and the merged vcf file including only 
variants genotyped in both original vcf files (Figure 46, bottom). The top plots show a 
strong separation between the DGRP and the GDL lines, only the second PC 
separates the Zimbabwe lines from the others. This indicates that the assumption 
that ungenotyped variants are similar to the reference allele biases the results by 
including an incorrect structure in the data, meaning that both vcf files are missing 
variants within the populations. The bottom plots show the expected separation 
between populations: the first PC splits the Zimbabwe lines and the second one the 
Beijing lines. The DGRP lines cluster with the Ithaca as expected. 
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Taken together these results show that it is not possible to merge all variants from 
two separate vcf files without performing a de novo genotyping. Following this result, 
we provided separate deltaSVM scored for the DGRP and GDL vcf files. 
 
Figure 46 – Merging vcf files from two different populations. Principal Component Analysis of 
variants from two independent vcf files. The two populations are the GDL and DGRP. (a) The plots 
show the results of merging all variants from the two vcf files. When a variant is genotyped only in one 
file, it is assumed that the other file has a reference allele. The first PC separates the DGRP lines from 
the GDL showing strong batch effects. (b) The plots show the results of merging only the variants 
genotyped in both vcf files. The first PC clearly separates the Zimbabwe lines as in Grenier et al.93, the 
third separates the Beijing lines. The DGRP lines cluster with the Ithaca lines that come from the same 
geographic location.  
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3 - Perspectives 
LS-GKM is able to learn tissue-specific features and can predict the effect of variants 
on chromatin accessibility. We are currently performing two experiments to validate 
the predictions of LS-GKM. In addition, we hope to set meaningful cutoffs for the 
deltaSVM scores, that correspond to a high chance of differential accessibility. In 
particular, we are performing tissue-specific ATAC-Seq to measure accessibility and 
SuRe to quantify promoter and enhancer function. 
 
3.1 Tissue-specific ATAC-Seq 
ATAC-Seq will be performed for two DGRP lines (DGRP-57 and DGRP-714) to 
validate the deltaSVM scores in vivo. This experiment is currently being performed in 
collaboration with Rebecca Rodrigues Viales from the Furlong laboratory. We 
collected DGRP-57 and DGRP-714 embryos staged at 10-12h and FACS-sorted the 
cells with the same procedure as for the DNase hypersensitivity assay (see “II - 
Genetic variation as a tool to associate cis Regulatory Modules with their target 
genes: 5.2.1 - DHS identification”). ATAC-seq is currently being performed on sorted 
populations of muscle and neuronal cells in both genetic backgrounds. After 
identifying differentially accessible peaks, I will compare the differential accessibility 
between the two lines with the deltaSVM scores predicted by LS-GKM. 
 
3.2 SuRe to measure variants impact on CRM function 
CRMs exert their function by recruiting Transcription Factors to the DNA. In this 
project, we used chromatin accessibility as a proxy for TF binding. By measuring TF 
binding, chromatin accessibility also correlates with CRM activity. A more direct way 
to assess promoter and enhancer activity78 is by quantifying self-transcription. SuRe 
is an in vitro technique capable of measuring self-transcription genome-wide in the 
chosen cell line20. We are currently performing SuRe in Drosophila Kc cells on 
genomic fragments from 6 DGRP and 6 GDL lines to measure differential activity of 
promoters and enhancers genome wide. This experiment is currently being 
performed in collaboration with Matteo Perino from the Furlong laboratory and Ludo 
Pagie and Marcel De Haas from the laboratory of Bas van Steensel. We plan to 
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measure differential activity across the genomic DNA for the two lines and identify 
the causal variants. We will then compare differential activity with the deltaSVM 
scores.  
 
  
IV - Impact of natural sequence variation on Drosophila melanogaster chromatin accessibility 
 
 
116 
4 - Discussion 
 
LS-GKM is an effective method to capture the predictive regulatory motifs of 
Drosophila melanogaster’s cis-regulatory elements. We identified tissue-specific 
DHS and separated them into promoter-proximal and promoter-distal (putative 
enhancer elements) for a total of six training sets. LS-GKM shows good performance 
on the small training sets provided in this study. After training the model on tissue-
specific DHS, we could retrieve the expected motifs for transcription factors that are 
important regulators in the relevant tissues. deltaSVM scores also provide insights 
into functional effect of variants on accessibility. We observed that variants have 
larger predicted effects on enhancers compared to promoter-proximal accessibility. 
In addition, rare variants have a larger effect on accessibility compared to common 
variants. 
In order to increase the relevance and usefulness of this resource, we will further 
validate the deltaSVM scores. We are currently performing tissue-specific ATAC-Seq 
on two DGRP lines to directly correlate deltaSVM scores with accessibility measures. 
We hope to identify a cutoff for deltaSVM scores over which the variants are very 
likely to have an effect on accessibility. The caQTL validation suggests that this is 
possible. In fact, Figure 42 shows that all deltaSVM scores with an absolute value 
larger than 6 correctly predict the direction of the caQTL. We will also try to assess 
the specificity and sensitivity of the deltaSVM scores. Finally, we will test if deltaSVM 
scores can predict promoter and enhancer activity measured by SuRe-seq. 
Predicting enhancer and promoter function will represent a greater challenge than 
predicting accessibility. In fact, deltaSVM scores are poor predictors of gene 
expression. Previous observation estimate that in roughly 30% of the cases 
accessibility and gene expression are negatively correlated123 suggesting that about 
30% of CRMs have a negative effect on transcription and might represent silencers. 
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117 
5 - Methods 
 
5.1 - LS-GKM training 
LS-GKM is a machine learning approach that can classify DNA sequences. The 
training is a crucial step that requires a careful selection of positive and negative 
(background) sequences. In this section, I will discuss the steps that were taken to 
train and assess the model. The pipeline is summarized in  Figure 40. 
 
5.1.1 - Identification of tissue-specific DHS  
The tissue-specific DHS were identified following the pipeline in “II - Genetic variation 
as a tool to associate cis Regulatory Modules with their target genes: 5.2.3 - Tissue-
specific DHS” independently for all time points (4-6 hpf, 6-8 hpf, 8-10 hpf, 10-12 hpf). 
If a DHS was defined as tissue-specific in one time point, then it was considered as 
being tissue-specific. DHS were then separated in promoter-proximal DHS and 
enhancers based on vicinity to TSS annotated in Flybase 6.13. If a DHS was closer 
than 500 bp to a known TSS it was annotated as promoter-proximal, otherwise, it 
was annotated as an enhancer. 
 
5.1.2 - Positive set  
We obtained the DHS sequences from BDGP6 genome assembly using bedtools88 
getfasta. We excluded the DHS that contained missing nucleotides (Ns) because 
they are not handled by LS-GKM. The DHS were divided into six sets corresponding 
to neuroectoderm promoter-proximal, neuroectoderm enhancer, mesoderm 
promoter-proximal, mesoderm enhancer, Double Negative promoter-proximal and 
Double Negative enhancer. 
 
IV - Impact of natural sequence variation on Drosophila melanogaster chromatin accessibility 
 
 
118 
5.1.3 - Negative set selection 
For each positive set, we selected five negative sets, each including the same 
number of sequences as the positive set. We removed known exon sequences and 
DHS from the BDGP6 Drosophila genome assembly and tiled the remaining genome 
in sequences of 300 bp. To match the sequence composition and increase the 
complexity of the most discriminative k-mers, we used the R package MatchIt132. 
MatchIt was employed so that the background sequence would match the nucleotide 
and di-nucleotide composition of the positive set. For each positive set, we selected 
five times more sequences from the non-exon non-DHS tiles that best matched the 
positive set. The matched sequences were then randomly divided in five batches to 
form five independent negative sets.  
 
5.1.4 - LS-GKM training 
We downloaded LS-GKM122 from GitHub (https://github.com/Dongwon-Lee/lsgkm/). 
Five independent replicate trainings were performed for each of the six DHS set 
using different background sequences. We ran LS-GKM with the options “-t 2 -l 10 -k 
6” to use gapped k-mers of total length 10 with 4 gaps. LS-GKM can be set to give 
more relevance to the k-mers in the center of the sequence. While this feature is 
valuable for ChIP-Seq data, we noticed a reduction of performance when using it 
with DHS data. Our pipeline was then run without this option (corresponding to “-t 2”). 
We performed 10 cross-validations for each independent training. LS-GKM performs 
cross-validations by excluding a random 10% of the positive and negative sequences 
form the training.  
All unique 10-mers were generated using nrkmers.py script provided with LS-GKM. 
We assigned SVM weights to k-mers using gkmpredic. We obtained final k-mer 
scores by averaging the scores across the 5 replicates. 
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5.2 - Variants scoring 
We analyzed variants from two independent populations: the Global Diversity Lines93 
(GDL) and Drosophila Genetic Reference Panel63 (DGRP). The variants overlapping 
a DHS were divided into two groups, depending if the DHS was promoter-proximal or 
enhancer. deltaSVM scores were computed using deltasvm.pl from LS-GKM 
package for the six trainings. Each variant overlapping a DHS was then associated to 
three deltaSVM scores corresponding to the tissue-specific effect on chromatin 
accessibility.  
We also computed DHS level scores for each line by summing the deltaSVM at the 
variant level. Delta SVM scores are computed by comparing the alternative allele to 
the reference allele: variants that have the reference allele have a deltaSVM of 0. 
Unknown genotypes were imputed by averaging the deltaSVM at the population 
level. For heterozygous variants, we averaged the deltaSVM of the parental alleles. 
The DHS level scores have proven to be less predictive than using the top score 
variant for the caQTL validation (“2.2 - Prediction of chromatin accessibility QTLs”). 
We will further test this approach to predict the tissue-specific ATAC-Seq and SuRe-
Seq data.  
 
 
5.3 - Validation of caQTLs 
We received the ATAC-Seq peaks and caQTL files described in Jacobs et al.124 from 
the laboratory of Stein Aerts. The coordinates were moved from BDGP5 to BDGP6 
using liftOver. The ATAC-Seq peaks overlapping embryonic DHS or exons were 
excluded. A total of 14,682 eye-antennal imaginal disc specific ATAC-Seq peaks 
were used in the training. We then obtained the three positive sets: all peaks, 
promoter-proximal peaks and enhancers (following as in “5.1.2 - Positive set”). The 
background sequences were selected following “5.1.3 - Negative set selection” with 
tiles of length 455 bp, corresponding to the median length of the ATAC-seq peaks. 
The training was performed for the three training sets separately following the same 
procedure as in “5.1.4 - LS-GKM training”. Finally, we scored the DGRP variants 
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using the three LS-GKM model trained on the eye-antennal imaginal disc specific 
ATAC-Seq peaks. Each variant was assigned two scores corresponding: either 
promoter-proximal or enhancer and all DHS. 
Jacobs et al.124 identify 4,288 caQTLs on 2,048 unique ATAC peaks and report the 
GLM fit statistics. We repeated the caQTL fit with a simple linear regression and 
used the Pearson r as a measure of direction and size of the QTL effect. If more 
caQTLs were overlapping the same peak they were excluded, since it was not 
possible to discriminate the causal variant. caQTLs with low effect size were 
excluded from the correlation (p-value > 0.01 or Pearson r < 0.5). We then performed 
three correlations between the three training sets scores and the corresponding 
caQTL Pearson r. 
 
 
5.4 - Identification of TF motifs enrichment from k-mers 
The enrichment plots in Figure 45 were obtained by comparing the distribution of the 
top matching k-mers best matching to the PWM to the global k-mers distribution. We 
collected a total of 1,796 high quality motifs for Drosophila from the following 
sources: 
• CIS-BP database133 (downloaded on 20 June 2018) 
• Fly Factor Survey (downloaded on 20 June 2018) 
• Jaspar Core134 Insecta (downloaded on 20 June 2018) 
• On the Fly135 (downloaded on 20 June 2018) 
• de novo motif call performed by Olga Sigalova in the Furlong laboratory from 
ModERN ChIP-Seq database136. 
• High quality mesodermal Transcription Factor motifs from ChIP-chip 
experiments (Zinzen et al.27) 
• Grainy head motif from Yao et al.137 
We matched each motif with all 10-mers (obtained in “5.1.4 - LS-GKM training”) 
using R Biostrings package138. Each motif was associated with the top 100 k-mers 
having a match score of at least 0.8. The k-mer enrichment score was obtained by 
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subtracting the median SVM weight of all the k-mer from the median SVM weight of 
matched k-mers, scaled by half of the range of the k-mer SVM weight: 
 
𝑚𝑒𝑑𝑖𝑎𝑛(𝑆𝑉𝑀=@G?V<W) 	− 	𝑚𝑒𝑑𝑖𝑎𝑛(𝑆𝑉𝑀@AA)
𝑚𝑎𝑥(𝑆𝑉𝑀@AA) 	− 	𝑚𝑖𝑛(𝑆𝑉𝑀@AA)
	× 2 
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 V - Conclusions 
 
In this thesis, I have presented three projects developed during my Ph.D. They are 
complementary since they each explore the relationship between the effects of 
natural sequence variation on the regulation of gene expression during Drosophila 
melanogaster embryonic development. 
In the first project, we built on the eQTL framework to specifically associate CRMs 
(using DNase hypersensitivity as a proxy) with their target genes. I identified 2,967 
DHS-eQTLs and in particular 2,005 promoter-proximal DHS to gene associations 
and 962 enhancers to gene associations. This represents, to my knowledge, the 
largest functional CRM-to-gene map in Drosophila. We validated the results in silico 
by enrichment of eQTL signal on DHS, enrichment of tissue concordance between 
DHS and target genes and Hi-C contact enrichment, and experimentally by RT-
qPCR. The results show extensive CRM sharing between genes. We also observe 
frequent long range gene regulation from both enhancers and promoter-proximal 
DHS. It will be crucial to assess if the promoter-proximal distal activity is classic cis 
regulation or if it can be attributed to trans effects. The predicted function of the 
regulated genes does not suggest that genes close to promoter-proximal DHS with 
distal activity are enriched for transcription factors. The ongoing CRISPR deletions of 
a number of selected promoter-proximal DHS-QTLs should shed light on this issue, 
especially if analyzed in an F1 context. 
In the second project, we performed RNA-Seq on 80 samples from the Global 
Diversity Lines, which were collected at 10-12 hpf of embryogenesis. We performed 
multiple quality-control tests to ensure that the gene expression dataset is of high 
quality. The GDL come from five continents and show transcriptional diversity. In 
particular, the African population is the most separated, confirming the observations 
at the genetic level while the lines of European descent have similar transcriptomes. 
The Netherlands lines overexpress genes involved in the cuticle formation at 10-12 
hpf, indicating an adaptation to the environment. I used this data to perform and 
eQTL analysis, which identified 903 gene and 2,021 exon eQTLs. This is, to my 
knowledge, the first map of splicing related eQTLs in Drosophila development. 
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In the third project, we applied LS-GKM (an SVM approach based on gapped k-
mers) to score variants for their predicted impact on chromatin accessibility. We 
trained LS-GKM on six tissue-specific training sets: neuroectodermal, mesodermal 
and double negative DHS divided in promoter-proximal and promoter-distal. The 
method shows very good performance despite the small training sets. We could 
retrieve tissue-specific TFBS from the scored k-mers validating the training. We then 
scored the genetic variants from the DGRP and GDL populations to provide the 
population genetics community with a resource for variant prioritization. Rare variants 
generally show higher absolute deltaSVM scores indicating a larger impact on 
chromatin accessibility. To confirm these results, and thereby increase the usability 
of this resource, we are performing tissue-specific ATAC-Seq on two DGRP lines. 
This will enable us to assess LS-GKM predictions and associate the deltaSVM 
scores with a measure of statistical confidence.  The resulting resource will then 
provide predictions for the functional impact of genetic variants on open chromatin 
(i.e. on enhancer and promoter occupancy).   
In summary, my Ph.D. has used population genetics as a tool to assign a function to 
regulatory elements at different levels.  First, by dissecting the functional impact of 
genetic variants on open-chromatin at enhancers and promoters (Chapter IV), by 
analyzing transcriptional diversity among flies from five continents (Chapter III), and 
then by functionally linking enhancers and promoter-proximal elements to their target 
genes (Chapter II), while uncovering an unexpected level of complexity and distal 
regulation, and potential enhancer sharing.  
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1 - Supplementary Figures 
 
 
 
Supplementary Figure 1 – eQTL distribution around target genes. The plot shows the distribution of 
different types of eQTLs around their target genes. From top to bottom and from left to right: LIMIX 
eQTLs on the entire cis window; LIMIX eQTLs on DHS; TW-eQTLs; DHS-eQTLs. TSS: Transcription 
Start Site, TES: Transcription End Site. 
0
100
200
300
400
500
-50Kb TSS TES +50Kb
Position of eQTL to gene
Co
un
ts
0
250
500
750
-50Kb TSS TES +50Kb
Position of TW-eQTL to gene
Co
un
ts
0
100
200
300
-50Kb TSS TES +50Kb
Position of eQTL to gene
Co
un
ts
0
50
100
150
200
-50Kb TSS TES +50Kb
Position of DHS−eQTL to gene
Co
un
ts
Entire cis window Only DHS within cis window
un
i-v
ar
ia
te
 te
st
m
ul
ti-
va
ria
te
 te
st
a b
c d
VI - Appendix 
 
 
126 
 
Supplementary Figure 2 - qqplots for different eQTL methods and tests. The quantile-quantile plots 
are shown by black points. The expected p-value distributions are shown as a solid black line with ±95% 
confidence intervals as dashed lines. 
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Supplementary Figure 3 -  Number of variants on DHS-eQTLs significant for mtSet and LIMIX. 
 
 
 
 
Supplementary Figure 4 – Number of variants and PCs necessary to explain them on DHS and 
Tiling Windows. (a) Number of variants (b) Number of Principal Components. DHS are shown in green 
while TW in yellow. 
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Supplementary Figure 5 – qPCR setup. (a) The plots show the distribution of gene expression values 
for promoter-proximal-eQTLs target genes divided by Maj and min alleles (based on the lowest p-value 
variant in the DHS). Two lines (one with the Maj, the other with the min allele) have been selected for 
RT-qPCR testing. The selected lines are indicated with an arrow. (b) Same as in (a) but for enhancer-
eQTLs. (c) Gene expression measured with RT-qPCR for the lines and the genes involved in promoter-
proximal-eQTLs indicated in (a). (d) Gene expression measured with RT-qPCR for the lines and the 
genes involved in enhancer-eQTLs indicated in (b). 
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Supplementary Figure 6 – Distribution of deltaSVM scores in 6 conditions. The figure shows the 
distribution of deltaSVM scores across the six training sets. 
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Supplementary Figure 7 – GDL gene-eQTL and exon-eQTL qqplots. (a) qqplot for gene-eQTLs 
called on the Global Diversity Lines. (b) qqplot for the exon-eQTLs. 
a b
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Supplementary Figure 8 – PCA for batch effects on the Global Diversity Lines RNA-Seq. PCA of 
GDL samples. All plots show the first three Principal Components. The points represent samples and 
are colored to distinguish potential sources of batch effects. 
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2 - Supplementary Tables 
 
 
Table 1 – Tissue-specific numbers for enhancer-eQTLs. 
enhancer-eQTLs DHS-eQTL 
Number 
of DHS 
Characterized 
enhancers 
Number 
of target 
genes 
Same gene 
/ assigned 
 6-8h 
Neuro 55 44 10 50 0 / 2 
Mesoderm 4 4 2 4 0 / 1 
Double 
Negative 23 21 2 23 1 / 4 
Multiple / 
all tissues 880 819 123 625 13 / 52 
10-12h 
Neuro 157 142 33 135 2 / 8 
Mesoderm 40 38 5 37 1 / 3 
Double 
Negative 78 68 5 70 0 / 4 
Multiple / 
all tissues 687 640 94 514 12 / 45 
 
 
 
 
 
 
 
 
 
 
 
   
133 
Table 2 – Enhancers associated to two genes.  
enhancers associated to 2 
genes 
Gene expression 
correlation 
BDGP concordance  
perfect / overlap / all 
58 34 2 / 4 / 4 
 
 
 
Table 3 – Promoter-proximal DHS and relationship with the target gene TSS. 
Number of 
targets for 
promoter-
proximal DHS 
Closest 
TSS Distal TSS 1 Distal TSS 2 
Gene 
expression 
correlation 
BDGP 
concordance 
perfect / 
overlap / all 
1 615     
1  1004    
2 96  56 8 / 19 / 19 
2  77 57 2 / 11 / 11 
 
 
 
 
 
 
 
 
VI - Appendix 
 
 
134 
Table 4 – BDGP expression tissue to FACS sorted tissue 
BDGP general tissue term FACS sorted tissues 
Maternal none 
Ubiquitous Neuro / Meso / Double Negative 
Gonad pole cells Double Negative 
Blastoderm Double Negative 
Mesoderm derivatives Meso 
Gut Double Negative 
Ectoderm Double Negative 
Nervous System Neuro 
Malphyngian tubule Double Negative 
Tracheal system Double Negative 
No staining none 
Sense organs ambiguous 
Amnioserosa Double Negative 
Hemolymph Double Negative 
Fat body Double Negative 
Mesectoderm ambiguous 
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3 - List of abbreviations 
 
 
ATAC-Seq  Assay for Transposase Accessible Chromatin Sequencing 
AUC   Area Under the Curve 
BAM   Binary Alignment Map 
BDGP   Berkeley Drosophila Genome Project 
BED   Browser Extensible Data 
CAGE   Cap Analysis Gene Expression 
ChIP-Seq  Chromatin immunoprecipitation and sequencing 
CRISPR  Clustered Regularly Interspaced Short Palindromic Repeats 
CRM   cis Regulatory Module 
DGRP   Drosophila Genetic Reference Panel 
DNA   Deoxyribonucleic Acid 
DNase I  Deoxyribonuclease I 
DHS  DNase Hypersensitive Site 
DPE   Downstream Promoter Element 
DRE   DNA Recognition Motif 
FACS   Fluorescence-Activated Cell Sorting 
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FDR   False Discovery Rate 
GDL   Global Diversity Lines 
GO    Gene Ontology 
GWAS   Genome Wide Association Studies 
Hi-C   High-throughput chromosome conformation capture 
hpf   hours post fertilization 
IDR   Irreproducible Discovery Rate 
LD   Linkage Disequilibrium 
LIMIX   Linear mixed model 
LS-GKM  Large Sample gapped k-mer support vector machine 
mtSet   multi trait Set test 
MQ    Mapping Quality 
pA   polyadenylation 
PCA   Principal Component Analysis 
PEER   Probabilistic Estimation of Expression Residuals 
PIC   Pre-Initiation Complex 
PRO-Seq  Precision nuclear Run-On Sequencing 
PWM   Position Weight Matrix 
QTL   Quantitative Trait Locus 
3 - List of abbreviations 
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eQTL  expression QTL 
caQTL  chromatin accessibility QTL 
hQTL  histone QTL 
DHS-eQTL DNase Hypersensitivity expression QTL 
TW-eQTL Tiling Window expression QTL 
RNA   Ribonucleic Acid 
mRNA  messenger RNA 
rRNA  ribosomal RNA 
RNA-Seq  RNA Sequencing 
RT-qPCR  Real Time quantitative Polymerase Chain Reaction  
SAM   Sequence Alignment Map 
STAR    Spliced Transcripts Alignment to a Reference  
STARR-Seq  Self-transcribing active regulatory region sequencing 
SuRe   Survey of Regulatory Elements 
TAD   Topologically Associating Domain 
TF   Transcription Factor 
 TFBS  Transcription Factor Binding Site 
TSS   Transcription Start Site 
VCF   Variance Call File 
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